data_2kmq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kmq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 CA--C 1.537 0.66 0 CA-C-O 121.993 0.747 . . . . 0.0 113.26 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.42 172.5 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.324 2.25 . . . . 0.0 111.709 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.8 t -111.5 118.92 37.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.821 1.248 . . . . 0.0 111.364 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.57 169.69 49.67 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 122.581 1.1 . . . . 0.0 112.479 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 t -79.16 -6.75 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.875 1.27 . . . . 0.0 111.5 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.24 -12.29 58.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.879 1.271 . . . . 0.0 112.412 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.44 30.97 17.57 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.178 1.37 . . . . 0.0 114.543 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -127.22 155.67 43.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.424 2.29 . . . . 0.0 110.067 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.9 m -82.52 140.49 33.29 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.538 1.535 . . . . 0.0 112.261 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -137.24 142.38 42.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.115 1.766 . . . . 0.0 110.706 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.09 -26.54 68.34 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.56 173.24 17.17 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.655 1.582 . . . . 0.0 111.784 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -59.08 -32.86 70.18 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.422 1.089 . . . . 0.0 113.241 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.4 m -54.76 -33.73 61.67 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.484 1.514 . . . . 0.0 113.506 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mm -81.21 -48.23 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.196 1.398 . . . . 0.0 110.649 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.48 -44.71 65.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.471 1.108 . . . . 0.0 110.29 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -59.78 -44.74 93.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.834 1.253 . . . . 0.0 112.396 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.43 -10.29 49.89 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.85 2.11 29.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.014 1.726 . . . . 0.0 112.133 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 6.13 88.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.838 1.685 . . . . 0.0 115.041 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.45 162.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.395 2.278 . . . . 0.0 109.223 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.9 p -119.0 155.86 30.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.96 171.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.08 140.13 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.114 -0.991 . . . . 0.0 110.519 174.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -125.42 -61.54 1.26 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.618 1.567 . . . . 0.0 109.897 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -134.62 173.51 11.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.819 1.248 . . . . 0.0 112.312 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -104.91 165.88 10.77 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.166 2.586 . . . . 0.0 112.951 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.22 166.61 6.0 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.146 1.831 . . . . 0.0 113.823 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.8 t -60.96 127.09 29.89 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.466 -1.02 . . . . 0.0 110.232 168.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.833 0 C-N-CA 124.003 0.921 . . . . 0.0 111.306 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 CA--C 1.538 0.699 0 CA-C-O 122.056 0.774 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.4 176.2 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.747 2.419 . . . . 0.0 111.538 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -119.65 119.75 34.63 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.694 1.597 . . . . 0.0 111.226 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.79 168.17 47.13 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.511 1.062 . . . . 0.0 112.268 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -74.42 -11.23 60.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.784 1.634 . . . . 0.0 112.036 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -78.76 -12.53 60.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.46 1.504 . . . . 0.0 112.157 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.68 30.82 17.26 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.287 1.423 . . . . 0.0 114.437 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -129.27 151.96 49.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.568 2.347 . . . . 0.0 110.344 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -80.37 140.42 36.07 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.624 1.57 . . . . 0.0 112.44 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -134.77 146.74 49.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.552 1.941 . . . . 0.0 110.985 172.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -22.74 67.05 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -158.62 171.05 20.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.255 1.422 . . . . 0.0 111.307 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -56.47 -35.64 68.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.823 1.249 . . . . 0.0 113.109 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.8 m -61.2 -27.65 68.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.828 1.251 . . . . 0.0 113.188 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 mm -84.56 -47.7 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.95 1.7 . . . . 0.0 110.261 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.24 -42.96 61.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.64 1.176 . . . . 0.0 111.031 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.05 -41.43 99.47 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.421 1.088 . . . . 0.0 112.637 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -67.65 -18.27 64.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -101.55 -1.83 32.0 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.818 1.647 . . . . 0.0 112.425 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.48 11.42 59.52 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.58 1.562 . . . . 0.0 115.639 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -101.63 169.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.594 2.358 . . . . 0.0 108.942 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.4 p -126.2 156.19 40.6 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.306 -1.496 . . . . 0.0 110.471 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.39 136.74 25.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 O-C-N 120.651 -1.281 . . . . 0.0 111.322 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -116.5 -58.58 2.07 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.358 1.463 . . . . 0.0 109.832 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -135.46 143.2 45.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.206 1.402 . . . . 0.0 112.282 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.56 166.14 24.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.726 1.61 . . . . 0.0 112.711 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 159.52 6.41 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.319 1.914 . . . . 0.0 113.641 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -60.4 131.35 50.49 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.063 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.55 0.95 0 C-N-CA 123.476 0.71 . . . . 0.0 111.622 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 CA-C-O 121.811 0.671 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.48 169.99 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.9 2.08 . . . . 0.0 111.849 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -113.64 118.64 34.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.378 1.471 . . . . 0.0 110.215 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.7 168.05 43.97 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 122.689 1.161 . . . . 0.0 112.278 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -75.22 -9.77 58.85 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.852 1.661 . . . . 0.0 111.844 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.06 -15.38 59.61 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.779 1.632 . . . . 0.0 112.113 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.48 34.2 14.63 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.432 1.491 . . . . 0.0 113.909 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -132.25 155.81 47.62 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.85 2.46 . . . . 0.0 110.038 -174.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -93.49 140.46 29.56 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.884 1.274 . . . . 0.0 112.705 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.01 138.06 41.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.74 1.616 . . . . 0.0 111.083 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.96 65.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.23 1.012 . . . . 0.0 113.638 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -174.49 4.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.597 1.159 . . . . 0.0 112.57 167.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -24.33 67.16 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.61 -2.58 4.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.174 1.79 . . . . 0.0 115.396 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -46.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.908 1.683 . . . . 0.0 113.501 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.83 53.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.895 0.855 . . . . 0.0 110.983 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.37 -22.74 57.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.989 1.315 . . . . 0.0 113.259 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -10.84 59.15 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.596 1.559 . . . . 0.0 113.197 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -108.9 -9.08 15.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.238 1.815 . . . . 0.0 112.688 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.9 57.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.736 1.636 . . . . 0.0 115.349 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.64 161.44 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.504 1.522 . . . . 0.0 109.347 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -122.1 144.67 48.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.841 1.256 . . . . 0.0 109.768 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.73 135.87 27.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.27 -1.519 . . . . 0.0 110.848 175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.47 -60.43 1.88 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.917 1.287 . . . . 0.0 109.285 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 p -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.357 1.463 . . . . 0.0 111.76 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -74.66 168.28 20.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.119 1.367 . . . . 0.0 112.681 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.0 159.22 12.07 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.106 1.812 . . . . 0.0 113.307 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 132.43 51.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.166 0.986 . . . . 0.0 110.758 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.891 0 O-C-N 121.738 -0.601 . . . . 0.0 111.683 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 CA-C-O 122.241 0.85 . . . . 0.0 113.758 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.93 171.04 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.562 2.345 . . . . 0.0 111.421 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 t -115.06 118.3 33.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.44 1.496 . . . . 0.0 110.321 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.97 167.18 48.97 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 122.464 1.035 . . . . 0.0 112.514 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -76.99 -12.15 59.9 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.584 1.554 . . . . 0.0 111.135 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.18 -14.59 59.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.589 1.555 . . . . 0.0 112.342 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.67 25.46 20.5 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.237 1.399 . . . . 0.0 115.145 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -121.93 152.07 40.05 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.385 2.274 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.4 m -80.66 143.95 32.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.25 1.42 . . . . 0.0 112.061 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -134.2 141.1 46.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.136 1.774 . . . . 0.0 110.59 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -24.67 64.77 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -159.76 -179.27 7.7 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.918 1.687 . . . . 0.0 110.809 166.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.7 p -63.33 -24.22 67.76 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 170.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.74 -14.59 53.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.55 1.54 . . . . 0.0 115.103 -170.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.07 -42.61 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.052 1.741 . . . . 0.0 113.339 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.99 39.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.985 0.898 . . . . 0.0 110.516 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -78.92 -29.03 43.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.427 1.491 . . . . 0.0 113.242 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.94 -27.23 64.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.435 1.094 . . . . 0.0 112.767 170.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.2 -24.25 23.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.839 1.255 . . . . 0.0 112.086 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.73 3.39 30.38 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.306 1.908 . . . . 0.0 114.996 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.53 158.69 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.31 1.844 . . . . 0.0 109.252 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 p -115.75 145.09 43.1 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.334 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.54 137.97 23.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 120.99 -1.069 . . . . 0.0 110.911 174.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -118.17 -57.82 2.05 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.028 1.331 . . . . 0.0 109.73 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -131.94 136.81 47.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -70.34 162.18 29.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.118 1.367 . . . . 0.0 112.223 172.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.97 162.66 19.62 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.647 2.07 . . . . 0.0 113.391 -171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.7 t -61.14 131.3 50.07 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.682 -0.893 . . . . 0.0 110.638 172.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 123.331 0.652 . . . . 0.0 111.295 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 CA--C 1.537 0.664 0 CA-C-O 122.153 0.814 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.67 172.6 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.306 2.243 . . . . 0.0 111.328 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 t -113.94 118.21 33.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.435 1.494 . . . . 0.0 110.999 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.53 169.09 45.03 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 122.426 1.015 . . . . 0.0 112.417 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.2 t -75.93 -13.64 60.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.359 1.464 . . . . 0.0 111.266 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -8.39 59.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.866 1.267 . . . . 0.0 112.475 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.05 26.3 29.21 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.008 1.29 . . . . 0.0 114.984 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -123.1 152.77 40.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.288 2.235 . . . . 0.0 110.397 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -78.25 139.84 38.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.598 1.559 . . . . 0.0 112.261 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -133.95 141.42 47.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.356 1.862 . . . . 0.0 110.512 171.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.28 67.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 0.0 113.282 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.39 172.41 17.33 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.505 1.122 . . . . 0.0 112.959 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -62.83 -26.89 68.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.376 1.471 . . . . 0.0 113.18 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.09 -22.66 63.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.49 1.516 . . . . 0.0 114.896 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pt -105.44 -43.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.8 -34.97 42.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.14 0.972 . . . . 0.0 111.258 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.74 -29.84 56.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.596 1.158 . . . . 0.0 113.751 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -75.57 -10.74 59.7 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.662 1.185 . . . . 0.0 113.118 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -103.6 -0.88 29.07 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.083 1.753 . . . . 0.0 112.36 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.94 80.45 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.842 1.687 . . . . 0.0 115.264 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 t -78.62 161.16 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.525 1.53 . . . . 0.0 109.207 171.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.5 p -119.96 151.65 38.63 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.313 1.045 . . . . 0.0 109.976 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.35 138.37 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -123.75 -61.27 1.39 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.391 1.476 . . . . 0.0 110.073 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.4 m -131.68 156.91 45.04 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.918 1.287 . . . . 0.0 111.981 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.08 169.2 15.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.807 2.043 . . . . 0.0 112.934 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.82 165.08 5.8 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.686 2.089 . . . . 0.0 114.189 -175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.3 t -62.81 127.83 33.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.357 -1.084 . . . . 0.0 110.45 170.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 124.229 1.011 . . . . 0.0 111.813 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 CA--C 1.536 0.613 0 CA-C-O 121.858 0.691 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.87 171.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 127.375 2.27 . . . . 0.0 111.971 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.0 119.51 38.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.191 1.396 . . . . 0.0 111.446 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.78 169.54 41.73 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 122.587 1.104 . . . . 0.0 112.443 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -78.58 -10.43 59.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.532 1.533 . . . . 0.0 111.249 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.41 -12.92 60.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.01 1.324 . . . . 0.0 112.247 168.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.75 30.45 23.78 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.368 1.461 . . . . 0.0 114.222 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -129.86 158.82 38.41 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.31 2.244 . . . . 0.0 110.782 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -87.93 139.39 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.684 1.594 . . . . 0.0 113.213 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -138.67 144.8 39.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.048 2.139 . . . . 0.0 109.931 174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.94 72.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.194 -0.941 . . . . 0.0 112.745 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -153.97 176.14 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.094 1.758 . . . . 0.0 111.836 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -68.86 -21.22 64.28 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.147 1.379 . . . . 0.0 114.384 170.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.09 -4.3 28.14 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.142 1.377 . . . . 0.0 114.57 -173.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.74 -42.19 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.178 1.791 . . . . 0.0 114.087 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.61 -35.06 40.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.229 0.922 . . . . 0.0 111.391 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -79.51 -18.71 51.33 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.304 1.442 . . . . 0.0 113.869 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 t -73.82 -10.93 60.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.151 1.38 . . . . 0.0 113.004 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -120.1 3.95 10.9 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.706 2.002 . . . . 0.0 112.572 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.11 1.43 84.47 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.978 1.752 . . . . 0.0 115.617 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.69 157.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.255 1.422 . . . . 0.0 109.097 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 p -115.19 154.57 28.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.351 1.06 . . . . 0.0 109.87 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.1 138.52 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 120.934 -1.104 . . . . 0.0 110.605 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -123.56 -61.84 1.36 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.603 1.561 . . . . 0.0 109.993 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -133.13 170.31 15.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.976 1.311 . . . . 0.0 112.599 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -98.36 168.23 10.34 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.202 2.601 . . . . 0.0 112.638 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.65 164.53 6.55 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.321 1.915 . . . . 0.0 113.764 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -61.19 129.07 39.5 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.583 -0.951 . . . . 0.0 110.443 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 123.678 0.791 . . . . 0.0 111.716 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 CA--C 1.537 0.669 0 CA-C-O 122.216 0.84 . . . . 0.0 113.531 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.8 170.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 128.06 2.544 . . . . 0.0 111.311 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -113.77 117.76 32.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.425 1.49 . . . . 0.0 110.352 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 167.88 48.59 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.544 1.08 . . . . 0.0 112.404 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 t -78.61 -7.57 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 111.301 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.82 -13.08 59.67 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.245 1.418 . . . . 0.0 112.247 170.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.0 31.58 14.5 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.026 1.298 . . . . 0.0 114.295 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -127.54 152.37 47.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.464 2.306 . . . . 0.0 110.327 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.7 m -85.2 140.63 30.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.513 1.525 . . . . 0.0 111.964 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.91 139.65 46.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.097 1.759 . . . . 0.0 110.626 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.25 -24.38 64.84 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -159.09 179.36 9.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.902 1.681 . . . . 0.0 110.734 163.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.1 p -62.75 -22.23 66.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.24 -26.99 68.12 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 -45.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.153 1.381 . . . . 0.0 113.475 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.49 -39.31 33.39 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.1 0.953 . . . . 0.0 110.899 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -78.71 -28.69 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.513 1.525 . . . . 0.0 113.714 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.85 -19.49 58.85 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.941 0.896 . . . . 0.0 112.854 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -89.08 -22.64 22.81 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.046 1.338 . . . . 0.0 112.079 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.59 2.66 37.54 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.655 2.074 . . . . 0.0 115.349 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.08 159.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.163 1.785 . . . . 0.0 109.257 168.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.5 p -117.72 145.54 44.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.427 173.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.83 136.79 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.073 -1.017 . . . . 0.0 110.929 174.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -117.06 -56.94 2.21 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.912 1.285 . . . . 0.0 109.896 -175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -134.11 141.84 47.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.75 1.62 . . . . 0.0 112.267 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.19 162.65 29.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.292 1.437 . . . . 0.0 112.329 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.69 162.79 22.64 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.77 2.129 . . . . 0.0 113.46 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -62.18 131.16 48.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.673 -0.898 . . . . 0.0 110.927 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 114.28 0.838 . . . . 0.0 114.28 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.23 171.27 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.514 2.326 . . . . 0.0 111.985 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 t -117.84 120.1 36.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.572 1.549 . . . . 0.0 110.598 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.88 48.67 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 122.774 1.208 . . . . 0.0 112.705 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -75.41 -11.14 59.98 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.719 2.008 . . . . 0.0 111.922 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.99 -13.77 59.6 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.523 1.529 . . . . 0.0 112.185 171.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.83 25.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.391 1.472 . . . . 0.0 114.533 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -121.59 149.58 42.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.22 2.208 . . . . 0.0 110.853 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -81.96 139.88 34.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.118 1.767 . . . . 0.0 112.05 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -133.2 141.27 48.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.247 1.819 . . . . 0.0 110.818 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.76 67.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.2 176.39 11.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.737 1.215 . . . . 0.0 112.317 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -64.0 -26.39 68.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.921 0.888 . . . . 0.0 113.306 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -60.39 -20.62 60.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.06 1.344 . . . . 0.0 114.552 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.8 -51.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 111.617 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.65 64.38 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.088 1.355 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.75 1.62 . . . . 0.0 113.075 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -84.56 -7.37 59.28 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.955 1.702 . . . . 0.0 113.316 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -113.31 1.71 15.26 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.315 1.846 . . . . 0.0 112.602 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 15.71 55.01 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.083 1.325 . . . . 0.0 115.373 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.76 159.26 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.311 1.844 . . . . 0.0 109.639 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.1 p -116.35 146.52 42.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.999 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.3 133.53 29.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 O-C-N 120.359 -1.463 . . . . 0.0 110.946 173.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -113.71 -58.68 2.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.775 1.23 . . . . 0.0 109.969 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -130.58 138.41 50.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.614 1.566 . . . . 0.0 111.946 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.48 164.44 26.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.689 1.596 . . . . 0.0 112.568 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 165.02 11.24 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.993 1.759 . . . . 0.0 113.397 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.43 133.5 55.11 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.376 -1.073 . . . . 0.0 111.024 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.888 0 C-N-CA 123.069 0.547 . . . . 0.0 111.489 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 122.424 0.927 . . . . 0.0 113.433 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.0 172.75 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 127.822 2.449 . . . . 0.0 111.287 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 t -114.56 115.55 27.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.285 1.434 . . . . 0.0 111.293 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.41 169.46 36.78 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 122.492 1.051 . . . . 0.0 112.228 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -79.57 -6.49 57.14 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.961 1.304 . . . . 0.0 111.2 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.88 -13.46 59.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.975 1.31 . . . . 0.0 112.149 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.82 31.19 24.44 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.326 1.441 . . . . 0.0 114.009 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -130.9 157.85 41.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.206 2.203 . . . . 0.0 110.749 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.7 m -89.1 138.02 31.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.365 1.466 . . . . 0.0 112.8 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.59 143.14 43.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.582 1.953 . . . . 0.0 110.368 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.97 -27.17 66.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 173.05 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 167.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -56.44 -32.86 65.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.914 1.686 . . . . 0.0 112.897 171.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -57.73 -27.97 63.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.412 1.085 . . . . 0.0 113.709 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 pt -104.93 -36.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.51 -30.59 31.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.477 1.035 . . . . 0.0 111.212 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -77.18 -28.61 54.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.672 1.589 . . . . 0.0 113.366 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.1 -10.14 59.47 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.147 0.979 . . . . 0.0 112.993 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -106.24 -0.8 24.19 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.987 1.715 . . . . 0.0 112.147 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.93 89.32 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.702 1.62 . . . . 0.0 115.331 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -81.09 163.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.418 1.487 . . . . 0.0 108.668 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -125.91 157.84 36.67 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.918 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.07 138.65 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 124.305 1.042 . . . . 0.0 111.398 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -124.35 -59.36 1.48 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.517 1.527 . . . . 0.0 110.307 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -134.59 167.87 20.01 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 112.293 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -100.87 167.52 10.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.223 2.209 . . . . 0.0 112.734 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 163.77 5.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.783 2.135 . . . . 0.0 112.97 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -62.07 126.09 26.12 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.254 -1.145 . . . . 0.0 110.98 169.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 124.786 1.234 . . . . 0.0 111.789 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 CA--C 1.535 0.526 0 CA-C-O 122.05 0.771 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.96 172.14 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.555 2.342 . . . . 0.0 111.089 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.3 t -114.28 116.86 29.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.082 1.353 . . . . 0.0 111.013 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.13 169.54 46.05 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 122.639 1.133 . . . . 0.0 112.666 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -74.85 -12.26 60.34 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 111.998 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.03 -8.58 59.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.28 1.432 . . . . 0.0 112.268 172.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.26 30.51 22.2 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.841 1.21 . . . . 0.0 114.591 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -126.29 152.87 45.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.578 2.351 . . . . 0.0 109.963 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.2 m -81.67 140.09 34.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.115 1.366 . . . . 0.0 111.882 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -132.08 138.92 48.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.927 1.691 . . . . 0.0 109.842 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -23.22 63.29 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.49 178.82 8.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.881 1.273 . . . . 0.0 112.264 166.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 p -72.09 -7.56 49.65 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.4 t -75.94 -17.88 59.57 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -48.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.906 1.282 . . . . 0.0 113.409 -174.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.34 -40.07 16.38 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.566 1.146 . . . . 0.0 111.645 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -71.8 -36.43 70.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.601 -1.182 . . . . 0.0 113.854 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.11 -22.87 63.94 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.381 1.472 . . . . 0.0 112.512 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -88.23 -28.62 21.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.565 1.146 . . . . 0.0 111.844 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.59 1.24 13.64 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.335 1.921 . . . . 0.0 115.17 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.6 t -72.93 159.78 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.47 1.908 . . . . 0.0 109.457 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -113.5 154.81 26.45 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.726 0.81 . . . . 0.0 110.449 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.36 135.82 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 120.53 -1.356 . . . . 0.0 110.651 174.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -121.44 -58.98 1.74 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.314 1.446 . . . . 0.0 110.309 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -131.09 159.25 38.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.458 1.103 . . . . 0.0 112.319 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.26 166.17 13.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.456 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 164.49 7.7 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.711 2.101 . . . . 0.0 113.679 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 t -62.26 128.07 34.32 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.493 -1.004 . . . . 0.0 110.677 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.852 0 C-N-CA 124.084 0.953 . . . . 0.0 111.611 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 CA--C 1.536 0.59 0 CA-C-O 121.79 0.662 . . . . 0.0 113.246 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.76 171.33 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 127.24 2.216 . . . . 0.0 111.417 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -119.83 107.07 12.72 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.392 1.877 . . . . 0.0 109.625 -172.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.41 167.93 51.47 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 122.559 1.088 . . . . 0.0 112.297 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -76.42 -12.29 60.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.852 1.261 . . . . 0.0 111.323 -172.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -81.15 -14.32 57.76 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.039 1.336 . . . . 0.0 112.635 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.81 15.24 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.587 1.089 . . . . 0.0 114.67 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -121.46 154.13 36.99 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.723 2.009 . . . . 0.0 110.439 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -79.9 140.86 36.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.315 1.446 . . . . 0.0 111.475 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -134.33 139.72 45.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.403 1.481 . . . . 0.0 109.86 171.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.79 69.75 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.465 -0.772 . . . . 0.0 112.643 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -154.08 169.79 22.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.923 1.289 . . . . 0.0 111.523 171.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.4 m -56.37 -23.76 39.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.626 1.57 . . . . 0.0 113.605 170.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.1 m -62.72 -13.78 36.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.49 -51.13 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.456 1.503 . . . . 0.0 111.203 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.25 -42.29 60.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.523 1.129 . . . . 0.0 111.463 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -70.38 -21.48 62.86 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -11.09 59.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.943 1.697 . . . . 0.0 113.424 171.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -112.24 3.44 17.15 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.755 2.022 . . . . 0.0 111.953 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.15 5.11 89.13 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.582 1.563 . . . . 0.0 114.784 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -85.54 161.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.481 1.913 . . . . 0.0 109.491 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.7 p -122.28 155.27 36.27 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.467 1.107 . . . . 0.0 110.278 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.38 139.39 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.261 -0.899 . . . . 0.0 110.626 174.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -125.78 -57.44 1.44 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.178 1.391 . . . . 0.0 109.973 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 154.73 43.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.285 1.434 . . . . 0.0 112.981 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -76.23 162.72 27.71 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.841 2.057 . . . . 0.0 111.775 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.08 170.87 8.73 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.347 1.927 . . . . 0.0 113.859 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -58.63 133.39 55.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.711 -0.876 . . . . 0.0 111.187 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.548 0.897 0 C-N-CA 125.827 1.651 . . . . 0.0 111.077 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 CA-C-O 121.69 0.621 . . . . 0.0 113.67 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.86 172.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.481 1.913 . . . . 0.0 112.217 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.6 t -114.06 119.93 38.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 111.579 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.09 169.48 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 122.505 1.058 . . . . 0.0 112.3 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.2 p -74.79 -10.65 59.71 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.431 1.492 . . . . 0.0 112.183 -175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -80.85 -13.36 59.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 0.0 112.189 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.12 25.96 27.5 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.146 1.355 . . . . 0.0 114.593 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -121.26 154.15 36.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.572 2.349 . . . . 0.0 110.043 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -80.57 140.29 35.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 112.261 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -134.69 140.62 46.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.327 1.851 . . . . 0.0 110.406 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.69 70.47 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.668 0.787 . . . . 0.0 112.942 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -155.68 173.87 16.1 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 111.338 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.2 p -62.77 -19.76 64.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -66.82 -14.05 62.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 pt -112.07 -40.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.54 -34.23 49.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.507 1.049 . . . . 0.0 111.57 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -82.09 -13.88 56.62 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.5 t -74.47 -18.82 60.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.515 1.126 . . . . 0.0 113.159 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -122.63 1.23 9.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.072 1.349 . . . . 0.0 114.103 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.66 -0.38 34.36 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.054 1.311 . . . . 0.0 116.345 163.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.33 158.16 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.814 1.246 . . . . 0.0 108.823 167.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.7 p -118.36 161.9 19.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.064 -1.023 . . . . 0.0 110.839 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.7 137.08 23.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 120.764 -1.21 . . . . 0.0 110.713 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -122.11 -60.4 1.58 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.622 1.569 . . . . 0.0 110.033 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -134.45 166.46 22.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 112.282 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.88 170.24 9.7 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.13 2.172 . . . . 0.0 112.843 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.39 163.84 5.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.343 1.925 . . . . 0.0 113.648 -172.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -60.29 127.83 33.72 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.426 -1.043 . . . . 0.0 110.403 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 124.113 0.965 . . . . 0.0 111.478 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 CA--C 1.536 0.625 0 N-CA-C 114.362 0.87 . . . . 0.0 114.362 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.96 169.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.21 2.204 . . . . 0.0 112.047 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.3 t -114.09 117.96 32.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.514 1.526 . . . . 0.0 110.454 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.36 169.46 49.58 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 122.707 1.171 . . . . 0.0 112.73 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 t -77.83 -8.39 57.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.147 1.379 . . . . 0.0 111.507 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 -8.29 58.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.877 1.271 . . . . 0.0 112.664 170.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.17 23.75 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.652 1.12 . . . . 0.0 115.14 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -122.88 154.17 38.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.592 2.357 . . . . 0.0 109.967 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -87.04 141.16 28.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.007 1.323 . . . . 0.0 111.638 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -133.44 138.0 46.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.968 1.707 . . . . 0.0 110.657 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.96 67.53 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -158.67 -178.43 7.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.941 1.296 . . . . 0.0 110.559 161.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 p -55.73 -23.49 29.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.477 1.511 . . . . 0.0 114.594 170.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 t -60.93 -16.77 46.07 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.618 1.567 . . . . 0.0 114.527 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.07 -49.39 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.417 1.487 . . . . 0.0 111.591 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.8 58.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.878 1.271 . . . . 0.0 111.101 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -68.95 -23.04 64.09 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.6 t -83.21 -3.59 57.55 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.576 1.55 . . . . 0.0 113.475 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -118.75 7.98 11.74 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.2 1.8 . . . . 0.0 112.327 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.42 7.08 87.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.328 1.442 . . . . 0.0 114.773 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -87.64 162.14 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.228 1.811 . . . . 0.0 109.601 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -125.24 150.72 46.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.341 1.057 . . . . 0.0 109.776 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.4 138.7 22.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.144 -0.973 . . . . 0.0 111.001 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.87 -57.98 1.99 Allowed 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 124.987 1.315 . . . . 0.0 109.649 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 p -133.33 135.02 44.53 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.264 1.425 . . . . 0.0 112.333 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -69.67 160.67 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.882 1.673 . . . . 0.0 111.939 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.96 161.04 22.62 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.372 1.939 . . . . 0.0 113.397 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 t -59.78 132.81 55.1 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.681 -0.893 . . . . 0.0 110.723 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.838 0 C-N-CA 123.13 0.572 . . . . 0.0 111.075 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 CA--C 1.532 0.408 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.2 m -135.93 174.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.006 1.722 . . . . 0.0 112.44 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 t -119.2 122.48 42.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.13 169.28 51.35 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 122.506 1.059 . . . . 0.0 112.556 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -77.9 -10.72 59.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.315 1.446 . . . . 0.0 111.502 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.949 1.3 . . . . 0.0 112.391 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.51 26.26 23.49 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.089 1.328 . . . . 0.0 114.958 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -121.8 151.75 40.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.234 2.213 . . . . 0.0 110.27 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.8 m -79.66 139.86 37.26 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.627 1.571 . . . . 0.0 111.712 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.57 141.62 48.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.931 1.692 . . . . 0.0 109.974 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.58 76.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.128 -0.357 . . . . 0.0 111.771 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -151.36 167.04 29.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.6 1.16 . . . . 0.0 111.784 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -64.73 -14.4 58.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.029 1.731 . . . . 0.0 114.514 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -67.59 -22.21 65.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.05 1.34 . . . . 0.0 113.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.6 mt -92.76 -54.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.553 1.141 . . . . 0.0 111.345 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.39 61.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.475 1.11 . . . . 0.0 111.301 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -68.49 -24.22 64.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.194 0.997 . . . . 0.0 113.616 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -8.58 58.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.801 1.641 . . . . 0.0 113.704 173.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -111.55 4.0 18.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.869 2.067 . . . . 0.0 112.129 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.34 2.57 90.55 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.668 1.604 . . . . 0.0 115.024 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 t -78.89 164.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.292 1.837 . . . . 0.0 109.223 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 p -124.94 158.27 33.99 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.175 0.99 . . . . 0.0 110.159 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.6 138.57 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.232 -0.918 . . . . 0.0 110.642 175.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -122.24 -60.36 1.57 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.761 1.624 . . . . 0.0 109.855 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -131.02 152.79 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.605 1.162 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.23 165.4 23.27 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.846 2.058 . . . . 0.0 111.076 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.43 158.77 7.32 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.518 2.009 . . . . 0.0 113.705 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.0 t -60.85 130.17 45.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.513 -0.992 . . . . 0.0 110.57 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.878 0 C-N-CA 123.594 0.757 . . . . 0.0 111.445 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 CA--C 1.534 0.482 0 CA-C-O 121.87 0.696 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.6 m -141.95 172.29 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 127.352 2.261 . . . . 0.0 111.552 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.4 t -112.71 116.75 30.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.465 1.506 . . . . 0.0 111.445 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.46 49.5 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.593 1.107 . . . . 0.0 112.268 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 t -78.77 -6.94 57.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.006 1.322 . . . . 0.0 111.474 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -84.62 -13.12 52.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 112.549 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.93 16.5 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.696 1.141 . . . . 0.0 115.012 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -124.28 153.73 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.366 2.266 . . . . 0.0 109.861 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.3 m -80.71 140.84 35.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.409 1.484 . . . . 0.0 111.995 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -132.88 142.98 49.21 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.049 1.74 . . . . 0.0 109.911 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.08 -22.79 67.08 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -155.85 165.27 36.99 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.679 1.592 . . . . 0.0 111.65 165.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -49.93 -32.36 14.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.19 2.196 . . . . 0.0 113.539 167.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -58.58 -33.16 69.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.016 0.927 . . . . 0.0 112.986 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 mm -85.51 -43.46 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 0.0 111.703 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.89 -42.96 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.573 0.749 . . . . 0.0 110.384 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -67.26 -34.58 77.73 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.452 1.101 . . . . 0.0 113.595 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.6 t -66.33 -15.77 63.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.574 1.149 . . . . 0.0 113.942 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -103.34 2.17 33.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 112.092 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.23 89.05 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.941 1.734 . . . . 0.0 115.068 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.33 158.46 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.449 1.9 . . . . 0.0 109.325 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -115.27 155.23 27.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.148 0.979 . . . . 0.0 109.886 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.72 139.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.058 -1.026 . . . . 0.0 110.709 175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -124.68 -59.54 1.44 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.617 1.567 . . . . 0.0 110.175 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -132.68 166.37 22.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.62 1.168 . . . . 0.0 112.928 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 162.98 13.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.989 2.516 . . . . 0.0 112.771 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.6 165.6 3.75 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.024 2.25 . . . . 0.0 113.27 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -59.76 124.52 20.41 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.849 1.26 . . . . 0.0 111.465 170.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.374 1.47 . . . . 0.0 111.617 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 CA-C-O 122.126 0.802 . . . . 0.0 113.667 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.3 m -136.08 172.0 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.671 2.389 . . . . 0.0 111.086 -176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.49 107.32 13.17 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.362 1.865 . . . . 0.0 109.583 -171.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.58 167.53 52.12 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.48 1.044 . . . . 0.0 112.238 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.3 p -76.33 -8.53 57.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.896 1.279 . . . . 0.0 112.112 -173.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.5 -14.14 49.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.357 1.463 . . . . 0.0 112.579 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.83 9.82 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.29 0.948 . . . . 0.0 113.879 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.01 153.67 46.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.203 2.201 . . . . 0.0 110.287 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.1 m -84.07 139.52 32.43 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.312 1.445 . . . . 0.0 111.799 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -135.62 137.08 41.56 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.311 1.444 . . . . 0.0 110.312 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.91 -23.29 67.29 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.16 -0.962 . . . . 0.0 113.04 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.62 172.64 17.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.985 0.914 . . . . 0.0 113.336 166.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t -58.08 -26.51 62.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.946 1.298 . . . . 0.0 113.47 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.97 -30.46 59.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.294 1.438 . . . . 0.0 113.501 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.36 -52.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.213 1.405 . . . . 0.0 111.599 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.36 64.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.965 1.306 . . . . 0.0 111.474 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -64.15 -29.13 70.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.794 1.237 . . . . 0.0 113.338 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.55 -7.76 59.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.065 1.346 . . . . 0.0 113.752 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -108.12 4.42 24.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.225 1.81 . . . . 0.0 112.036 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.24 6.61 87.77 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.453 1.502 . . . . 0.0 114.598 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.6 t -89.24 164.22 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.757 2.023 . . . . 0.0 109.246 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -123.73 161.25 25.54 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.93 1.292 . . . . 0.0 110.205 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.11 136.03 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 120.787 -1.195 . . . . 0.0 110.324 174.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -119.28 -61.38 1.64 Allowed 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.505 1.522 . . . . 0.0 109.688 -177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 t -133.76 171.55 13.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.7 1.2 . . . . 0.0 112.833 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.77 168.93 11.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.434 2.694 . . . . 0.0 112.688 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.39 174.28 5.75 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.398 1.951 . . . . 0.0 113.808 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 t -59.42 127.55 32.65 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.575 -0.956 . . . . 0.0 110.863 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.823 0 C-N-CA 125.64 1.576 . . . . 0.0 111.051 -173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 CA--C 1.537 0.629 0 CA-C-O 121.547 0.561 . . . . 0.0 113.462 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 m -138.01 173.25 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.881 1.672 . . . . 0.0 112.631 -174.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.22 119.05 34.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.525 1.53 . . . . 0.0 111.663 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.94 169.05 43.26 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 122.609 1.116 . . . . 0.0 112.786 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -78.71 -9.06 59.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.372 1.469 . . . . 0.0 112.303 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.48 -13.15 59.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.153 1.381 . . . . 0.0 112.143 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.57 34.56 15.96 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.875 1.226 . . . . 0.0 113.828 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -124.94 159.51 31.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.388 2.275 . . . . 0.0 110.255 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -100.21 136.77 39.59 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.453 1.501 . . . . 0.0 112.155 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -138.8 150.25 45.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.525 1.53 . . . . 0.0 111.569 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.17 -23.46 67.32 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -157.97 170.05 23.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.774 2.03 . . . . 0.0 110.655 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -59.6 -29.44 67.98 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.249 1.42 . . . . 0.0 113.428 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 t -54.81 -51.11 66.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.817 1.647 . . . . 0.0 112.563 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.478 ' H ' HD11 ' A' ' 26' ' ' ILE . 3.5 mp -61.07 -48.18 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.247 1.419 . . . . 0.0 111.07 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.82 70.59 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.594 0.711 . . . . 0.0 110.087 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -71.75 -24.65 61.81 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -18.02 64.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.27 1.428 . . . . 0.0 113.942 168.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -113.26 -1.83 14.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.019 1.727 . . . . 0.0 112.621 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.73 2.11 82.08 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.785 1.66 . . . . 0.0 115.184 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -72.41 161.16 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.344 1.458 . . . . 0.0 108.672 165.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.0 p -120.78 167.27 12.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.645 1.178 . . . . 0.0 110.485 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.9 140.85 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 120.714 -1.241 . . . . 0.0 110.891 174.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.82 -61.06 1.4 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.053 1.741 . . . . 0.0 109.811 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -134.77 164.93 26.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 112.459 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -95.94 168.63 10.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.315 2.246 . . . . 0.0 112.121 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.65 160.16 7.38 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.331 1.919 . . . . 0.0 112.842 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 p -64.68 122.69 17.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.293 -1.122 . . . . 0.0 110.806 169.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 C-N-CA 124.651 1.18 . . . . 0.0 111.947 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 CA--C 1.536 0.59 0 CA-C-O 122.226 0.844 . . . . 0.0 112.816 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.24 172.82 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 128.161 2.584 . . . . 0.0 110.866 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.33 116.4 28.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.002 1.321 . . . . 0.0 111.292 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.65 168.26 43.44 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.481 1.045 . . . . 0.0 112.42 172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.6 t -78.55 -11.07 59.94 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.006 1.322 . . . . 0.0 111.376 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.03 -12.82 60.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.93 1.292 . . . . 0.0 112.331 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.85 28.79 17.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.08 1.324 . . . . 0.0 114.72 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -125.82 154.29 42.84 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.286 2.234 . . . . 0.0 110.377 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -83.91 140.74 31.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.785 1.634 . . . . 0.0 112.373 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.88 141.97 42.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.303 1.841 . . . . 0.0 110.21 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.94 -19.76 65.36 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -154.68 169.61 23.49 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.303 1.441 . . . . 0.0 111.861 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.5 p -56.15 -29.55 60.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.726 1.611 . . . . 0.0 113.816 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -61.5 -33.97 74.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.784 0.802 . . . . 0.0 112.571 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mt -78.13 -44.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.329 1.451 . . . . 0.0 111.106 -175.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.44 -43.5 68.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.791 0.837 . . . . 0.0 110.149 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.76 -42.61 97.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.392 1.077 . . . . 0.0 112.884 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.8 t -58.69 -20.26 46.97 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.705 1.202 . . . . 0.0 113.862 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -106.14 3.55 28.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.027 1.731 . . . . 0.0 112.272 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 3.91 89.02 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.755 1.645 . . . . 0.0 115.351 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.44 160.73 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.375 1.87 . . . . 0.0 109.076 170.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.5 p -118.76 153.47 34.37 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.17 0.988 . . . . 0.0 109.815 172.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.19 139.86 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.17 -0.956 . . . . 0.0 110.761 175.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.73 -60.13 1.62 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.651 1.58 . . . . 0.0 109.939 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -134.09 158.3 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.436 1.095 . . . . 0.0 112.41 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.94 166.12 20.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 112.945 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.27 163.56 4.5 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.471 1.986 . . . . 0.0 114.16 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.9 t -61.04 127.75 33.07 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.448 -1.03 . . . . 0.0 110.789 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 124.13 0.972 . . . . 0.0 111.512 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 CA-C-O 121.629 0.595 . . . . 0.0 113.558 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -132.52 172.38 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.596 1.958 . . . . 0.0 111.646 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -122.69 106.83 11.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.308 1.843 . . . . 0.0 109.69 -169.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.53 167.89 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 122.592 1.107 . . . . 0.0 112.411 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.3 t -77.28 -11.94 59.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.574 1.15 . . . . 0.0 111.226 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.12 -11.84 59.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.058 1.343 . . . . 0.0 112.508 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 38.05 11.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.719 1.152 . . . . 0.0 113.792 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 -130.28 154.24 47.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.99 2.116 . . . . 0.0 110.639 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.0 m -83.09 139.66 33.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.434 1.494 . . . . 0.0 111.999 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -135.22 140.52 45.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.942 171.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.9 70.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.49 -0.756 . . . . 0.0 112.623 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.47 174.21 14.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.048 1.339 . . . . 0.0 111.271 170.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -61.32 -24.64 66.58 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.876 1.27 . . . . 0.0 113.873 170.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.88 -32.33 65.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.013 1.325 . . . . 0.0 113.618 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.818 1.247 . . . . 0.0 112.114 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.04 -40.81 64.21 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.427 1.091 . . . . 0.0 111.418 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -66.81 -30.28 70.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.026 1.331 . . . . 0.0 112.97 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.56 -11.58 60.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.724 1.61 . . . . 0.0 113.789 174.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.94 3.63 18.95 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.539 1.935 . . . . 0.0 111.962 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.32 90.02 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.77 1.652 . . . . 0.0 115.093 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.43 156.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.827 1.651 . . . . 0.0 109.248 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.5 p -115.3 156.17 25.93 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.228 1.011 . . . . 0.0 110.064 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.15 137.34 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.181 -0.949 . . . . 0.0 110.246 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -121.29 -60.85 1.59 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 125.576 1.55 . . . . 0.0 109.664 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -133.03 171.84 13.44 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.812 1.245 . . . . 0.0 112.687 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.45 168.95 9.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.864 2.466 . . . . 0.0 111.971 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.11 168.49 10.79 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.983 1.754 . . . . 0.0 112.953 -170.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.3 t -58.64 128.98 39.92 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.578 -0.954 . . . . 0.0 110.416 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 126.001 1.72 . . . . 0.0 110.725 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 CA--C 1.535 0.528 0 CA-C-O 122.398 0.916 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.55 170.02 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.919 2.487 . . . . 0.0 111.252 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -110.41 115.61 29.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.818 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.5 42.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 122.488 1.049 . . . . 0.0 112.546 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -77.49 -13.73 59.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.839 1.256 . . . . 0.0 111.104 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.36 -13.52 59.81 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.978 1.311 . . . . 0.0 112.471 171.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.07 60.97 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.953 1.739 . . . . 0.0 115.547 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.55 166.75 11.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.169 1.388 . . . . 0.0 111.427 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -92.48 139.24 30.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.88 1.672 . . . . 0.0 111.813 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -135.76 138.49 42.71 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.672 1.589 . . . . 0.0 110.454 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.66 -26.34 67.0 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -158.5 174.44 15.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.394 1.478 . . . . 0.0 111.98 167.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.0 t -67.62 -14.43 62.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.281 1.432 . . . . 0.0 114.683 171.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 t -69.39 -23.91 63.79 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.589 -1.319 . . . . 0.0 113.939 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.02 -47.55 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.996 1.318 . . . . 0.0 113.881 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.16 37.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.836 0.826 . . . . 0.0 111.557 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -79.2 -22.88 44.29 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.939 1.296 . . . . 0.0 113.887 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.38 -21.4 59.68 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.388 1.475 . . . . 0.0 112.719 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.27 -27.08 16.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.089 1.356 . . . . 0.0 112.119 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.26 0.23 16.5 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.25 1.881 . . . . 0.0 115.312 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.26 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.032 1.733 . . . . 0.0 109.255 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.3 p -119.5 154.59 33.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.111 0.965 . . . . 0.0 110.183 171.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.91 140.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.256 -0.902 . . . . 0.0 110.794 176.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.9 -62.22 1.13 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.579 1.552 . . . . 0.0 109.919 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -128.37 164.33 22.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.384 1.474 . . . . 0.0 111.995 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 167.4 11.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.629 2.372 . . . . 0.0 112.697 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.28 166.66 7.4 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.431 1.967 . . . . 0.0 113.95 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -63.68 128.03 33.99 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.616 -0.932 . . . . 0.0 110.547 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 124.649 1.18 . . . . 0.0 112.036 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -89.02 158.94 17.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.884 1.274 . . . . 0.0 111.016 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -152.61 147.28 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.301 1.84 . . . . 0.0 110.27 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.3 m -72.92 140.55 47.54 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.595 -0.691 . . . . 0.0 112.396 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.13 100.86 13.18 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.41 1.484 . . . . 0.0 110.65 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.1 t -50.5 128.81 25.51 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.848 1.259 . . . . 0.0 113.273 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.29 169.05 23.2 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.76 2.973 . . . . 0.0 112.662 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -84.19 4.03 32.49 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.378 1.871 . . . . 0.0 114.73 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.9 tp -61.1 160.15 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.344 1.857 . . . . 0.0 113.068 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 pp -115.74 -172.83 2.23 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.087 2.155 . . . . 0.0 111.687 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt 52.1 71.12 1.57 Allowed Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 125.946 1.698 . . . . 0.0 112.333 -169.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.22 171.73 7.34 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.445 2.764 . . . . 0.0 113.26 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.42 172.5 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.324 2.25 . . . . 0.0 111.709 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.8 t -111.5 118.92 37.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.821 1.248 . . . . 0.0 111.364 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.57 169.69 49.67 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 122.581 1.1 . . . . 0.0 112.479 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 t -79.16 -6.75 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.875 1.27 . . . . 0.0 111.5 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.24 -12.29 58.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.879 1.271 . . . . 0.0 112.412 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.44 30.97 17.57 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.178 1.37 . . . . 0.0 114.543 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -127.22 155.67 43.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.424 2.29 . . . . 0.0 110.067 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.9 m -82.52 140.49 33.29 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.538 1.535 . . . . 0.0 112.261 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -137.24 142.38 42.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.115 1.766 . . . . 0.0 110.706 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.09 -26.54 68.34 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.56 173.24 17.17 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.655 1.582 . . . . 0.0 111.784 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -59.08 -32.86 70.18 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.422 1.089 . . . . 0.0 113.241 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.4 m -54.76 -33.73 61.67 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.484 1.514 . . . . 0.0 113.506 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mm -81.21 -48.23 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.196 1.398 . . . . 0.0 110.649 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.48 -44.71 65.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.471 1.108 . . . . 0.0 110.29 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -59.78 -44.74 93.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.834 1.253 . . . . 0.0 112.396 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.43 -10.29 49.89 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.85 2.11 29.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.014 1.726 . . . . 0.0 112.133 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 6.13 88.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.838 1.685 . . . . 0.0 115.041 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.45 162.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.395 2.278 . . . . 0.0 109.223 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.9 p -119.0 155.86 30.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.96 171.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.08 140.13 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.114 -0.991 . . . . 0.0 110.519 174.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -125.42 -61.54 1.26 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.618 1.567 . . . . 0.0 109.897 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -134.62 173.51 11.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.819 1.248 . . . . 0.0 112.312 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -104.91 165.88 10.77 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.166 2.586 . . . . 0.0 112.951 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.22 166.61 6.0 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.146 1.831 . . . . 0.0 113.823 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.8 t -60.96 127.09 29.89 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.466 -1.02 . . . . 0.0 110.232 168.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.92 142.79 65.34 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.003 0.921 . . . . 0.0 111.306 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -72.13 167.43 26.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.959 2.44 . . . . 0.0 111.983 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 m -71.54 -10.47 59.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.841 1.256 . . . . 0.0 112.844 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.52 -6.3 9.17 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.966 2.222 . . . . 0.0 114.2 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.782 2.033 . . . . 0.0 110.772 177.035 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.39 -21.2 18.51 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.37 153.89 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.385 1.474 . . . . 0.0 111.641 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 83.2 m -132.32 15.21 4.57 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.626 1.57 . . . . 0.0 114.647 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.51 92.2 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.11 2.964 . . . . 0.0 115.675 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.7 p -74.81 161.28 78.35 Favored Pre-proline 0 CA--C 1.553 1.08 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.0 -13.24 15.83 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.966 3.11 . . . . 0.0 114.613 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 tptp 46.39 54.27 8.73 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.966 2.506 . . . . 0.0 113.366 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.9 tt -91.05 12.11 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.46 1.904 . . . . 0.0 114.272 -170.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.54 17.53 10.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.818 2.047 . . . . 0.0 114.295 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -132.84 65.59 74.52 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.625 1.17 . . . . 0.0 113.162 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 170.16 12.17 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.724 2.949 . . . . 0.0 113.77 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -140.4 176.2 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.747 2.419 . . . . 0.0 111.538 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -119.65 119.75 34.63 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.694 1.597 . . . . 0.0 111.226 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.79 168.17 47.13 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.511 1.062 . . . . 0.0 112.268 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -74.42 -11.23 60.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.784 1.634 . . . . 0.0 112.036 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -78.76 -12.53 60.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.46 1.504 . . . . 0.0 112.157 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.68 30.82 17.26 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.287 1.423 . . . . 0.0 114.437 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -129.27 151.96 49.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.568 2.347 . . . . 0.0 110.344 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -80.37 140.42 36.07 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.624 1.57 . . . . 0.0 112.44 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -134.77 146.74 49.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.552 1.941 . . . . 0.0 110.985 172.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -22.74 67.05 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -158.62 171.05 20.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.255 1.422 . . . . 0.0 111.307 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -56.47 -35.64 68.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.823 1.249 . . . . 0.0 113.109 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.8 m -61.2 -27.65 68.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.828 1.251 . . . . 0.0 113.188 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 mm -84.56 -47.7 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.95 1.7 . . . . 0.0 110.261 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.24 -42.96 61.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.64 1.176 . . . . 0.0 111.031 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.05 -41.43 99.47 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.421 1.088 . . . . 0.0 112.637 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -67.65 -18.27 64.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -101.55 -1.83 32.0 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.818 1.647 . . . . 0.0 112.425 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.48 11.42 59.52 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.58 1.562 . . . . 0.0 115.639 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -101.63 169.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.594 2.358 . . . . 0.0 108.942 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.4 p -126.2 156.19 40.6 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.306 -1.496 . . . . 0.0 110.471 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.39 136.74 25.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 O-C-N 120.651 -1.281 . . . . 0.0 111.322 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -116.5 -58.58 2.07 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.358 1.463 . . . . 0.0 109.832 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -135.46 143.2 45.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.206 1.402 . . . . 0.0 112.282 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.56 166.14 24.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.726 1.61 . . . . 0.0 112.711 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 159.52 6.41 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.319 1.914 . . . . 0.0 113.641 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -60.4 131.35 50.49 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.063 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 133.04 78.72 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.476 0.71 . . . . 0.0 111.622 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.58 168.19 23.35 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.438 2.759 . . . . 0.0 112.605 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.9 m -104.44 -32.68 8.9 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.386 1.074 . . . . 0.0 112.711 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.7 10.93 5.74 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.568 1.556 . . . . 0.0 115.404 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 N--CA 1.485 1.295 0 C-N-CA 126.181 1.792 . . . . 0.0 110.929 179.263 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -129.51 -53.79 1.17 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.273 1.429 . . . . 0.0 113.061 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.27 142.16 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.928 1.691 . . . . 0.0 110.512 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.4 m -77.96 137.47 38.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.669 0.787 . . . . 0.0 111.167 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.66 128.79 37.38 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.797 0.839 . . . . 0.0 111.997 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -67.04 152.29 96.2 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.678 0.791 . . . . 0.0 112.811 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.09 172.06 16.3 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.989 3.126 . . . . 0.0 112.289 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -124.9 49.43 1.86 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.798 1.639 . . . . 0.0 112.147 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.2 tt -132.69 151.17 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.024 1.73 . . . . 0.0 111.096 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.12 -172.0 2.58 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.793 1.637 . . . . 0.0 111.133 172.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 58.01 69.73 1.45 Allowed Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 126.829 2.051 . . . . 0.0 112.374 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -64.73 175.14 3.84 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.161 3.241 . . . . 0.0 113.559 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.48 169.99 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.9 2.08 . . . . 0.0 111.849 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -113.64 118.64 34.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.378 1.471 . . . . 0.0 110.215 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.7 168.05 43.97 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 122.689 1.161 . . . . 0.0 112.278 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -75.22 -9.77 58.85 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.852 1.661 . . . . 0.0 111.844 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.06 -15.38 59.61 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.779 1.632 . . . . 0.0 112.113 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.48 34.2 14.63 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.432 1.491 . . . . 0.0 113.909 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -132.25 155.81 47.62 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.85 2.46 . . . . 0.0 110.038 -174.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -93.49 140.46 29.56 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.884 1.274 . . . . 0.0 112.705 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.01 138.06 41.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.74 1.616 . . . . 0.0 111.083 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.96 65.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.23 1.012 . . . . 0.0 113.638 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -174.49 4.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.597 1.159 . . . . 0.0 112.57 167.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -24.33 67.16 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.61 -2.58 4.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.174 1.79 . . . . 0.0 115.396 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -46.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.908 1.683 . . . . 0.0 113.501 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.83 53.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.895 0.855 . . . . 0.0 110.983 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.37 -22.74 57.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.989 1.315 . . . . 0.0 113.259 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -10.84 59.15 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.596 1.559 . . . . 0.0 113.197 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -108.9 -9.08 15.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.238 1.815 . . . . 0.0 112.688 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.9 57.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.736 1.636 . . . . 0.0 115.349 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.64 161.44 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.504 1.522 . . . . 0.0 109.347 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -122.1 144.67 48.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.841 1.256 . . . . 0.0 109.768 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.73 135.87 27.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.27 -1.519 . . . . 0.0 110.848 175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.47 -60.43 1.88 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.917 1.287 . . . . 0.0 109.285 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 p -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.357 1.463 . . . . 0.0 111.76 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -74.66 168.28 20.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.119 1.367 . . . . 0.0 112.681 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.0 159.22 12.07 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.106 1.812 . . . . 0.0 113.307 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 132.43 51.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.166 0.986 . . . . 0.0 110.758 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.26 142.16 46.95 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.738 -0.601 . . . . 0.0 111.683 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.16 160.66 44.92 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.17 2.58 . . . . 0.0 112.614 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.5 m -82.55 -60.56 2.15 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.231 1.012 . . . . 0.0 111.671 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.72 8.99 0.05 OUTLIER Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.759 1.171 . . . . 0.0 115.864 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.785 2.034 . . . . 0.0 111.943 -179.062 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.229 0.062 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -126.23 83.75 2.2 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.41 1.884 . . . . 0.0 110.64 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.12 147.53 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.422 1.489 . . . . 0.0 111.311 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.4 p -68.6 118.45 11.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.966 1.307 . . . . 0.0 112.401 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.96 169.93 16.46 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.239 1.016 . . . . 0.0 112.467 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.6 p -125.95 152.86 73.48 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.713 1.605 . . . . 0.0 111.364 168.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.65 179.25 6.69 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.649 2.899 . . . . 0.0 112.372 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -111.39 -2.88 15.45 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.581 1.553 . . . . 0.0 114.311 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -68.78 134.64 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.846 1.658 . . . . 0.0 110.792 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.58 47.91 0.63 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.45 1.9 . . . . 0.0 112.594 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -130.12 68.78 81.44 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 125.582 1.553 . . . . 0.0 111.677 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.17 170.46 11.85 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.525 2.817 . . . . 0.0 113.758 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.93 171.04 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.562 2.345 . . . . 0.0 111.421 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 t -115.06 118.3 33.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.44 1.496 . . . . 0.0 110.321 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.97 167.18 48.97 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 122.464 1.035 . . . . 0.0 112.514 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -76.99 -12.15 59.9 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.584 1.554 . . . . 0.0 111.135 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.18 -14.59 59.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.589 1.555 . . . . 0.0 112.342 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.67 25.46 20.5 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.237 1.399 . . . . 0.0 115.145 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -121.93 152.07 40.05 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.385 2.274 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.4 m -80.66 143.95 32.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.25 1.42 . . . . 0.0 112.061 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -134.2 141.1 46.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.136 1.774 . . . . 0.0 110.59 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -24.67 64.77 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -159.76 -179.27 7.7 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.918 1.687 . . . . 0.0 110.809 166.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.7 p -63.33 -24.22 67.76 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 170.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.74 -14.59 53.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.55 1.54 . . . . 0.0 115.103 -170.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.07 -42.61 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.052 1.741 . . . . 0.0 113.339 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.99 39.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.985 0.898 . . . . 0.0 110.516 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -78.92 -29.03 43.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.427 1.491 . . . . 0.0 113.242 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.94 -27.23 64.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.435 1.094 . . . . 0.0 112.767 170.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.2 -24.25 23.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.839 1.255 . . . . 0.0 112.086 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.73 3.39 30.38 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.306 1.908 . . . . 0.0 114.996 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.53 158.69 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.31 1.844 . . . . 0.0 109.252 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 p -115.75 145.09 43.1 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.334 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.54 137.97 23.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 120.99 -1.069 . . . . 0.0 110.911 174.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -118.17 -57.82 2.05 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.028 1.331 . . . . 0.0 109.73 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -131.94 136.81 47.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -70.34 162.18 29.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.118 1.367 . . . . 0.0 112.223 172.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.97 162.66 19.62 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.647 2.07 . . . . 0.0 113.391 -171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.7 t -61.14 131.3 50.07 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.682 -0.893 . . . . 0.0 110.638 172.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.05 140.43 73.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.331 0.652 . . . . 0.0 111.295 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.88 165.98 30.48 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.936 2.424 . . . . 0.0 112.467 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.9 p -72.76 -11.46 60.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.488 1.515 . . . . 0.0 113.842 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.76 -8.83 4.9 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 126.528 2.013 . . . . 0.0 114.224 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.113 1.765 . . . . 0.0 113.097 173.799 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -73.31 -60.96 2.0 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.222 1.009 . . . . 0.0 111.791 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.35 158.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.146 0.978 . . . . 0.0 111.921 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.0 t -102.12 -31.03 10.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.873 1.269 . . . . 0.0 113.657 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.9 -44.5 0.15 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.092 1.357 . . . . 0.0 113.207 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.2 t 42.96 66.74 4.15 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.88 2.072 . . . . 0.0 113.831 -174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 160.25 50.45 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.385 2.723 . . . . 0.0 113.053 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -80.21 67.14 5.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.058 1.743 . . . . 0.0 111.396 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.6 tp -136.55 140.14 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.295 1.438 . . . . 0.0 111.608 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 tp -92.0 -163.94 1.11 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.71 1.604 . . . . 0.0 111.379 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt 52.09 71.56 1.45 Allowed Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.501 1.92 . . . . 0.0 112.64 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.28 169.23 11.21 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.148 2.565 . . . . 0.0 113.307 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.67 172.6 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.306 2.243 . . . . 0.0 111.328 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 t -113.94 118.21 33.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.435 1.494 . . . . 0.0 110.999 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.53 169.09 45.03 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 122.426 1.015 . . . . 0.0 112.417 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.2 t -75.93 -13.64 60.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.359 1.464 . . . . 0.0 111.266 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -8.39 59.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.866 1.267 . . . . 0.0 112.475 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.05 26.3 29.21 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.008 1.29 . . . . 0.0 114.984 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -123.1 152.77 40.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.288 2.235 . . . . 0.0 110.397 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -78.25 139.84 38.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.598 1.559 . . . . 0.0 112.261 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -133.95 141.42 47.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.356 1.862 . . . . 0.0 110.512 171.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.28 67.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 0.0 113.282 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.39 172.41 17.33 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.505 1.122 . . . . 0.0 112.959 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -62.83 -26.89 68.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.376 1.471 . . . . 0.0 113.18 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.09 -22.66 63.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.49 1.516 . . . . 0.0 114.896 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pt -105.44 -43.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.8 -34.97 42.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.14 0.972 . . . . 0.0 111.258 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.74 -29.84 56.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.596 1.158 . . . . 0.0 113.751 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -75.57 -10.74 59.7 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.662 1.185 . . . . 0.0 113.118 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -103.6 -0.88 29.07 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.083 1.753 . . . . 0.0 112.36 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.94 80.45 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.842 1.687 . . . . 0.0 115.264 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 t -78.62 161.16 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.525 1.53 . . . . 0.0 109.207 171.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.5 p -119.96 151.65 38.63 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.313 1.045 . . . . 0.0 109.976 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.35 138.37 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -123.75 -61.27 1.39 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.391 1.476 . . . . 0.0 110.073 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.4 m -131.68 156.91 45.04 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.918 1.287 . . . . 0.0 111.981 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.08 169.2 15.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.807 2.043 . . . . 0.0 112.934 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.82 165.08 5.8 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.686 2.089 . . . . 0.0 114.189 -175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.3 t -62.81 127.83 33.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.357 -1.084 . . . . 0.0 110.45 170.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.23 136.78 60.81 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.229 1.011 . . . . 0.0 111.813 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.33 161.26 46.25 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.772 2.315 . . . . 0.0 112.14 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.7 p -83.5 -0.07 48.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.29 1.436 . . . . 0.0 114.068 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.03 -11.71 0.23 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.214 1.387 . . . . 0.0 115.603 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.39 1.876 . . . . 0.0 111.281 174.558 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -114.91 -38.86 3.81 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.412 1.485 . . . . 0.0 113.567 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.68 125.31 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.082 1.353 . . . . 0.0 110.172 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.8 -71.93 0.69 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.081 0.953 . . . . 0.0 111.247 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.6 171.37 18.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.368 1.867 . . . . 0.0 111.944 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 p -152.76 72.87 7.29 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.367 1.467 . . . . 0.0 111.952 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.0 164.6 34.07 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.72 2.947 . . . . 0.0 112.722 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -128.75 -1.87 5.37 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -170.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.6 tt -61.8 150.71 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.898 1.279 . . . . 0.0 112.268 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.11 -175.93 1.29 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.242 1.417 . . . . 0.0 112.281 169.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt 57.86 71.48 1.05 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.911 2.084 . . . . 0.0 112.607 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.01 175.54 3.06 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.497 2.798 . . . . 0.0 113.255 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.87 171.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 127.375 2.27 . . . . 0.0 111.971 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.0 119.51 38.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.191 1.396 . . . . 0.0 111.446 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.78 169.54 41.73 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 122.587 1.104 . . . . 0.0 112.443 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -78.58 -10.43 59.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.532 1.533 . . . . 0.0 111.249 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.41 -12.92 60.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.01 1.324 . . . . 0.0 112.247 168.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.75 30.45 23.78 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.368 1.461 . . . . 0.0 114.222 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -129.86 158.82 38.41 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.31 2.244 . . . . 0.0 110.782 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -87.93 139.39 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.684 1.594 . . . . 0.0 113.213 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -138.67 144.8 39.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.048 2.139 . . . . 0.0 109.931 174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.94 72.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.194 -0.941 . . . . 0.0 112.745 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -153.97 176.14 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.094 1.758 . . . . 0.0 111.836 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -68.86 -21.22 64.28 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.147 1.379 . . . . 0.0 114.384 170.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.09 -4.3 28.14 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.142 1.377 . . . . 0.0 114.57 -173.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.74 -42.19 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.178 1.791 . . . . 0.0 114.087 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.61 -35.06 40.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.229 0.922 . . . . 0.0 111.391 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -79.51 -18.71 51.33 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.304 1.442 . . . . 0.0 113.869 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 t -73.82 -10.93 60.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.151 1.38 . . . . 0.0 113.004 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -120.1 3.95 10.9 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.706 2.002 . . . . 0.0 112.572 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.11 1.43 84.47 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.978 1.752 . . . . 0.0 115.617 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.69 157.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.255 1.422 . . . . 0.0 109.097 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 p -115.19 154.57 28.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.351 1.06 . . . . 0.0 109.87 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.1 138.52 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 120.934 -1.104 . . . . 0.0 110.605 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -123.56 -61.84 1.36 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.603 1.561 . . . . 0.0 109.993 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -133.13 170.31 15.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.976 1.311 . . . . 0.0 112.599 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -98.36 168.23 10.34 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.202 2.601 . . . . 0.0 112.638 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.65 164.53 6.55 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.321 1.915 . . . . 0.0 113.764 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -61.19 129.07 39.5 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.583 -0.951 . . . . 0.0 110.443 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.65 136.37 55.53 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 123.678 0.791 . . . . 0.0 111.716 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.56 157.8 57.79 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.922 2.415 . . . . 0.0 112.566 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.5 p -90.4 -11.21 41.15 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.141 1.377 . . . . 0.0 114.088 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.09 30.17 0.75 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.475 1.512 . . . . 0.0 114.909 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.504 1.921 . . . . 0.0 113.653 177.539 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -62.51 116.61 5.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.82 1.248 . . . . 0.0 112.08 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.02 121.14 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.645 1.578 . . . . 0.0 111.249 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 90.1 m -100.15 -5.89 27.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.51 131.6 51.26 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.503 1.047 . . . . 0.0 111.295 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.0 p -66.37 152.87 93.86 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.86 171.13 18.5 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.384 2.723 . . . . 0.0 112.532 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -92.99 -0.88 57.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.189 1.795 . . . . 0.0 115.259 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.3 tt -66.26 157.64 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.749 1.619 . . . . 0.0 112.973 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.0 tp -100.27 41.59 1.16 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.466 1.907 . . . . 0.0 111.947 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -125.9 70.51 66.95 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 125.825 1.65 . . . . 0.0 112.255 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.35 170.01 14.31 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.26 2.64 . . . . 0.0 113.531 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.8 170.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 128.06 2.544 . . . . 0.0 111.311 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -113.77 117.76 32.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.425 1.49 . . . . 0.0 110.352 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 167.88 48.59 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.544 1.08 . . . . 0.0 112.404 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 t -78.61 -7.57 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 111.301 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.82 -13.08 59.67 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.245 1.418 . . . . 0.0 112.247 170.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.0 31.58 14.5 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.026 1.298 . . . . 0.0 114.295 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -127.54 152.37 47.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.464 2.306 . . . . 0.0 110.327 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.7 m -85.2 140.63 30.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.513 1.525 . . . . 0.0 111.964 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.91 139.65 46.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.097 1.759 . . . . 0.0 110.626 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.25 -24.38 64.84 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -159.09 179.36 9.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.902 1.681 . . . . 0.0 110.734 163.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.1 p -62.75 -22.23 66.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.24 -26.99 68.12 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 -45.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.153 1.381 . . . . 0.0 113.475 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.49 -39.31 33.39 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.1 0.953 . . . . 0.0 110.899 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -78.71 -28.69 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.513 1.525 . . . . 0.0 113.714 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.85 -19.49 58.85 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.941 0.896 . . . . 0.0 112.854 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -89.08 -22.64 22.81 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.046 1.338 . . . . 0.0 112.079 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.59 2.66 37.54 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.655 2.074 . . . . 0.0 115.349 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.08 159.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.163 1.785 . . . . 0.0 109.257 168.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.5 p -117.72 145.54 44.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.427 173.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.83 136.79 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.073 -1.017 . . . . 0.0 110.929 174.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -117.06 -56.94 2.21 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.912 1.285 . . . . 0.0 109.896 -175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -134.11 141.84 47.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.75 1.62 . . . . 0.0 112.267 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.19 162.65 29.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.292 1.437 . . . . 0.0 112.329 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.69 162.79 22.64 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.77 2.129 . . . . 0.0 113.46 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -62.18 131.16 48.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.673 -0.898 . . . . 0.0 110.927 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.71 139.36 62.57 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.13 159.67 51.48 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.972 2.448 . . . . 0.0 112.629 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 m -81.03 -13.38 58.87 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.644 1.177 . . . . 0.0 112.572 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.64 22.62 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.358 1.456 . . . . 0.0 114.692 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.1 tt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 126.232 1.813 . . . . 0.0 113.591 176.589 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.73 -75.63 0.52 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.755 -1.215 . . . . 0.0 110.331 175.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.1 158.98 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.04 1.336 . . . . 0.0 111.05 169.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.8 m -113.24 147.74 36.91 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.134 1.374 . . . . 0.0 111.114 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.88 158.57 30.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.224 0.61 . . . . 0.0 112.248 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 p -106.12 155.06 39.14 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.018 1.327 . . . . 0.0 112.175 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.1 174.45 12.76 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.254 2.636 . . . . 0.0 111.589 170.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -103.85 -4.66 23.24 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.051 1.341 . . . . 0.0 113.741 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.8 mm -69.0 147.44 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.602 1.961 . . . . 0.0 110.808 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.68 -161.59 0.3 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.017 1.727 . . . . 0.0 112.175 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.22 72.9 0.91 Allowed Pre-proline 0 N--CA 1.481 1.111 0 C-N-CA 127.144 2.178 . . . . 0.0 112.951 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.36 173.92 5.78 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.163 3.242 . . . . 0.0 114.28 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -136.23 171.27 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.514 2.326 . . . . 0.0 111.985 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 t -117.84 120.1 36.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.572 1.549 . . . . 0.0 110.598 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.88 48.67 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 122.774 1.208 . . . . 0.0 112.705 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -75.41 -11.14 59.98 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.719 2.008 . . . . 0.0 111.922 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.99 -13.77 59.6 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.523 1.529 . . . . 0.0 112.185 171.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.83 25.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.391 1.472 . . . . 0.0 114.533 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -121.59 149.58 42.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.22 2.208 . . . . 0.0 110.853 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -81.96 139.88 34.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.118 1.767 . . . . 0.0 112.05 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -133.2 141.27 48.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.247 1.819 . . . . 0.0 110.818 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.76 67.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.2 176.39 11.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.737 1.215 . . . . 0.0 112.317 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -64.0 -26.39 68.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.921 0.888 . . . . 0.0 113.306 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -60.39 -20.62 60.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.06 1.344 . . . . 0.0 114.552 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.8 -51.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 111.617 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.65 64.38 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.088 1.355 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.75 1.62 . . . . 0.0 113.075 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -84.56 -7.37 59.28 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.955 1.702 . . . . 0.0 113.316 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -113.31 1.71 15.26 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.315 1.846 . . . . 0.0 112.602 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 15.71 55.01 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.083 1.325 . . . . 0.0 115.373 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.76 159.26 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.311 1.844 . . . . 0.0 109.639 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.1 p -116.35 146.52 42.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.999 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.3 133.53 29.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 O-C-N 120.359 -1.463 . . . . 0.0 110.946 173.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -113.71 -58.68 2.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.775 1.23 . . . . 0.0 109.969 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -130.58 138.41 50.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.614 1.566 . . . . 0.0 111.946 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.48 164.44 26.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.689 1.596 . . . . 0.0 112.568 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 165.02 11.24 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.993 1.759 . . . . 0.0 113.397 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.43 133.5 55.11 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.376 -1.073 . . . . 0.0 111.024 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.76 143.69 75.36 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.069 0.547 . . . . 0.0 111.489 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.44 160.01 45.38 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.207 2.605 . . . . 0.0 112.757 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.7 p -84.29 -15.28 47.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.203 1.401 . . . . 0.0 114.269 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.52 1.04 0.32 Allowed Glycine 0 CA--C 1.539 1.572 0 N-CA-C 116.363 1.305 . . . . 0.0 116.363 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 C--O 1.255 1.353 0 C-N-CA 126.294 1.838 . . . . 0.0 112.027 178.292 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.7 tptm . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -142.18 -55.74 0.45 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.304 1.842 . . . . 0.0 112.163 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.55 102.42 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.754 1.222 . . . . 0.0 109.929 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.4 m -118.01 124.99 49.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.215 1.806 . . . . 0.0 111.182 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.8 26.48 1.91 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.683 1.993 . . . . 0.0 116.295 171.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.6 p -63.58 151.8 87.34 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -166.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.09 177.85 8.37 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.814 3.01 . . . . 0.0 112.389 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -106.25 -2.12 22.75 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.084 1.754 . . . . 0.0 113.877 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mm -81.38 130.33 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.418 1.887 . . . . 0.0 111.691 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.05 51.13 1.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.18 1.792 . . . . 0.0 112.829 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -130.23 76.12 78.28 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.101 1.76 . . . . 0.0 110.766 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.61 169.18 14.86 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.116 2.544 . . . . 0.0 113.433 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.0 172.75 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 127.822 2.449 . . . . 0.0 111.287 -177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 t -114.56 115.55 27.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.285 1.434 . . . . 0.0 111.293 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.41 169.46 36.78 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 122.492 1.051 . . . . 0.0 112.228 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -79.57 -6.49 57.14 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.961 1.304 . . . . 0.0 111.2 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.88 -13.46 59.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.975 1.31 . . . . 0.0 112.149 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.82 31.19 24.44 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.326 1.441 . . . . 0.0 114.009 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -130.9 157.85 41.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.206 2.203 . . . . 0.0 110.749 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.7 m -89.1 138.02 31.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.365 1.466 . . . . 0.0 112.8 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.59 143.14 43.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.582 1.953 . . . . 0.0 110.368 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.97 -27.17 66.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 173.05 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 167.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -56.44 -32.86 65.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.914 1.686 . . . . 0.0 112.897 171.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -57.73 -27.97 63.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.412 1.085 . . . . 0.0 113.709 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 pt -104.93 -36.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.51 -30.59 31.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.477 1.035 . . . . 0.0 111.212 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -77.18 -28.61 54.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.672 1.589 . . . . 0.0 113.366 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.1 -10.14 59.47 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.147 0.979 . . . . 0.0 112.993 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -106.24 -0.8 24.19 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.987 1.715 . . . . 0.0 112.147 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.93 89.32 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.702 1.62 . . . . 0.0 115.331 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -81.09 163.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.418 1.487 . . . . 0.0 108.668 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -125.91 157.84 36.67 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.918 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.07 138.65 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 124.305 1.042 . . . . 0.0 111.398 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -124.35 -59.36 1.48 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.517 1.527 . . . . 0.0 110.307 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -134.59 167.87 20.01 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 112.293 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -100.87 167.52 10.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.223 2.209 . . . . 0.0 112.734 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 163.77 5.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.783 2.135 . . . . 0.0 112.97 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -62.07 126.09 26.12 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.254 -1.145 . . . . 0.0 110.98 169.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.67 146.54 76.81 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.786 1.234 . . . . 0.0 111.789 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.67 159.87 47.7 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.903 2.402 . . . . 0.0 112.005 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 50.9 m -80.77 -16.42 53.87 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.061 0.944 . . . . 0.0 112.422 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.69 4.57 7.35 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.034 1.778 . . . . 0.0 114.968 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.1 mt . . . . . 0 C--O 1.253 1.251 0 C-N-CA 127.166 2.186 . . . . 0.0 110.29 -177.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.767 0.317 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -140.4 160.69 39.43 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.285 2.234 . . . . 0.0 110.743 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.17 157.88 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.791 1.636 . . . . 0.0 111.016 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 p -66.38 117.06 8.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.607 1.163 . . . . 0.0 111.82 170.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.48 154.96 41.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.687 0.795 . . . . 0.0 112.269 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -68.62 154.56 94.41 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.64 0.776 . . . . 0.0 111.976 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.02 176.61 9.69 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.075 3.184 . . . . 0.0 113.019 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.5 5.18 6.87 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.857 1.663 . . . . 0.0 114.428 -174.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.4 mm -104.19 142.57 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.362 1.465 . . . . 0.0 111.173 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.71 22.26 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.366 1.866 . . . . 0.0 114.993 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.9 mmpt? -113.92 80.15 5.13 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 126.458 1.903 . . . . 0.0 111.448 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.67 165.71 24.59 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.635 2.224 . . . . 0.0 112.901 172.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.96 172.14 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.555 2.342 . . . . 0.0 111.089 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.3 t -114.28 116.86 29.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.082 1.353 . . . . 0.0 111.013 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.13 169.54 46.05 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 122.639 1.133 . . . . 0.0 112.666 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -74.85 -12.26 60.34 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 111.998 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.03 -8.58 59.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.28 1.432 . . . . 0.0 112.268 172.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.26 30.51 22.2 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.841 1.21 . . . . 0.0 114.591 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -126.29 152.87 45.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.578 2.351 . . . . 0.0 109.963 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.2 m -81.67 140.09 34.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.115 1.366 . . . . 0.0 111.882 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -132.08 138.92 48.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.927 1.691 . . . . 0.0 109.842 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -23.22 63.29 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.49 178.82 8.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.881 1.273 . . . . 0.0 112.264 166.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 p -72.09 -7.56 49.65 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.4 t -75.94 -17.88 59.57 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -48.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.906 1.282 . . . . 0.0 113.409 -174.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.34 -40.07 16.38 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.566 1.146 . . . . 0.0 111.645 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -71.8 -36.43 70.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.601 -1.182 . . . . 0.0 113.854 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.11 -22.87 63.94 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.381 1.472 . . . . 0.0 112.512 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -88.23 -28.62 21.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.565 1.146 . . . . 0.0 111.844 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.59 1.24 13.64 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.335 1.921 . . . . 0.0 115.17 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.6 t -72.93 159.78 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.47 1.908 . . . . 0.0 109.457 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -113.5 154.81 26.45 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.726 0.81 . . . . 0.0 110.449 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.36 135.82 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 120.53 -1.356 . . . . 0.0 110.651 174.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -121.44 -58.98 1.74 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.314 1.446 . . . . 0.0 110.309 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -131.09 159.25 38.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.458 1.103 . . . . 0.0 112.319 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.26 166.17 13.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.456 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 164.49 7.7 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.711 2.101 . . . . 0.0 113.679 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 t -62.26 128.07 34.32 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.493 -1.004 . . . . 0.0 110.677 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.73 141.78 69.12 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.084 0.953 . . . . 0.0 111.611 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.65 164.39 35.74 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.951 2.434 . . . . 0.0 112.206 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 p -84.28 -27.6 27.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.358 1.063 . . . . 0.0 113.123 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.87 27.04 0.02 OUTLIER Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.844 1.211 . . . . 0.0 115.172 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.5 tt . . . . . 0 C--O 1.255 1.372 0 C-N-CA 125.561 1.545 . . . . 0.0 113.76 -179.735 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.6 mptt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -138.99 111.85 7.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.379 1.872 . . . . 0.0 110.871 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.42 161.19 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.614 1.966 . . . . 0.0 109.98 174.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.0 p -66.51 154.55 40.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.68 12.07 3.17 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.672 1.589 . . . . 0.0 113.591 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.2 m 43.11 65.54 5.34 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 127.03 2.132 . . . . 0.0 113.965 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.1 158.26 55.52 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.888 3.059 . . . . 0.0 113.21 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 5.73 48.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.355 1.862 . . . . 0.0 115.07 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.4 tt -53.77 140.42 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 126.694 1.998 . . . . 0.0 113.028 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.93 -178.75 6.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.385 1.474 . . . . 0.0 111.914 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 mttm 50.79 69.47 2.58 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 126.617 1.967 . . . . 0.0 112.598 -171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.13 169.19 11.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.477 2.785 . . . . 0.0 113.246 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.76 171.33 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 127.24 2.216 . . . . 0.0 111.417 -176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -119.83 107.07 12.72 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.392 1.877 . . . . 0.0 109.625 -172.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.41 167.93 51.47 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 122.559 1.088 . . . . 0.0 112.297 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -76.42 -12.29 60.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.852 1.261 . . . . 0.0 111.323 -172.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -81.15 -14.32 57.76 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.039 1.336 . . . . 0.0 112.635 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.81 15.24 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.587 1.089 . . . . 0.0 114.67 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -121.46 154.13 36.99 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.723 2.009 . . . . 0.0 110.439 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -79.9 140.86 36.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.315 1.446 . . . . 0.0 111.475 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -134.33 139.72 45.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.403 1.481 . . . . 0.0 109.86 171.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.79 69.75 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.465 -0.772 . . . . 0.0 112.643 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -154.08 169.79 22.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.923 1.289 . . . . 0.0 111.523 171.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.4 m -56.37 -23.76 39.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.626 1.57 . . . . 0.0 113.605 170.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.1 m -62.72 -13.78 36.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.49 -51.13 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.456 1.503 . . . . 0.0 111.203 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.25 -42.29 60.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.523 1.129 . . . . 0.0 111.463 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -70.38 -21.48 62.86 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -11.09 59.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.943 1.697 . . . . 0.0 113.424 171.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -112.24 3.44 17.15 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.755 2.022 . . . . 0.0 111.953 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.15 5.11 89.13 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.582 1.563 . . . . 0.0 114.784 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -85.54 161.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.481 1.913 . . . . 0.0 109.491 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.7 p -122.28 155.27 36.27 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.467 1.107 . . . . 0.0 110.278 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.38 139.39 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.261 -0.899 . . . . 0.0 110.626 174.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -125.78 -57.44 1.44 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.178 1.391 . . . . 0.0 109.973 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 154.73 43.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.285 1.434 . . . . 0.0 112.981 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -76.23 162.72 27.71 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.841 2.057 . . . . 0.0 111.775 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.08 170.87 8.73 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.347 1.927 . . . . 0.0 113.859 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -58.63 133.39 55.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.711 -0.876 . . . . 0.0 111.187 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.49 143.84 79.91 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.827 1.651 . . . . 0.0 111.077 -173.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.86 -178.9 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.225 2.617 . . . . 0.0 112.369 175.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.9 m 69.33 31.44 3.88 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.41 1.484 . . . . 0.0 111.486 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.63 -14.68 0.04 OUTLIER Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.939 1.257 . . . . 0.0 115.507 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.252 1.197 0 CA-C-N 118.678 1.239 . . . . 0.0 112.755 173.53 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -144.1 148.43 35.11 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.588 1.555 . . . . 0.0 111.569 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.6 151.35 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.444 1.898 . . . . 0.0 110.507 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.1 m -89.63 138.67 31.27 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.739 0.816 . . . . 0.0 111.648 173.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.97 144.63 26.43 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 111.438 170.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.3 p -75.92 154.26 84.92 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.619 0.767 . . . . 0.0 112.468 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.25 164.13 34.89 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.951 2.434 . . . . 0.0 111.705 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -81.52 -17.23 49.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 tt -54.8 141.94 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.806 1.642 . . . . 0.0 112.807 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.08 -167.44 1.3 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.226 1.41 . . . . 0.0 112.179 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.8 tttm 54.75 71.21 1.37 Allowed Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 126.821 2.049 . . . . 0.0 112.556 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.5 178.59 2.05 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.169 3.246 . . . . 0.0 113.67 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.5 m -134.86 172.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.481 1.913 . . . . 0.0 112.217 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.6 t -114.06 119.93 38.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 111.579 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.09 169.48 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 122.505 1.058 . . . . 0.0 112.3 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.2 p -74.79 -10.65 59.71 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.431 1.492 . . . . 0.0 112.183 -175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -80.85 -13.36 59.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 0.0 112.189 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.12 25.96 27.5 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.146 1.355 . . . . 0.0 114.593 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -121.26 154.15 36.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.572 2.349 . . . . 0.0 110.043 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -80.57 140.29 35.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 112.261 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -134.69 140.62 46.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.327 1.851 . . . . 0.0 110.406 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.69 70.47 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.668 0.787 . . . . 0.0 112.942 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -155.68 173.87 16.1 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 111.338 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.2 p -62.77 -19.76 64.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -66.82 -14.05 62.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 pt -112.07 -40.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.54 -34.23 49.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.507 1.049 . . . . 0.0 111.57 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -82.09 -13.88 56.62 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.5 t -74.47 -18.82 60.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.515 1.126 . . . . 0.0 113.159 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -122.63 1.23 9.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.072 1.349 . . . . 0.0 114.103 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.66 -0.38 34.36 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.054 1.311 . . . . 0.0 116.345 163.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.33 158.16 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.814 1.246 . . . . 0.0 108.823 167.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.7 p -118.36 161.9 19.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.064 -1.023 . . . . 0.0 110.839 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.7 137.08 23.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 120.764 -1.21 . . . . 0.0 110.713 175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -122.11 -60.4 1.58 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.622 1.569 . . . . 0.0 110.033 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -134.45 166.46 22.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 112.282 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.88 170.24 9.7 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.13 2.172 . . . . 0.0 112.843 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.39 163.84 5.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.343 1.925 . . . . 0.0 113.648 -172.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -60.29 127.83 33.72 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.426 -1.043 . . . . 0.0 110.403 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.2 135.92 69.4 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.113 0.965 . . . . 0.0 111.478 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.52 159.21 53.6 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.845 2.363 . . . . 0.0 112.561 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -80.19 -7.85 59.16 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.59 2.2 29.1 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 126.138 1.828 . . . . 0.0 114.723 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.65 1.98 . . . . 0.0 113.457 177.08 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.426 0.155 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -109.4 171.89 7.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.862 2.065 . . . . 0.0 111.038 175.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.1 t 49.48 62.82 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 127.002 2.121 . . . . 0.0 111.888 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.6 m -66.73 141.97 57.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.841 0.856 . . . . 0.0 110.836 171.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.07 132.87 49.53 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.1 0.56 . . . . 0.0 110.977 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.4 p -58.65 151.11 53.92 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.814 0.846 . . . . 0.0 113.099 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.62 176.29 9.54 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.115 3.21 . . . . 0.0 112.919 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -112.23 25.68 11.31 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.698 1.999 . . . . 0.0 112.686 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.92 147.01 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.841 1.656 . . . . 0.0 109.562 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 mp -75.12 -161.9 0.16 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.963 1.705 . . . . 0.0 111.452 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt 57.48 66.79 2.74 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 126.816 2.047 . . . . 0.0 112.927 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.97 173.3 5.01 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.477 3.452 . . . . 0.0 114.362 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.96 169.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.21 2.204 . . . . 0.0 112.047 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.3 t -114.09 117.96 32.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.514 1.526 . . . . 0.0 110.454 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.36 169.46 49.58 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 122.707 1.171 . . . . 0.0 112.73 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 t -77.83 -8.39 57.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.147 1.379 . . . . 0.0 111.507 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 -8.29 58.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.877 1.271 . . . . 0.0 112.664 170.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.17 23.75 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.652 1.12 . . . . 0.0 115.14 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -122.88 154.17 38.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.592 2.357 . . . . 0.0 109.967 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -87.04 141.16 28.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.007 1.323 . . . . 0.0 111.638 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -133.44 138.0 46.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.968 1.707 . . . . 0.0 110.657 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.96 67.53 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -158.67 -178.43 7.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.941 1.296 . . . . 0.0 110.559 161.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 p -55.73 -23.49 29.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.477 1.511 . . . . 0.0 114.594 170.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 t -60.93 -16.77 46.07 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.618 1.567 . . . . 0.0 114.527 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.07 -49.39 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.417 1.487 . . . . 0.0 111.591 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.8 58.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.878 1.271 . . . . 0.0 111.101 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -68.95 -23.04 64.09 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.6 t -83.21 -3.59 57.55 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.576 1.55 . . . . 0.0 113.475 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -118.75 7.98 11.74 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.2 1.8 . . . . 0.0 112.327 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.42 7.08 87.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.328 1.442 . . . . 0.0 114.773 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -87.64 162.14 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.228 1.811 . . . . 0.0 109.601 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -125.24 150.72 46.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.341 1.057 . . . . 0.0 109.776 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.4 138.7 22.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.144 -0.973 . . . . 0.0 111.001 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.87 -57.98 1.99 Allowed 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 124.987 1.315 . . . . 0.0 109.649 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 p -133.33 135.02 44.53 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.264 1.425 . . . . 0.0 112.333 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -69.67 160.67 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.882 1.673 . . . . 0.0 111.939 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.96 161.04 22.62 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.372 1.939 . . . . 0.0 113.397 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 t -59.78 132.81 55.1 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.681 -0.893 . . . . 0.0 110.723 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.32 143.11 63.99 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.13 0.572 . . . . 0.0 111.075 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.34 169.76 18.88 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.936 2.424 . . . . 0.0 111.949 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.8 p -69.49 -14.23 62.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.358 1.463 . . . . 0.0 113.782 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.74 -13.16 3.41 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 127.099 2.285 . . . . 0.0 113.817 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tp . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.946 1.698 . . . . 0.0 113.145 174.182 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -125.75 73.14 1.32 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.866 1.666 . . . . 0.0 110.966 -173.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.2 t -129.59 104.01 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.69 1.596 . . . . 0.0 110.077 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 t -75.65 -173.21 2.11 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.701 1.201 . . . . 0.0 112.776 176.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.09 -27.23 52.82 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.49 1.516 . . . . 0.0 114.895 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.5 t 37.8 63.63 3.44 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 127.907 2.483 . . . . 0.0 114.801 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.65 166.84 28.76 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.954 3.103 . . . . 0.0 113.19 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -121.46 1.76 10.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.134 1.774 . . . . 0.0 113.729 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.1 mt -58.52 131.85 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.611 1.564 . . . . 0.0 109.645 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.23 -177.84 0.31 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.464 1.906 . . . . 0.0 114.545 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 tptm 61.08 67.77 1.37 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 127.091 2.156 . . . . 0.0 111.951 -174.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -65.52 169.62 12.4 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.798 2.999 . . . . 0.0 113.853 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.2 m -135.93 174.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.006 1.722 . . . . 0.0 112.44 -176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 t -119.2 122.48 42.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.13 169.28 51.35 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 122.506 1.059 . . . . 0.0 112.556 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -77.9 -10.72 59.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.315 1.446 . . . . 0.0 111.502 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.949 1.3 . . . . 0.0 112.391 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.51 26.26 23.49 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.089 1.328 . . . . 0.0 114.958 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -121.8 151.75 40.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.234 2.213 . . . . 0.0 110.27 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.8 m -79.66 139.86 37.26 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.627 1.571 . . . . 0.0 111.712 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.57 141.62 48.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.931 1.692 . . . . 0.0 109.974 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.58 76.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.128 -0.357 . . . . 0.0 111.771 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -151.36 167.04 29.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.6 1.16 . . . . 0.0 111.784 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -64.73 -14.4 58.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.029 1.731 . . . . 0.0 114.514 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -67.59 -22.21 65.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.05 1.34 . . . . 0.0 113.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.6 mt -92.76 -54.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.553 1.141 . . . . 0.0 111.345 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.39 61.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.475 1.11 . . . . 0.0 111.301 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -68.49 -24.22 64.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.194 0.997 . . . . 0.0 113.616 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -8.58 58.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.801 1.641 . . . . 0.0 113.704 173.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -111.55 4.0 18.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.869 2.067 . . . . 0.0 112.129 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.34 2.57 90.55 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.668 1.604 . . . . 0.0 115.024 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 t -78.89 164.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.292 1.837 . . . . 0.0 109.223 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 p -124.94 158.27 33.99 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.175 0.99 . . . . 0.0 110.159 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.6 138.57 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.232 -0.918 . . . . 0.0 110.642 175.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -122.24 -60.36 1.57 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.761 1.624 . . . . 0.0 109.855 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -131.02 152.79 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.605 1.162 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.23 165.4 23.27 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.846 2.058 . . . . 0.0 111.076 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.43 158.77 7.32 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.518 2.009 . . . . 0.0 113.705 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.0 t -60.85 130.17 45.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.513 -0.992 . . . . 0.0 110.57 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.65 143.33 75.14 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.594 0.757 . . . . 0.0 111.445 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.54 157.94 48.25 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.999 2.466 . . . . 0.0 112.738 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.8 m -79.76 -25.48 41.0 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.451 1.1 . . . . 0.0 112.495 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.8 0.86 0.55 Allowed Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.281 1.419 . . . . 0.0 115.845 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 mm . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.358 1.863 . . . . 0.0 111.805 179.206 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -73.15 -15.63 61.46 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 119.762 -1.836 . . . . 0.0 115.924 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.98 129.81 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.333 1.853 . . . . 0.0 110.182 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.4 m -68.03 135.94 53.05 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.246 0.546 . . . . 0.0 111.992 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.2 145.47 30.97 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.518 1.127 . . . . 0.0 111.568 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.31 152.21 85.39 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.498 1.119 . . . . 0.0 113.616 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.56 178.73 5.88 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.097 3.198 . . . . 0.0 112.452 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.447 ' HA ' ' HE2' ' A' ' 8' ' ' LYS . 9.7 mmpt? -94.62 -7.22 41.54 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.461 1.504 . . . . 0.0 114.573 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.2 tt -65.88 155.98 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.599 1.16 . . . . 0.0 111.928 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.16 70.35 0.74 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.629 1.572 . . . . 0.0 109.77 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -151.91 67.3 7.08 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 125.642 1.577 . . . . 0.0 111.492 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.73 165.04 24.5 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.697 2.264 . . . . 0.0 112.944 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.6 m -141.95 172.29 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 127.352 2.261 . . . . 0.0 111.552 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.4 t -112.71 116.75 30.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.465 1.506 . . . . 0.0 111.445 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.46 49.5 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.593 1.107 . . . . 0.0 112.268 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 t -78.77 -6.94 57.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.006 1.322 . . . . 0.0 111.474 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -84.62 -13.12 52.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 112.549 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.93 16.5 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.696 1.141 . . . . 0.0 115.012 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -124.28 153.73 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.366 2.266 . . . . 0.0 109.861 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.3 m -80.71 140.84 35.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.409 1.484 . . . . 0.0 111.995 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -132.88 142.98 49.21 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.049 1.74 . . . . 0.0 109.911 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.08 -22.79 67.08 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -155.85 165.27 36.99 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.679 1.592 . . . . 0.0 111.65 165.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -49.93 -32.36 14.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.19 2.196 . . . . 0.0 113.539 167.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -58.58 -33.16 69.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.016 0.927 . . . . 0.0 112.986 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 mm -85.51 -43.46 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 0.0 111.703 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.89 -42.96 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.573 0.749 . . . . 0.0 110.384 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -67.26 -34.58 77.73 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.452 1.101 . . . . 0.0 113.595 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.6 t -66.33 -15.77 63.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.574 1.149 . . . . 0.0 113.942 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -103.34 2.17 33.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 112.092 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.23 89.05 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.941 1.734 . . . . 0.0 115.068 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.33 158.46 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.449 1.9 . . . . 0.0 109.325 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -115.27 155.23 27.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.148 0.979 . . . . 0.0 109.886 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.72 139.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.058 -1.026 . . . . 0.0 110.709 175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -124.68 -59.54 1.44 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.617 1.567 . . . . 0.0 110.175 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -132.68 166.37 22.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.62 1.168 . . . . 0.0 112.928 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 162.98 13.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.989 2.516 . . . . 0.0 112.771 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.6 165.6 3.75 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.024 2.25 . . . . 0.0 113.27 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -59.76 124.52 20.41 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.849 1.26 . . . . 0.0 111.465 170.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.74 140.44 58.91 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.374 1.47 . . . . 0.0 111.617 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.81 -176.89 1.65 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.744 2.963 . . . . 0.0 113.367 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.0 m 67.65 49.81 0.94 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.982 1.713 . . . . 0.0 110.296 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.95 -0.39 0.2 Allowed Glycine 0 CA--C 1.538 1.512 0 N-CA-C 117.121 1.608 . . . . 0.0 117.121 172.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.255 1.391 0 CA-C-N 119.299 1.549 . . . . 0.0 110.595 175.069 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.333 0.111 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -22.51 66.07 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.09 117.36 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.96 1.704 . . . . 0.0 109.995 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m -71.82 140.89 49.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.812 0.845 . . . . 0.0 111.237 171.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.8 120.12 13.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.671 0.789 . . . . 0.0 110.978 170.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.5 m -57.3 145.63 66.18 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.31 1.044 . . . . 0.0 112.777 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.87 165.35 32.84 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.609 2.873 . . . . 0.0 112.344 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -92.05 -8.48 45.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.119 1.368 . . . . 0.0 114.508 -174.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 tt -67.41 156.13 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.638 1.575 . . . . 0.0 112.839 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.7 mt -88.44 -160.86 0.68 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.303 1.841 . . . . 0.0 111.356 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 55.29 70.41 1.6 Allowed Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 126.969 2.108 . . . . 0.0 112.555 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.63 169.31 11.59 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.382 2.721 . . . . 0.0 113.667 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.3 m -136.08 172.0 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.671 2.389 . . . . 0.0 111.086 -176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.49 107.32 13.17 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.362 1.865 . . . . 0.0 109.583 -171.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.58 167.53 52.12 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.48 1.044 . . . . 0.0 112.238 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.3 p -76.33 -8.53 57.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.896 1.279 . . . . 0.0 112.112 -173.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.5 -14.14 49.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.357 1.463 . . . . 0.0 112.579 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.83 9.82 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.29 0.948 . . . . 0.0 113.879 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.01 153.67 46.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.203 2.201 . . . . 0.0 110.287 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.1 m -84.07 139.52 32.43 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.312 1.445 . . . . 0.0 111.799 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -135.62 137.08 41.56 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.311 1.444 . . . . 0.0 110.312 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.91 -23.29 67.29 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.16 -0.962 . . . . 0.0 113.04 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.62 172.64 17.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.985 0.914 . . . . 0.0 113.336 166.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t -58.08 -26.51 62.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.946 1.298 . . . . 0.0 113.47 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.97 -30.46 59.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.294 1.438 . . . . 0.0 113.501 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.36 -52.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.213 1.405 . . . . 0.0 111.599 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.36 64.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.965 1.306 . . . . 0.0 111.474 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -64.15 -29.13 70.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.794 1.237 . . . . 0.0 113.338 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.55 -7.76 59.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.065 1.346 . . . . 0.0 113.752 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -108.12 4.42 24.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.225 1.81 . . . . 0.0 112.036 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.24 6.61 87.77 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.453 1.502 . . . . 0.0 114.598 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.6 t -89.24 164.22 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.757 2.023 . . . . 0.0 109.246 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -123.73 161.25 25.54 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.93 1.292 . . . . 0.0 110.205 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.11 136.03 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 120.787 -1.195 . . . . 0.0 110.324 174.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -119.28 -61.38 1.64 Allowed 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.505 1.522 . . . . 0.0 109.688 -177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 t -133.76 171.55 13.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.7 1.2 . . . . 0.0 112.833 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.77 168.93 11.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.434 2.694 . . . . 0.0 112.688 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.39 174.28 5.75 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.398 1.951 . . . . 0.0 113.808 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 t -59.42 127.55 32.65 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.575 -0.956 . . . . 0.0 110.863 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.43 135.78 84.04 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.64 1.576 . . . . 0.0 111.051 -173.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.61 155.5 63.01 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.85 2.366 . . . . 0.0 113.14 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.6 m -89.63 40.31 0.99 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.633 1.573 . . . . 0.0 111.697 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.07 -0.57 25.51 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.726 1.632 . . . . 0.0 115.632 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.888 2.075 . . . . 0.0 110.835 177.672 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -135.44 150.23 49.8 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.075 1.75 . . . . 0.0 110.67 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.07 -23.09 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 m -98.27 -53.69 3.28 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.077 1.351 . . . . 0.0 111.893 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.99 29.68 3.6 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.685 1.994 . . . . 0.0 114.904 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.7 m 49.57 83.54 0.22 Allowed Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 127.681 2.392 . . . . 0.0 113.508 -172.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.61 174.46 12.19 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.264 3.309 . . . . 0.0 112.724 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -133.69 75.61 1.61 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.028 1.731 . . . . 0.0 110.871 -171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.34 138.37 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.975 2.11 . . . . 0.0 108.311 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.35 178.4 4.57 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.428 1.491 . . . . 0.0 112.576 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt 57.81 68.91 1.71 Allowed Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 126.766 2.026 . . . . 0.0 112.055 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -66.15 172.33 8.88 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 124.051 3.167 . . . . 0.0 113.462 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 m -138.01 173.25 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.881 1.672 . . . . 0.0 112.631 -174.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.22 119.05 34.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.525 1.53 . . . . 0.0 111.663 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.94 169.05 43.26 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 122.609 1.116 . . . . 0.0 112.786 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -78.71 -9.06 59.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.372 1.469 . . . . 0.0 112.303 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.48 -13.15 59.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.153 1.381 . . . . 0.0 112.143 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.57 34.56 15.96 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.875 1.226 . . . . 0.0 113.828 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -124.94 159.51 31.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.388 2.275 . . . . 0.0 110.255 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -100.21 136.77 39.59 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.453 1.501 . . . . 0.0 112.155 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -138.8 150.25 45.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.525 1.53 . . . . 0.0 111.569 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.17 -23.46 67.32 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -157.97 170.05 23.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.774 2.03 . . . . 0.0 110.655 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -59.6 -29.44 67.98 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.249 1.42 . . . . 0.0 113.428 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 t -54.81 -51.11 66.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.817 1.647 . . . . 0.0 112.563 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.478 ' H ' HD11 ' A' ' 26' ' ' ILE . 3.5 mp -61.07 -48.18 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.247 1.419 . . . . 0.0 111.07 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.82 70.59 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.594 0.711 . . . . 0.0 110.087 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -71.75 -24.65 61.81 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -18.02 64.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.27 1.428 . . . . 0.0 113.942 168.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -113.26 -1.83 14.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.019 1.727 . . . . 0.0 112.621 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.73 2.11 82.08 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.785 1.66 . . . . 0.0 115.184 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -72.41 161.16 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.344 1.458 . . . . 0.0 108.672 165.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.0 p -120.78 167.27 12.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.645 1.178 . . . . 0.0 110.485 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.9 140.85 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 120.714 -1.241 . . . . 0.0 110.891 174.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.82 -61.06 1.4 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.053 1.741 . . . . 0.0 109.811 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -134.77 164.93 26.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 112.459 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -95.94 168.63 10.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.315 2.246 . . . . 0.0 112.121 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.65 160.16 7.38 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.331 1.919 . . . . 0.0 112.842 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 p -64.68 122.69 17.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.293 -1.122 . . . . 0.0 110.806 169.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 149.67 90.06 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.651 1.18 . . . . 0.0 111.947 -176.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.57 159.53 42.64 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.038 2.492 . . . . 0.0 112.945 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.0 p -101.93 -13.04 17.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.851 1.66 . . . . 0.0 113.707 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.13 -19.31 3.89 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.357 1.932 . . . . 0.0 114.66 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.253 1.273 0 C-N-CA 125.87 1.668 . . . . 0.0 110.538 172.368 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 110.758 -0.089 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.75 70.63 1.44 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.869 1.668 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.69 128.98 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.718 1.207 . . . . 0.0 112.286 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.2 m -97.21 14.39 26.09 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.416 1.886 . . . . 0.0 114.06 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.92 24.76 7.89 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.222 1.809 . . . . 0.0 113.947 -170.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.0 p -60.85 153.36 64.86 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.083 1.753 . . . . 0.0 115.341 -170.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.57 175.99 10.66 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.899 3.066 . . . . 0.0 112.773 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -122.72 8.72 9.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.487 1.915 . . . . 0.0 113.309 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.5 mt -66.18 137.35 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.462 2.305 . . . . 0.0 111.101 -174.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 tp -77.72 37.12 0.22 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.913 1.685 . . . . 0.0 113.722 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -130.81 70.95 82.59 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 125.695 1.598 . . . . 0.0 111.606 173.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.79 164.82 22.92 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.547 2.164 . . . . 0.0 112.816 172.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.24 172.82 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 128.161 2.584 . . . . 0.0 110.866 -177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.33 116.4 28.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.002 1.321 . . . . 0.0 111.292 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.65 168.26 43.44 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.481 1.045 . . . . 0.0 112.42 172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.6 t -78.55 -11.07 59.94 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.006 1.322 . . . . 0.0 111.376 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.03 -12.82 60.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.93 1.292 . . . . 0.0 112.331 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.85 28.79 17.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.08 1.324 . . . . 0.0 114.72 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -125.82 154.29 42.84 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.286 2.234 . . . . 0.0 110.377 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -83.91 140.74 31.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.785 1.634 . . . . 0.0 112.373 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.88 141.97 42.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.303 1.841 . . . . 0.0 110.21 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.94 -19.76 65.36 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -154.68 169.61 23.49 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.303 1.441 . . . . 0.0 111.861 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.5 p -56.15 -29.55 60.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.726 1.611 . . . . 0.0 113.816 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -61.5 -33.97 74.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.784 0.802 . . . . 0.0 112.571 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mt -78.13 -44.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.329 1.451 . . . . 0.0 111.106 -175.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.44 -43.5 68.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.791 0.837 . . . . 0.0 110.149 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.76 -42.61 97.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.392 1.077 . . . . 0.0 112.884 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.8 t -58.69 -20.26 46.97 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.705 1.202 . . . . 0.0 113.862 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -106.14 3.55 28.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.027 1.731 . . . . 0.0 112.272 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 3.91 89.02 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.755 1.645 . . . . 0.0 115.351 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.44 160.73 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.375 1.87 . . . . 0.0 109.076 170.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.5 p -118.76 153.47 34.37 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.17 0.988 . . . . 0.0 109.815 172.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.19 139.86 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.17 -0.956 . . . . 0.0 110.761 175.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.73 -60.13 1.62 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.651 1.58 . . . . 0.0 109.939 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -134.09 158.3 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.436 1.095 . . . . 0.0 112.41 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.94 166.12 20.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 112.945 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.27 163.56 4.5 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.471 1.986 . . . . 0.0 114.16 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.9 t -61.04 127.75 33.07 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.448 -1.03 . . . . 0.0 110.789 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 146.42 78.54 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.13 0.972 . . . . 0.0 111.512 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.57 -177.2 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.452 2.768 . . . . 0.0 112.69 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.3 m 70.46 42.79 0.85 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.626 1.571 . . . . 0.0 110.803 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.13 21.3 0.1 OUTLIER Glycine 0 CA--C 1.537 1.427 0 N-CA-C 116.109 1.203 . . . . 0.0 116.109 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.782 1.633 . . . . 0.0 111.84 178.391 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -68.71 -22.98 64.32 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.55 160.32 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.761 2.024 . . . . 0.0 110.177 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.7 p -64.91 169.76 4.92 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.963 0.905 . . . . 0.0 113.196 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.84 162.93 30.67 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.203 1.401 . . . . 0.0 111.443 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.8 m -121.68 70.32 26.3 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.46 1.904 . . . . 0.0 111.36 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.55 162.3 40.23 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.56 2.84 . . . . 0.0 112.716 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -91.76 7.85 39.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.188 1.795 . . . . 0.0 113.79 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.6 tp -49.72 131.06 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 127.481 2.312 . . . . 0.0 112.953 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.17 176.21 4.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.205 1.402 . . . . 0.0 112.955 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? 51.59 65.43 6.48 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 126.566 1.946 . . . . 0.0 112.532 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.84 175.39 3.05 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.753 2.968 . . . . 0.0 113.558 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.7 m -132.52 172.38 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.596 1.958 . . . . 0.0 111.646 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -122.69 106.83 11.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.308 1.843 . . . . 0.0 109.69 -169.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.53 167.89 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 122.592 1.107 . . . . 0.0 112.411 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.3 t -77.28 -11.94 59.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.574 1.15 . . . . 0.0 111.226 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.12 -11.84 59.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.058 1.343 . . . . 0.0 112.508 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 38.05 11.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.719 1.152 . . . . 0.0 113.792 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 -130.28 154.24 47.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.99 2.116 . . . . 0.0 110.639 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.0 m -83.09 139.66 33.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.434 1.494 . . . . 0.0 111.999 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -135.22 140.52 45.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.942 171.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.9 70.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.49 -0.756 . . . . 0.0 112.623 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.47 174.21 14.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.048 1.339 . . . . 0.0 111.271 170.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -61.32 -24.64 66.58 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.876 1.27 . . . . 0.0 113.873 170.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.88 -32.33 65.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.013 1.325 . . . . 0.0 113.618 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.818 1.247 . . . . 0.0 112.114 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.04 -40.81 64.21 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.427 1.091 . . . . 0.0 111.418 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -66.81 -30.28 70.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.026 1.331 . . . . 0.0 112.97 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.56 -11.58 60.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.724 1.61 . . . . 0.0 113.789 174.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.94 3.63 18.95 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.539 1.935 . . . . 0.0 111.962 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.32 90.02 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.77 1.652 . . . . 0.0 115.093 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.43 156.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.827 1.651 . . . . 0.0 109.248 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.5 p -115.3 156.17 25.93 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.228 1.011 . . . . 0.0 110.064 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.15 137.34 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.181 -0.949 . . . . 0.0 110.246 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -121.29 -60.85 1.59 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 125.576 1.55 . . . . 0.0 109.664 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -133.03 171.84 13.44 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.812 1.245 . . . . 0.0 112.687 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.45 168.95 9.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.864 2.466 . . . . 0.0 111.971 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.11 168.49 10.79 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.983 1.754 . . . . 0.0 112.953 -170.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.3 t -58.64 128.98 39.92 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.578 -0.954 . . . . 0.0 110.416 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.88 139.8 91.04 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.001 1.72 . . . . 0.0 110.725 -174.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.81 179.29 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.248 2.632 . . . . 0.0 112.498 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.4 m 65.78 30.32 10.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.146 1.379 . . . . 0.0 111.467 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.08 -8.04 0.04 OUTLIER Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.341 1.448 . . . . 0.0 115.785 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 tt . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.818 1.647 . . . . 0.0 113.339 173.04 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.4 tttt . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 120.888 0.375 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -98.45 -21.56 16.49 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.4 138.63 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.761 2.024 . . . . 0.0 109.695 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 94.2 m -76.79 157.38 31.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.14 0.576 . . . . 0.0 111.885 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.33 168.78 15.22 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.417 0.687 . . . . 0.0 112.275 170.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.67 154.25 80.54 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.207 1.403 . . . . 0.0 111.826 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.46 169.44 22.4 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.275 2.65 . . . . 0.0 112.595 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -102.87 56.02 0.76 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.623 1.569 . . . . 0.0 111.925 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 tt -129.4 143.65 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.854 1.662 . . . . 0.0 111.584 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 tp -93.11 42.65 1.1 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.469 1.508 . . . . 0.0 111.91 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -123.65 66.58 37.09 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 126.483 1.913 . . . . 0.0 111.536 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.95 167.54 19.49 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.537 2.158 . . . . 0.0 112.941 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.55 170.02 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.919 2.487 . . . . 0.0 111.252 -177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -110.41 115.61 29.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.818 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.5 42.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 122.488 1.049 . . . . 0.0 112.546 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -77.49 -13.73 59.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.839 1.256 . . . . 0.0 111.104 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.36 -13.52 59.81 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.978 1.311 . . . . 0.0 112.471 171.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.07 60.97 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.953 1.739 . . . . 0.0 115.547 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.55 166.75 11.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.169 1.388 . . . . 0.0 111.427 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -92.48 139.24 30.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.88 1.672 . . . . 0.0 111.813 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -135.76 138.49 42.71 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.672 1.589 . . . . 0.0 110.454 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.66 -26.34 67.0 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -158.5 174.44 15.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.394 1.478 . . . . 0.0 111.98 167.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.0 t -67.62 -14.43 62.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.281 1.432 . . . . 0.0 114.683 171.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 t -69.39 -23.91 63.79 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.589 -1.319 . . . . 0.0 113.939 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.02 -47.55 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.996 1.318 . . . . 0.0 113.881 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.16 37.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.836 0.826 . . . . 0.0 111.557 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -79.2 -22.88 44.29 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.939 1.296 . . . . 0.0 113.887 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.38 -21.4 59.68 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.388 1.475 . . . . 0.0 112.719 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.27 -27.08 16.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.089 1.356 . . . . 0.0 112.119 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.26 0.23 16.5 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.25 1.881 . . . . 0.0 115.312 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.26 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.032 1.733 . . . . 0.0 109.255 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.3 p -119.5 154.59 33.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.111 0.965 . . . . 0.0 110.183 171.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.91 140.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.256 -0.902 . . . . 0.0 110.794 176.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.9 -62.22 1.13 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.579 1.552 . . . . 0.0 109.919 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -128.37 164.33 22.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.384 1.474 . . . . 0.0 111.995 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 167.4 11.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.629 2.372 . . . . 0.0 112.697 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.28 166.66 7.4 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.431 1.967 . . . . 0.0 113.95 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -63.68 128.03 33.99 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.616 -0.932 . . . . 0.0 110.547 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.19 142.57 44.16 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.649 1.18 . . . . 0.0 112.036 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.81 167.12 27.46 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.278 2.652 . . . . 0.0 112.695 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.3 p -75.82 -9.12 58.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.088 1.355 . . . . 0.0 114.176 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.51 10.9 30.24 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.458 1.504 . . . . 0.0 114.959 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.7 tt . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.929 1.692 . . . . 0.0 113.668 176.244 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 CA--C 1.537 0.66 0 CA-C-O 121.993 0.747 . . . . 0.0 113.26 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.3 m -134.42 172.5 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.324 2.25 . . . . 0.0 111.709 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.8 t -111.5 118.92 37.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.821 1.248 . . . . 0.0 111.364 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.57 169.69 49.67 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 122.581 1.1 . . . . 0.0 112.479 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 t -79.16 -6.75 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.875 1.27 . . . . 0.0 111.5 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.24 -12.29 58.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.879 1.271 . . . . 0.0 112.412 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.44 30.97 17.57 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.178 1.37 . . . . 0.0 114.543 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -127.22 155.67 43.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.424 2.29 . . . . 0.0 110.067 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.9 m -82.52 140.49 33.29 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.538 1.535 . . . . 0.0 112.261 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -137.24 142.38 42.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.115 1.766 . . . . 0.0 110.706 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.09 -26.54 68.34 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.56 173.24 17.17 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.655 1.582 . . . . 0.0 111.784 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -59.08 -32.86 70.18 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.422 1.089 . . . . 0.0 113.241 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.4 m -54.76 -33.73 61.67 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.484 1.514 . . . . 0.0 113.506 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mm -81.21 -48.23 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.196 1.398 . . . . 0.0 110.649 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.48 -44.71 65.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.471 1.108 . . . . 0.0 110.29 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -59.78 -44.74 93.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.834 1.253 . . . . 0.0 112.396 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.43 -10.29 49.89 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.85 2.11 29.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.014 1.726 . . . . 0.0 112.133 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 6.13 88.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.838 1.685 . . . . 0.0 115.041 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.45 162.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.395 2.278 . . . . 0.0 109.223 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.9 p -119.0 155.86 30.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.96 171.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -68.08 140.13 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.114 -0.991 . . . . 0.0 110.519 174.38 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -125.42 -61.54 1.26 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.618 1.567 . . . . 0.0 109.897 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -134.62 173.51 11.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.819 1.248 . . . . 0.0 112.312 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -104.91 165.88 10.77 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.166 2.586 . . . . 0.0 112.951 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.22 166.61 6.0 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.146 1.831 . . . . 0.0 113.823 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.8 t -60.96 127.09 29.89 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.466 -1.02 . . . . 0.0 110.232 168.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.833 0 C-N-CA 124.003 0.921 . . . . 0.0 111.306 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 CA--C 1.538 0.699 0 CA-C-O 122.056 0.774 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.761 ' HB ' HD11 ' A' ' 34' ' ' ILE . 28.0 m -140.4 176.2 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.747 2.419 . . . . 0.0 111.538 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -119.65 119.75 34.63 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.694 1.597 . . . . 0.0 111.226 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.79 168.17 47.13 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.511 1.062 . . . . 0.0 112.268 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -74.42 -11.23 60.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.784 1.634 . . . . 0.0 112.036 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -78.76 -12.53 60.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.46 1.504 . . . . 0.0 112.157 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.68 30.82 17.26 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.287 1.423 . . . . 0.0 114.437 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -129.27 151.96 49.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.568 2.347 . . . . 0.0 110.344 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -80.37 140.42 36.07 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.624 1.57 . . . . 0.0 112.44 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -134.77 146.74 49.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.552 1.941 . . . . 0.0 110.985 172.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -22.74 67.05 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -158.62 171.05 20.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.255 1.422 . . . . 0.0 111.307 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -56.47 -35.64 68.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.823 1.249 . . . . 0.0 113.109 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.8 m -61.2 -27.65 68.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.828 1.251 . . . . 0.0 113.188 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 mm -84.56 -47.7 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.95 1.7 . . . . 0.0 110.261 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.24 -42.96 61.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.64 1.176 . . . . 0.0 111.031 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.05 -41.43 99.47 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.421 1.088 . . . . 0.0 112.637 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -67.65 -18.27 64.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -101.55 -1.83 32.0 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.818 1.647 . . . . 0.0 112.425 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.48 11.42 59.52 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.58 1.562 . . . . 0.0 115.639 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -101.63 169.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.594 2.358 . . . . 0.0 108.942 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.4 p -126.2 156.19 40.6 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.306 -1.496 . . . . 0.0 110.471 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.761 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.39 136.74 25.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 O-C-N 120.651 -1.281 . . . . 0.0 111.322 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -116.5 -58.58 2.07 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.358 1.463 . . . . 0.0 109.832 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -135.46 143.2 45.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.206 1.402 . . . . 0.0 112.282 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.56 166.14 24.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.726 1.61 . . . . 0.0 112.711 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 159.52 6.41 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.319 1.914 . . . . 0.0 113.641 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -60.4 131.35 50.49 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.063 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.55 0.95 0 C-N-CA 123.476 0.71 . . . . 0.0 111.622 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 CA-C-O 121.811 0.671 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.9 m -134.48 169.99 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.9 2.08 . . . . 0.0 111.849 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -113.64 118.64 34.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.378 1.471 . . . . 0.0 110.215 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.7 168.05 43.97 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 122.689 1.161 . . . . 0.0 112.278 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -75.22 -9.77 58.85 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.852 1.661 . . . . 0.0 111.844 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.06 -15.38 59.61 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.779 1.632 . . . . 0.0 112.113 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.48 34.2 14.63 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.432 1.491 . . . . 0.0 113.909 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -132.25 155.81 47.62 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.85 2.46 . . . . 0.0 110.038 -174.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -93.49 140.46 29.56 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.884 1.274 . . . . 0.0 112.705 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.01 138.06 41.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.74 1.616 . . . . 0.0 111.083 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.96 65.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.23 1.012 . . . . 0.0 113.638 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -174.49 4.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.597 1.159 . . . . 0.0 112.57 167.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -24.33 67.16 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.61 -2.58 4.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.174 1.79 . . . . 0.0 115.396 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -46.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.908 1.683 . . . . 0.0 113.501 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.83 53.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.895 0.855 . . . . 0.0 110.983 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.37 -22.74 57.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.989 1.315 . . . . 0.0 113.259 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -10.84 59.15 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.596 1.559 . . . . 0.0 113.197 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -108.9 -9.08 15.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.238 1.815 . . . . 0.0 112.688 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.9 57.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.736 1.636 . . . . 0.0 115.349 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.64 161.44 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.504 1.522 . . . . 0.0 109.347 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -122.1 144.67 48.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.841 1.256 . . . . 0.0 109.768 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.561 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -63.73 135.87 27.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.27 -1.519 . . . . 0.0 110.848 175.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.47 -60.43 1.88 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.917 1.287 . . . . 0.0 109.285 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 p -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.357 1.463 . . . . 0.0 111.76 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -74.66 168.28 20.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.119 1.367 . . . . 0.0 112.681 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.0 159.22 12.07 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.106 1.812 . . . . 0.0 113.307 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 132.43 51.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.166 0.986 . . . . 0.0 110.758 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.891 0 O-C-N 121.738 -0.601 . . . . 0.0 111.683 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 CA-C-O 122.241 0.85 . . . . 0.0 113.758 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 34' ' ' ILE . 26.9 m -136.93 171.04 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.562 2.345 . . . . 0.0 111.421 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 t -115.06 118.3 33.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.44 1.496 . . . . 0.0 110.321 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.97 167.18 48.97 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 122.464 1.035 . . . . 0.0 112.514 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -76.99 -12.15 59.9 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.584 1.554 . . . . 0.0 111.135 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.18 -14.59 59.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.589 1.555 . . . . 0.0 112.342 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.67 25.46 20.5 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.237 1.399 . . . . 0.0 115.145 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -121.93 152.07 40.05 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.385 2.274 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.4 m -80.66 143.95 32.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.25 1.42 . . . . 0.0 112.061 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -134.2 141.1 46.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.136 1.774 . . . . 0.0 110.59 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -24.67 64.77 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -159.76 -179.27 7.7 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.918 1.687 . . . . 0.0 110.809 166.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.7 p -63.33 -24.22 67.76 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 170.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.74 -14.59 53.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.55 1.54 . . . . 0.0 115.103 -170.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.07 -42.61 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.052 1.741 . . . . 0.0 113.339 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.99 39.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.985 0.898 . . . . 0.0 110.516 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -78.92 -29.03 43.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.427 1.491 . . . . 0.0 113.242 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.94 -27.23 64.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.435 1.094 . . . . 0.0 112.767 170.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.2 -24.25 23.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.839 1.255 . . . . 0.0 112.086 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.73 3.39 30.38 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.306 1.908 . . . . 0.0 114.996 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.53 158.69 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.31 1.844 . . . . 0.0 109.252 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 p -115.75 145.09 43.1 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.334 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -63.54 137.97 23.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 120.99 -1.069 . . . . 0.0 110.911 174.208 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -118.17 -57.82 2.05 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.028 1.331 . . . . 0.0 109.73 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -131.94 136.81 47.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -70.34 162.18 29.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.118 1.367 . . . . 0.0 112.223 172.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.97 162.66 19.62 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.647 2.07 . . . . 0.0 113.391 -171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.7 t -61.14 131.3 50.07 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.682 -0.893 . . . . 0.0 110.638 172.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 123.331 0.652 . . . . 0.0 111.295 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 CA--C 1.537 0.664 0 CA-C-O 122.153 0.814 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.675 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.1 m -136.67 172.6 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.306 2.243 . . . . 0.0 111.328 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 t -113.94 118.21 33.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.435 1.494 . . . . 0.0 110.999 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.53 169.09 45.03 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 122.426 1.015 . . . . 0.0 112.417 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.2 t -75.93 -13.64 60.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.359 1.464 . . . . 0.0 111.266 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -8.39 59.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.866 1.267 . . . . 0.0 112.475 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.05 26.3 29.21 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.008 1.29 . . . . 0.0 114.984 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -123.1 152.77 40.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.288 2.235 . . . . 0.0 110.397 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -78.25 139.84 38.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.598 1.559 . . . . 0.0 112.261 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -133.95 141.42 47.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.356 1.862 . . . . 0.0 110.512 171.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.28 67.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 0.0 113.282 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.39 172.41 17.33 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.505 1.122 . . . . 0.0 112.959 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -62.83 -26.89 68.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.376 1.471 . . . . 0.0 113.18 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.09 -22.66 63.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.49 1.516 . . . . 0.0 114.896 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pt -105.44 -43.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.8 -34.97 42.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.14 0.972 . . . . 0.0 111.258 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.74 -29.84 56.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.596 1.158 . . . . 0.0 113.751 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -75.57 -10.74 59.7 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.662 1.185 . . . . 0.0 113.118 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -103.6 -0.88 29.07 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.083 1.753 . . . . 0.0 112.36 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.94 80.45 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.842 1.687 . . . . 0.0 115.264 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 t -78.62 161.16 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.525 1.53 . . . . 0.0 109.207 171.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.5 p -119.96 151.65 38.63 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.313 1.045 . . . . 0.0 109.976 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.35 138.37 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 175.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -123.75 -61.27 1.39 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.391 1.476 . . . . 0.0 110.073 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.4 m -131.68 156.91 45.04 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.918 1.287 . . . . 0.0 111.981 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.08 169.2 15.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.807 2.043 . . . . 0.0 112.934 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.82 165.08 5.8 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.686 2.089 . . . . 0.0 114.189 -175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.3 t -62.81 127.83 33.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.357 -1.084 . . . . 0.0 110.45 170.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 124.229 1.011 . . . . 0.0 111.813 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 CA--C 1.536 0.613 0 CA-C-O 121.858 0.691 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.626 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.6 m -131.87 171.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 127.375 2.27 . . . . 0.0 111.971 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.0 119.51 38.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.191 1.396 . . . . 0.0 111.446 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.78 169.54 41.73 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 122.587 1.104 . . . . 0.0 112.443 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -78.58 -10.43 59.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.532 1.533 . . . . 0.0 111.249 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.41 -12.92 60.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.01 1.324 . . . . 0.0 112.247 168.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.75 30.45 23.78 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.368 1.461 . . . . 0.0 114.222 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -129.86 158.82 38.41 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.31 2.244 . . . . 0.0 110.782 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -87.93 139.39 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.684 1.594 . . . . 0.0 113.213 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -138.67 144.8 39.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.048 2.139 . . . . 0.0 109.931 174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.94 72.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.194 -0.941 . . . . 0.0 112.745 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -153.97 176.14 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.094 1.758 . . . . 0.0 111.836 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -68.86 -21.22 64.28 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.147 1.379 . . . . 0.0 114.384 170.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.09 -4.3 28.14 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.142 1.377 . . . . 0.0 114.57 -173.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.74 -42.19 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.178 1.791 . . . . 0.0 114.087 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.61 -35.06 40.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.229 0.922 . . . . 0.0 111.391 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -79.51 -18.71 51.33 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.304 1.442 . . . . 0.0 113.869 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 t -73.82 -10.93 60.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.151 1.38 . . . . 0.0 113.004 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -120.1 3.95 10.9 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.706 2.002 . . . . 0.0 112.572 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.11 1.43 84.47 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.978 1.752 . . . . 0.0 115.617 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.69 157.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.255 1.422 . . . . 0.0 109.097 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 p -115.19 154.57 28.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.351 1.06 . . . . 0.0 109.87 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.1 138.52 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 120.934 -1.104 . . . . 0.0 110.605 173.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -123.56 -61.84 1.36 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.603 1.561 . . . . 0.0 109.993 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -133.13 170.31 15.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.976 1.311 . . . . 0.0 112.599 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -98.36 168.23 10.34 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.202 2.601 . . . . 0.0 112.638 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.65 164.53 6.55 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.321 1.915 . . . . 0.0 113.764 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -61.19 129.07 39.5 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.583 -0.951 . . . . 0.0 110.443 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 123.678 0.791 . . . . 0.0 111.716 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 CA--C 1.537 0.669 0 CA-C-O 122.216 0.84 . . . . 0.0 113.531 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -137.8 170.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 128.06 2.544 . . . . 0.0 111.311 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -113.77 117.76 32.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.425 1.49 . . . . 0.0 110.352 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 167.88 48.59 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.544 1.08 . . . . 0.0 112.404 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 t -78.61 -7.57 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 111.301 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.82 -13.08 59.67 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.245 1.418 . . . . 0.0 112.247 170.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.0 31.58 14.5 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.026 1.298 . . . . 0.0 114.295 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -127.54 152.37 47.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.464 2.306 . . . . 0.0 110.327 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.7 m -85.2 140.63 30.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.513 1.525 . . . . 0.0 111.964 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.91 139.65 46.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.097 1.759 . . . . 0.0 110.626 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.25 -24.38 64.84 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -159.09 179.36 9.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.902 1.681 . . . . 0.0 110.734 163.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.1 p -62.75 -22.23 66.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.24 -26.99 68.12 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 -45.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.153 1.381 . . . . 0.0 113.475 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.49 -39.31 33.39 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.1 0.953 . . . . 0.0 110.899 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -78.71 -28.69 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.513 1.525 . . . . 0.0 113.714 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.85 -19.49 58.85 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.941 0.896 . . . . 0.0 112.854 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -89.08 -22.64 22.81 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.046 1.338 . . . . 0.0 112.079 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.59 2.66 37.54 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.655 2.074 . . . . 0.0 115.349 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.08 159.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.163 1.785 . . . . 0.0 109.257 168.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.5 p -117.72 145.54 44.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.427 173.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.456 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -62.83 136.79 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.073 -1.017 . . . . 0.0 110.929 174.348 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -117.06 -56.94 2.21 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.912 1.285 . . . . 0.0 109.896 -175.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -134.11 141.84 47.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.75 1.62 . . . . 0.0 112.267 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.19 162.65 29.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.292 1.437 . . . . 0.0 112.329 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.69 162.79 22.64 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.77 2.129 . . . . 0.0 113.46 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -62.18 131.16 48.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.673 -0.898 . . . . 0.0 110.927 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 114.28 0.838 . . . . 0.0 114.28 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' A' ' 34' ' ' ILE . 28.7 m -136.23 171.27 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.514 2.326 . . . . 0.0 111.985 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 t -117.84 120.1 36.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.572 1.549 . . . . 0.0 110.598 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.88 48.67 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 122.774 1.208 . . . . 0.0 112.705 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -75.41 -11.14 59.98 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.719 2.008 . . . . 0.0 111.922 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.99 -13.77 59.6 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.523 1.529 . . . . 0.0 112.185 171.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.83 25.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.391 1.472 . . . . 0.0 114.533 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -121.59 149.58 42.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.22 2.208 . . . . 0.0 110.853 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -81.96 139.88 34.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.118 1.767 . . . . 0.0 112.05 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -133.2 141.27 48.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.247 1.819 . . . . 0.0 110.818 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.76 67.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.2 176.39 11.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.737 1.215 . . . . 0.0 112.317 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -64.0 -26.39 68.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.921 0.888 . . . . 0.0 113.306 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -60.39 -20.62 60.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.06 1.344 . . . . 0.0 114.552 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.8 -51.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 111.617 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.65 64.38 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.088 1.355 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.75 1.62 . . . . 0.0 113.075 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -84.56 -7.37 59.28 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.955 1.702 . . . . 0.0 113.316 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -113.31 1.71 15.26 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.315 1.846 . . . . 0.0 112.602 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 15.71 55.01 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.083 1.325 . . . . 0.0 115.373 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.76 159.26 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.311 1.844 . . . . 0.0 109.639 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.1 p -116.35 146.52 42.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.999 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -64.3 133.53 29.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 O-C-N 120.359 -1.463 . . . . 0.0 110.946 173.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -113.71 -58.68 2.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.775 1.23 . . . . 0.0 109.969 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -130.58 138.41 50.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.614 1.566 . . . . 0.0 111.946 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.48 164.44 26.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.689 1.596 . . . . 0.0 112.568 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 165.02 11.24 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.993 1.759 . . . . 0.0 113.397 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.43 133.5 55.11 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.376 -1.073 . . . . 0.0 111.024 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.888 0 C-N-CA 123.069 0.547 . . . . 0.0 111.489 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 122.424 0.927 . . . . 0.0 113.433 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.5 m -140.0 172.75 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 127.822 2.449 . . . . 0.0 111.287 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 t -114.56 115.55 27.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.285 1.434 . . . . 0.0 111.293 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.41 169.46 36.78 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 122.492 1.051 . . . . 0.0 112.228 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -79.57 -6.49 57.14 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.961 1.304 . . . . 0.0 111.2 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.88 -13.46 59.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.975 1.31 . . . . 0.0 112.149 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.82 31.19 24.44 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.326 1.441 . . . . 0.0 114.009 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -130.9 157.85 41.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.206 2.203 . . . . 0.0 110.749 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.7 m -89.1 138.02 31.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.365 1.466 . . . . 0.0 112.8 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.59 143.14 43.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.582 1.953 . . . . 0.0 110.368 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.97 -27.17 66.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 173.05 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 167.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -56.44 -32.86 65.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.914 1.686 . . . . 0.0 112.897 171.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -57.73 -27.97 63.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.412 1.085 . . . . 0.0 113.709 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 pt -104.93 -36.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.51 -30.59 31.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.477 1.035 . . . . 0.0 111.212 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -77.18 -28.61 54.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.672 1.589 . . . . 0.0 113.366 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.1 -10.14 59.47 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.147 0.979 . . . . 0.0 112.993 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -106.24 -0.8 24.19 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.987 1.715 . . . . 0.0 112.147 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.93 89.32 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.702 1.62 . . . . 0.0 115.331 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -81.09 163.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.418 1.487 . . . . 0.0 108.668 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -125.91 157.84 36.67 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.918 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.673 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.07 138.65 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 124.305 1.042 . . . . 0.0 111.398 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -124.35 -59.36 1.48 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.517 1.527 . . . . 0.0 110.307 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -134.59 167.87 20.01 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 112.293 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -100.87 167.52 10.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.223 2.209 . . . . 0.0 112.734 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 163.77 5.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.783 2.135 . . . . 0.0 112.97 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -62.07 126.09 26.12 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.254 -1.145 . . . . 0.0 110.98 169.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 124.786 1.234 . . . . 0.0 111.789 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 CA--C 1.535 0.526 0 CA-C-O 122.05 0.771 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.674 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.5 m -139.96 172.14 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.555 2.342 . . . . 0.0 111.089 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.3 t -114.28 116.86 29.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.082 1.353 . . . . 0.0 111.013 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.13 169.54 46.05 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 122.639 1.133 . . . . 0.0 112.666 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -74.85 -12.26 60.34 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 111.998 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.03 -8.58 59.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.28 1.432 . . . . 0.0 112.268 172.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.26 30.51 22.2 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.841 1.21 . . . . 0.0 114.591 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -126.29 152.87 45.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.578 2.351 . . . . 0.0 109.963 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.2 m -81.67 140.09 34.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.115 1.366 . . . . 0.0 111.882 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -132.08 138.92 48.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.927 1.691 . . . . 0.0 109.842 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -23.22 63.29 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.49 178.82 8.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.881 1.273 . . . . 0.0 112.264 166.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 p -72.09 -7.56 49.65 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.4 t -75.94 -17.88 59.57 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -48.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.906 1.282 . . . . 0.0 113.409 -174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.34 -40.07 16.38 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.566 1.146 . . . . 0.0 111.645 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -71.8 -36.43 70.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.601 -1.182 . . . . 0.0 113.854 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.11 -22.87 63.94 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.381 1.472 . . . . 0.0 112.512 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -88.23 -28.62 21.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.565 1.146 . . . . 0.0 111.844 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.59 1.24 13.64 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.335 1.921 . . . . 0.0 115.17 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.6 t -72.93 159.78 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.47 1.908 . . . . 0.0 109.457 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -113.5 154.81 26.45 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.726 0.81 . . . . 0.0 110.449 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.36 135.82 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 120.53 -1.356 . . . . 0.0 110.651 174.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -121.44 -58.98 1.74 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.314 1.446 . . . . 0.0 110.309 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -131.09 159.25 38.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.458 1.103 . . . . 0.0 112.319 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.26 166.17 13.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.456 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 164.49 7.7 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.711 2.101 . . . . 0.0 113.679 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 t -62.26 128.07 34.32 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.493 -1.004 . . . . 0.0 110.677 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.852 0 C-N-CA 124.084 0.953 . . . . 0.0 111.611 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 CA--C 1.536 0.59 0 CA-C-O 121.79 0.662 . . . . 0.0 113.246 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.763 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.6 m -132.76 171.33 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 127.24 2.216 . . . . 0.0 111.417 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -119.83 107.07 12.72 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.392 1.877 . . . . 0.0 109.625 -172.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.41 167.93 51.47 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 122.559 1.088 . . . . 0.0 112.297 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -76.42 -12.29 60.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.852 1.261 . . . . 0.0 111.323 -172.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -81.15 -14.32 57.76 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.039 1.336 . . . . 0.0 112.635 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.81 15.24 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.587 1.089 . . . . 0.0 114.67 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -121.46 154.13 36.99 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.723 2.009 . . . . 0.0 110.439 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -79.9 140.86 36.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.315 1.446 . . . . 0.0 111.475 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -134.33 139.72 45.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.403 1.481 . . . . 0.0 109.86 171.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.79 69.75 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.465 -0.772 . . . . 0.0 112.643 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -154.08 169.79 22.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.923 1.289 . . . . 0.0 111.523 171.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.4 m -56.37 -23.76 39.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.626 1.57 . . . . 0.0 113.605 170.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.1 m -62.72 -13.78 36.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.49 -51.13 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.456 1.503 . . . . 0.0 111.203 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.25 -42.29 60.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.523 1.129 . . . . 0.0 111.463 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -70.38 -21.48 62.86 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -11.09 59.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.943 1.697 . . . . 0.0 113.424 171.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -112.24 3.44 17.15 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.755 2.022 . . . . 0.0 111.953 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.15 5.11 89.13 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.582 1.563 . . . . 0.0 114.784 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -85.54 161.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.481 1.913 . . . . 0.0 109.491 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.7 p -122.28 155.27 36.27 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.467 1.107 . . . . 0.0 110.278 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -66.38 139.39 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.261 -0.899 . . . . 0.0 110.626 174.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -125.78 -57.44 1.44 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.178 1.391 . . . . 0.0 109.973 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 154.73 43.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.285 1.434 . . . . 0.0 112.981 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -76.23 162.72 27.71 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.841 2.057 . . . . 0.0 111.775 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.08 170.87 8.73 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.347 1.927 . . . . 0.0 113.859 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -58.63 133.39 55.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.711 -0.876 . . . . 0.0 111.187 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.548 0.897 0 C-N-CA 125.827 1.651 . . . . 0.0 111.077 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 CA-C-O 121.69 0.621 . . . . 0.0 113.67 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.632 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.5 m -134.86 172.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.481 1.913 . . . . 0.0 112.217 -176.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.6 t -114.06 119.93 38.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 111.579 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.09 169.48 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 122.505 1.058 . . . . 0.0 112.3 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.2 p -74.79 -10.65 59.71 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.431 1.492 . . . . 0.0 112.183 -175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -80.85 -13.36 59.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 0.0 112.189 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.12 25.96 27.5 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.146 1.355 . . . . 0.0 114.593 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -121.26 154.15 36.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.572 2.349 . . . . 0.0 110.043 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -80.57 140.29 35.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 112.261 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -134.69 140.62 46.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.327 1.851 . . . . 0.0 110.406 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.69 70.47 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.668 0.787 . . . . 0.0 112.942 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -155.68 173.87 16.1 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 111.338 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.2 p -62.77 -19.76 64.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -66.82 -14.05 62.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 pt -112.07 -40.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.54 -34.23 49.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.507 1.049 . . . . 0.0 111.57 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -82.09 -13.88 56.62 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.5 t -74.47 -18.82 60.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.515 1.126 . . . . 0.0 113.159 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -122.63 1.23 9.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.072 1.349 . . . . 0.0 114.103 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.66 -0.38 34.36 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.054 1.311 . . . . 0.0 116.345 163.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.33 158.16 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.814 1.246 . . . . 0.0 108.823 167.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.7 p -118.36 161.9 19.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.064 -1.023 . . . . 0.0 110.839 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.7 137.08 23.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 120.764 -1.21 . . . . 0.0 110.713 175.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -122.11 -60.4 1.58 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.622 1.569 . . . . 0.0 110.033 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -134.45 166.46 22.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 112.282 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.88 170.24 9.7 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.13 2.172 . . . . 0.0 112.843 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.39 163.84 5.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.343 1.925 . . . . 0.0 113.648 -172.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -60.29 127.83 33.72 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.426 -1.043 . . . . 0.0 110.403 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 124.113 0.965 . . . . 0.0 111.478 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 CA--C 1.536 0.625 0 N-CA-C 114.362 0.87 . . . . 0.0 114.362 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.7 m -135.96 169.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.21 2.204 . . . . 0.0 112.047 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.3 t -114.09 117.96 32.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.514 1.526 . . . . 0.0 110.454 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.36 169.46 49.58 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 122.707 1.171 . . . . 0.0 112.73 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 t -77.83 -8.39 57.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.147 1.379 . . . . 0.0 111.507 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 -8.29 58.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.877 1.271 . . . . 0.0 112.664 170.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.17 23.75 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.652 1.12 . . . . 0.0 115.14 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -122.88 154.17 38.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.592 2.357 . . . . 0.0 109.967 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -87.04 141.16 28.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.007 1.323 . . . . 0.0 111.638 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -133.44 138.0 46.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.968 1.707 . . . . 0.0 110.657 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.96 67.53 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -158.67 -178.43 7.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.941 1.296 . . . . 0.0 110.559 161.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 p -55.73 -23.49 29.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.477 1.511 . . . . 0.0 114.594 170.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 t -60.93 -16.77 46.07 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.618 1.567 . . . . 0.0 114.527 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.07 -49.39 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.417 1.487 . . . . 0.0 111.591 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.8 58.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.878 1.271 . . . . 0.0 111.101 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -68.95 -23.04 64.09 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.6 t -83.21 -3.59 57.55 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.576 1.55 . . . . 0.0 113.475 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -118.75 7.98 11.74 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.2 1.8 . . . . 0.0 112.327 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.42 7.08 87.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.328 1.442 . . . . 0.0 114.773 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -87.64 162.14 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.228 1.811 . . . . 0.0 109.601 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -125.24 150.72 46.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.341 1.057 . . . . 0.0 109.776 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.487 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -62.4 138.7 22.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.144 -0.973 . . . . 0.0 111.001 174.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.87 -57.98 1.99 Allowed 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 124.987 1.315 . . . . 0.0 109.649 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 p -133.33 135.02 44.53 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.264 1.425 . . . . 0.0 112.333 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -69.67 160.67 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.882 1.673 . . . . 0.0 111.939 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.96 161.04 22.62 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.372 1.939 . . . . 0.0 113.397 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 t -59.78 132.81 55.1 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.681 -0.893 . . . . 0.0 110.723 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.838 0 C-N-CA 123.13 0.572 . . . . 0.0 111.075 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 CA--C 1.532 0.408 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.631 ' HB ' HD11 ' A' ' 34' ' ' ILE . 32.2 m -135.93 174.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.006 1.722 . . . . 0.0 112.44 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 t -119.2 122.48 42.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.13 169.28 51.35 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 122.506 1.059 . . . . 0.0 112.556 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -77.9 -10.72 59.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.315 1.446 . . . . 0.0 111.502 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.949 1.3 . . . . 0.0 112.391 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.51 26.26 23.49 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.089 1.328 . . . . 0.0 114.958 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -121.8 151.75 40.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.234 2.213 . . . . 0.0 110.27 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.8 m -79.66 139.86 37.26 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.627 1.571 . . . . 0.0 111.712 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.57 141.62 48.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.931 1.692 . . . . 0.0 109.974 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.58 76.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.128 -0.357 . . . . 0.0 111.771 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -151.36 167.04 29.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.6 1.16 . . . . 0.0 111.784 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -64.73 -14.4 58.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.029 1.731 . . . . 0.0 114.514 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -67.59 -22.21 65.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.05 1.34 . . . . 0.0 113.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.6 mt -92.76 -54.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.553 1.141 . . . . 0.0 111.345 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.39 61.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.475 1.11 . . . . 0.0 111.301 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -68.49 -24.22 64.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.194 0.997 . . . . 0.0 113.616 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -8.58 58.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.801 1.641 . . . . 0.0 113.704 173.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -111.55 4.0 18.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.869 2.067 . . . . 0.0 112.129 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.34 2.57 90.55 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.668 1.604 . . . . 0.0 115.024 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 t -78.89 164.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.292 1.837 . . . . 0.0 109.223 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 p -124.94 158.27 33.99 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.175 0.99 . . . . 0.0 110.159 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.631 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.6 138.57 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.232 -0.918 . . . . 0.0 110.642 175.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -122.24 -60.36 1.57 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.761 1.624 . . . . 0.0 109.855 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -131.02 152.79 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.605 1.162 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.23 165.4 23.27 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.846 2.058 . . . . 0.0 111.076 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.43 158.77 7.32 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.518 2.009 . . . . 0.0 113.705 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.0 t -60.85 130.17 45.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.513 -0.992 . . . . 0.0 110.57 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.878 0 C-N-CA 123.594 0.757 . . . . 0.0 111.445 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 CA--C 1.534 0.482 0 CA-C-O 121.87 0.696 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' A' ' 34' ' ' ILE . 31.6 m -141.95 172.29 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 127.352 2.261 . . . . 0.0 111.552 -175.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.4 t -112.71 116.75 30.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.465 1.506 . . . . 0.0 111.445 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.46 49.5 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.593 1.107 . . . . 0.0 112.268 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 t -78.77 -6.94 57.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.006 1.322 . . . . 0.0 111.474 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -84.62 -13.12 52.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 112.549 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.93 16.5 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.696 1.141 . . . . 0.0 115.012 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -124.28 153.73 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.366 2.266 . . . . 0.0 109.861 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.3 m -80.71 140.84 35.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.409 1.484 . . . . 0.0 111.995 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -132.88 142.98 49.21 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.049 1.74 . . . . 0.0 109.911 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.08 -22.79 67.08 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -155.85 165.27 36.99 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.679 1.592 . . . . 0.0 111.65 165.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -49.93 -32.36 14.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.19 2.196 . . . . 0.0 113.539 167.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -58.58 -33.16 69.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.016 0.927 . . . . 0.0 112.986 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 mm -85.51 -43.46 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 0.0 111.703 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.89 -42.96 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.573 0.749 . . . . 0.0 110.384 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -67.26 -34.58 77.73 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.452 1.101 . . . . 0.0 113.595 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.6 t -66.33 -15.77 63.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.574 1.149 . . . . 0.0 113.942 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -103.34 2.17 33.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 112.092 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.23 89.05 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.941 1.734 . . . . 0.0 115.068 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.33 158.46 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.449 1.9 . . . . 0.0 109.325 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -115.27 155.23 27.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.148 0.979 . . . . 0.0 109.886 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.666 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.72 139.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.058 -1.026 . . . . 0.0 110.709 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -124.68 -59.54 1.44 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.617 1.567 . . . . 0.0 110.175 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -132.68 166.37 22.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.62 1.168 . . . . 0.0 112.928 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 162.98 13.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.989 2.516 . . . . 0.0 112.771 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.6 165.6 3.75 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.024 2.25 . . . . 0.0 113.27 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -59.76 124.52 20.41 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.849 1.26 . . . . 0.0 111.465 170.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.374 1.47 . . . . 0.0 111.617 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 CA-C-O 122.126 0.802 . . . . 0.0 113.667 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.699 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.3 m -136.08 172.0 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.671 2.389 . . . . 0.0 111.086 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.49 107.32 13.17 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.362 1.865 . . . . 0.0 109.583 -171.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.58 167.53 52.12 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.48 1.044 . . . . 0.0 112.238 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.3 p -76.33 -8.53 57.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.896 1.279 . . . . 0.0 112.112 -173.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.5 -14.14 49.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.357 1.463 . . . . 0.0 112.579 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.83 9.82 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.29 0.948 . . . . 0.0 113.879 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.01 153.67 46.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.203 2.201 . . . . 0.0 110.287 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.1 m -84.07 139.52 32.43 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.312 1.445 . . . . 0.0 111.799 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -135.62 137.08 41.56 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.311 1.444 . . . . 0.0 110.312 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.91 -23.29 67.29 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.16 -0.962 . . . . 0.0 113.04 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.62 172.64 17.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.985 0.914 . . . . 0.0 113.336 166.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t -58.08 -26.51 62.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.946 1.298 . . . . 0.0 113.47 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.97 -30.46 59.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.294 1.438 . . . . 0.0 113.501 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.36 -52.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.213 1.405 . . . . 0.0 111.599 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.36 64.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.965 1.306 . . . . 0.0 111.474 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -64.15 -29.13 70.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.794 1.237 . . . . 0.0 113.338 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.55 -7.76 59.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.065 1.346 . . . . 0.0 113.752 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -108.12 4.42 24.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.225 1.81 . . . . 0.0 112.036 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.24 6.61 87.77 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.453 1.502 . . . . 0.0 114.598 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.6 t -89.24 164.22 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.757 2.023 . . . . 0.0 109.246 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -123.73 161.25 25.54 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.93 1.292 . . . . 0.0 110.205 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.699 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -72.11 136.03 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 120.787 -1.195 . . . . 0.0 110.324 174.483 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -119.28 -61.38 1.64 Allowed 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.505 1.522 . . . . 0.0 109.688 -177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 t -133.76 171.55 13.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.7 1.2 . . . . 0.0 112.833 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.77 168.93 11.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.434 2.694 . . . . 0.0 112.688 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.39 174.28 5.75 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.398 1.951 . . . . 0.0 113.808 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 t -59.42 127.55 32.65 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.575 -0.956 . . . . 0.0 110.863 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.823 0 C-N-CA 125.64 1.576 . . . . 0.0 111.051 -173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 CA--C 1.537 0.629 0 CA-C-O 121.547 0.561 . . . . 0.0 113.462 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.6 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.2 m -138.01 173.25 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.881 1.672 . . . . 0.0 112.631 -174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.22 119.05 34.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.525 1.53 . . . . 0.0 111.663 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.94 169.05 43.26 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 122.609 1.116 . . . . 0.0 112.786 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -78.71 -9.06 59.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.372 1.469 . . . . 0.0 112.303 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.48 -13.15 59.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.153 1.381 . . . . 0.0 112.143 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.57 34.56 15.96 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.875 1.226 . . . . 0.0 113.828 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -124.94 159.51 31.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.388 2.275 . . . . 0.0 110.255 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -100.21 136.77 39.59 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.453 1.501 . . . . 0.0 112.155 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -138.8 150.25 45.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.525 1.53 . . . . 0.0 111.569 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.17 -23.46 67.32 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -157.97 170.05 23.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.774 2.03 . . . . 0.0 110.655 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -59.6 -29.44 67.98 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.249 1.42 . . . . 0.0 113.428 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 t -54.81 -51.11 66.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.817 1.647 . . . . 0.0 112.563 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.627 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.5 mp -61.07 -48.18 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.247 1.419 . . . . 0.0 111.07 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.82 70.59 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.594 0.711 . . . . 0.0 110.087 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -71.75 -24.65 61.81 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -18.02 64.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.27 1.428 . . . . 0.0 113.942 168.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -113.26 -1.83 14.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.019 1.727 . . . . 0.0 112.621 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.73 2.11 82.08 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.785 1.66 . . . . 0.0 115.184 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -72.41 161.16 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.344 1.458 . . . . 0.0 108.672 165.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.0 p -120.78 167.27 12.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.645 1.178 . . . . 0.0 110.485 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.6 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -77.9 140.85 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 120.714 -1.241 . . . . 0.0 110.891 174.161 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.82 -61.06 1.4 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.053 1.741 . . . . 0.0 109.811 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -134.77 164.93 26.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 112.459 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -95.94 168.63 10.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.315 2.246 . . . . 0.0 112.121 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.65 160.16 7.38 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.331 1.919 . . . . 0.0 112.842 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 p -64.68 122.69 17.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.293 -1.122 . . . . 0.0 110.806 169.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 C-N-CA 124.651 1.18 . . . . 0.0 111.947 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 CA--C 1.536 0.59 0 CA-C-O 122.226 0.844 . . . . 0.0 112.816 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.2 m -140.24 172.82 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 128.161 2.584 . . . . 0.0 110.866 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.33 116.4 28.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.002 1.321 . . . . 0.0 111.292 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.65 168.26 43.44 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.481 1.045 . . . . 0.0 112.42 172.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.6 t -78.55 -11.07 59.94 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.006 1.322 . . . . 0.0 111.376 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.03 -12.82 60.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.93 1.292 . . . . 0.0 112.331 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.85 28.79 17.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.08 1.324 . . . . 0.0 114.72 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -125.82 154.29 42.84 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.286 2.234 . . . . 0.0 110.377 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -83.91 140.74 31.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.785 1.634 . . . . 0.0 112.373 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.88 141.97 42.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.303 1.841 . . . . 0.0 110.21 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.94 -19.76 65.36 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -154.68 169.61 23.49 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.303 1.441 . . . . 0.0 111.861 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.5 p -56.15 -29.55 60.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.726 1.611 . . . . 0.0 113.816 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -61.5 -33.97 74.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.784 0.802 . . . . 0.0 112.571 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mt -78.13 -44.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.329 1.451 . . . . 0.0 111.106 -175.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.44 -43.5 68.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.791 0.837 . . . . 0.0 110.149 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.76 -42.61 97.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.392 1.077 . . . . 0.0 112.884 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.8 t -58.69 -20.26 46.97 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.705 1.202 . . . . 0.0 113.862 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -106.14 3.55 28.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.027 1.731 . . . . 0.0 112.272 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 3.91 89.02 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.755 1.645 . . . . 0.0 115.351 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.44 160.73 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.375 1.87 . . . . 0.0 109.076 170.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.5 p -118.76 153.47 34.37 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.17 0.988 . . . . 0.0 109.815 172.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -67.19 139.86 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.17 -0.956 . . . . 0.0 110.761 175.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.73 -60.13 1.62 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.651 1.58 . . . . 0.0 109.939 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -134.09 158.3 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.436 1.095 . . . . 0.0 112.41 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.94 166.12 20.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 112.945 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.27 163.56 4.5 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.471 1.986 . . . . 0.0 114.16 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.9 t -61.04 127.75 33.07 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.448 -1.03 . . . . 0.0 110.789 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 124.13 0.972 . . . . 0.0 111.512 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 CA-C-O 121.629 0.595 . . . . 0.0 113.558 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.67 ' HB ' HD11 ' A' ' 34' ' ' ILE . 30.7 m -132.52 172.38 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.596 1.958 . . . . 0.0 111.646 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -122.69 106.83 11.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.308 1.843 . . . . 0.0 109.69 -169.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.53 167.89 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 122.592 1.107 . . . . 0.0 112.411 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.3 t -77.28 -11.94 59.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.574 1.15 . . . . 0.0 111.226 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.12 -11.84 59.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.058 1.343 . . . . 0.0 112.508 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 38.05 11.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.719 1.152 . . . . 0.0 113.792 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 -130.28 154.24 47.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.99 2.116 . . . . 0.0 110.639 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.0 m -83.09 139.66 33.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.434 1.494 . . . . 0.0 111.999 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -135.22 140.52 45.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.942 171.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.9 70.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.49 -0.756 . . . . 0.0 112.623 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.47 174.21 14.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.048 1.339 . . . . 0.0 111.271 170.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -61.32 -24.64 66.58 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.876 1.27 . . . . 0.0 113.873 170.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.88 -32.33 65.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.013 1.325 . . . . 0.0 113.618 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.818 1.247 . . . . 0.0 112.114 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.04 -40.81 64.21 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.427 1.091 . . . . 0.0 111.418 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -66.81 -30.28 70.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.026 1.331 . . . . 0.0 112.97 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.56 -11.58 60.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.724 1.61 . . . . 0.0 113.789 174.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.94 3.63 18.95 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.539 1.935 . . . . 0.0 111.962 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.32 90.02 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.77 1.652 . . . . 0.0 115.093 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.43 156.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.827 1.651 . . . . 0.0 109.248 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.5 p -115.3 156.17 25.93 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.228 1.011 . . . . 0.0 110.064 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.67 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.15 137.34 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.181 -0.949 . . . . 0.0 110.246 174.147 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -121.29 -60.85 1.59 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 125.576 1.55 . . . . 0.0 109.664 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -133.03 171.84 13.44 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.812 1.245 . . . . 0.0 112.687 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.45 168.95 9.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.864 2.466 . . . . 0.0 111.971 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.11 168.49 10.79 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.983 1.754 . . . . 0.0 112.953 -170.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.3 t -58.64 128.98 39.92 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.578 -0.954 . . . . 0.0 110.416 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 126.001 1.72 . . . . 0.0 110.725 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 CA--C 1.535 0.528 0 CA-C-O 122.398 0.916 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.684 ' HB ' HD11 ' A' ' 34' ' ' ILE . 26.5 m -136.55 170.02 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.919 2.487 . . . . 0.0 111.252 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -110.41 115.61 29.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.818 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.5 42.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 122.488 1.049 . . . . 0.0 112.546 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -77.49 -13.73 59.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.839 1.256 . . . . 0.0 111.104 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.36 -13.52 59.81 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.978 1.311 . . . . 0.0 112.471 171.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.07 60.97 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.953 1.739 . . . . 0.0 115.547 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.55 166.75 11.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.169 1.388 . . . . 0.0 111.427 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -92.48 139.24 30.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.88 1.672 . . . . 0.0 111.813 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -135.76 138.49 42.71 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.672 1.589 . . . . 0.0 110.454 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.66 -26.34 67.0 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -158.5 174.44 15.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.394 1.478 . . . . 0.0 111.98 167.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.0 t -67.62 -14.43 62.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.281 1.432 . . . . 0.0 114.683 171.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 t -69.39 -23.91 63.79 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.589 -1.319 . . . . 0.0 113.939 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.02 -47.55 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.996 1.318 . . . . 0.0 113.881 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.16 37.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.836 0.826 . . . . 0.0 111.557 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -79.2 -22.88 44.29 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.939 1.296 . . . . 0.0 113.887 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.38 -21.4 59.68 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.388 1.475 . . . . 0.0 112.719 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.27 -27.08 16.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.089 1.356 . . . . 0.0 112.119 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.26 0.23 16.5 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.25 1.881 . . . . 0.0 115.312 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.26 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.032 1.733 . . . . 0.0 109.255 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.3 p -119.5 154.59 33.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.111 0.965 . . . . 0.0 110.183 171.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.91 140.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.256 -0.902 . . . . 0.0 110.794 176.633 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.9 -62.22 1.13 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.579 1.552 . . . . 0.0 109.919 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -128.37 164.33 22.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.384 1.474 . . . . 0.0 111.995 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 167.4 11.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.629 2.372 . . . . 0.0 112.697 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.28 166.66 7.4 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.431 1.967 . . . . 0.0 113.95 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -63.68 128.03 33.99 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.616 -0.932 . . . . 0.0 110.547 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 124.649 1.18 . . . . 0.0 112.036 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -89.02 158.94 17.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.884 1.274 . . . . 0.0 111.016 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -152.61 147.28 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.301 1.84 . . . . 0.0 110.27 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.3 m -72.92 140.55 47.54 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.595 -0.691 . . . . 0.0 112.396 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.13 100.86 13.18 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.41 1.484 . . . . 0.0 110.65 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.1 t -50.5 128.81 25.51 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.848 1.259 . . . . 0.0 113.273 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 26' ' ' ILE . 85.3 Cg_endo -73.29 169.05 23.2 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.76 2.973 . . . . 0.0 112.662 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -84.19 4.03 32.49 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.378 1.871 . . . . 0.0 114.73 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.9 tp -61.1 160.15 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.344 1.857 . . . . 0.0 113.068 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 pp -115.74 -172.83 2.23 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.087 2.155 . . . . 0.0 111.687 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt 52.1 71.12 1.57 Allowed Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 125.946 1.698 . . . . 0.0 112.333 -169.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.22 171.73 7.34 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.445 2.764 . . . . 0.0 113.26 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.3 m -134.42 172.5 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.324 2.25 . . . . 0.0 111.709 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.8 t -111.5 118.92 37.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.821 1.248 . . . . 0.0 111.364 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.57 169.69 49.67 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 122.581 1.1 . . . . 0.0 112.479 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 t -79.16 -6.75 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.875 1.27 . . . . 0.0 111.5 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.24 -12.29 58.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.879 1.271 . . . . 0.0 112.412 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.44 30.97 17.57 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.178 1.37 . . . . 0.0 114.543 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -127.22 155.67 43.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.424 2.29 . . . . 0.0 110.067 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.9 m -82.52 140.49 33.29 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.538 1.535 . . . . 0.0 112.261 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -137.24 142.38 42.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.115 1.766 . . . . 0.0 110.706 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.09 -26.54 68.34 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.56 173.24 17.17 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.655 1.582 . . . . 0.0 111.784 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -59.08 -32.86 70.18 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.422 1.089 . . . . 0.0 113.241 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.4 m -54.76 -33.73 61.67 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.484 1.514 . . . . 0.0 113.506 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 7' ' ' PRO . 4.5 mm -81.21 -48.23 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.196 1.398 . . . . 0.0 110.649 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.48 -44.71 65.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.471 1.108 . . . . 0.0 110.29 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -59.78 -44.74 93.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.834 1.253 . . . . 0.0 112.396 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.43 -10.29 49.89 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.85 2.11 29.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.014 1.726 . . . . 0.0 112.133 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 6.13 88.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.838 1.685 . . . . 0.0 115.041 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.45 162.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.395 2.278 . . . . 0.0 109.223 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.9 p -119.0 155.86 30.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.96 171.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -68.08 140.13 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.114 -0.991 . . . . 0.0 110.519 174.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -125.42 -61.54 1.26 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.618 1.567 . . . . 0.0 109.897 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -134.62 173.51 11.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.819 1.248 . . . . 0.0 112.312 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -104.91 165.88 10.77 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.166 2.586 . . . . 0.0 112.951 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.22 166.61 6.0 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.146 1.831 . . . . 0.0 113.823 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.8 t -60.96 127.09 29.89 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.466 -1.02 . . . . 0.0 110.232 168.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.92 142.79 65.34 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.003 0.921 . . . . 0.0 111.306 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -72.13 167.43 26.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.959 2.44 . . . . 0.0 111.983 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 m -71.54 -10.47 59.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.841 1.256 . . . . 0.0 112.844 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.52 -6.3 9.17 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.966 2.222 . . . . 0.0 114.2 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.782 2.033 . . . . 0.0 110.772 177.035 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.39 -21.2 18.51 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.37 153.89 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.385 1.474 . . . . 0.0 111.641 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 83.2 m -132.32 15.21 4.57 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.626 1.57 . . . . 0.0 114.647 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.51 92.2 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.11 2.964 . . . . 0.0 115.675 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.7 p -74.81 161.28 78.35 Favored Pre-proline 0 CA--C 1.553 1.08 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.0 -13.24 15.83 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.966 3.11 . . . . 0.0 114.613 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 tptp 46.39 54.27 8.73 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.966 2.506 . . . . 0.0 113.366 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.9 tt -91.05 12.11 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.46 1.904 . . . . 0.0 114.272 -170.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.54 17.53 10.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.818 2.047 . . . . 0.0 114.295 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -132.84 65.59 74.52 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.625 1.17 . . . . 0.0 113.162 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 170.16 12.17 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.724 2.949 . . . . 0.0 113.77 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.761 ' HB ' HD11 ' A' ' 34' ' ' ILE . 28.0 m -140.4 176.2 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.747 2.419 . . . . 0.0 111.538 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -119.65 119.75 34.63 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.694 1.597 . . . . 0.0 111.226 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.79 168.17 47.13 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.511 1.062 . . . . 0.0 112.268 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -74.42 -11.23 60.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.784 1.634 . . . . 0.0 112.036 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -78.76 -12.53 60.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.46 1.504 . . . . 0.0 112.157 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.68 30.82 17.26 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.287 1.423 . . . . 0.0 114.437 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -129.27 151.96 49.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.568 2.347 . . . . 0.0 110.344 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -80.37 140.42 36.07 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.624 1.57 . . . . 0.0 112.44 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -134.77 146.74 49.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.552 1.941 . . . . 0.0 110.985 172.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -22.74 67.05 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -158.62 171.05 20.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.255 1.422 . . . . 0.0 111.307 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -56.47 -35.64 68.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.823 1.249 . . . . 0.0 113.109 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.8 m -61.2 -27.65 68.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.828 1.251 . . . . 0.0 113.188 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 mm -84.56 -47.7 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.95 1.7 . . . . 0.0 110.261 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.24 -42.96 61.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.64 1.176 . . . . 0.0 111.031 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.05 -41.43 99.47 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.421 1.088 . . . . 0.0 112.637 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -67.65 -18.27 64.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -101.55 -1.83 32.0 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.818 1.647 . . . . 0.0 112.425 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.48 11.42 59.52 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.58 1.562 . . . . 0.0 115.639 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -101.63 169.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.594 2.358 . . . . 0.0 108.942 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.4 p -126.2 156.19 40.6 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.306 -1.496 . . . . 0.0 110.471 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.761 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.39 136.74 25.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 O-C-N 120.651 -1.281 . . . . 0.0 111.322 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -116.5 -58.58 2.07 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.358 1.463 . . . . 0.0 109.832 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -135.46 143.2 45.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.206 1.402 . . . . 0.0 112.282 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.56 166.14 24.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.726 1.61 . . . . 0.0 112.711 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 159.52 6.41 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.319 1.914 . . . . 0.0 113.641 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -60.4 131.35 50.49 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.063 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 133.04 78.72 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.476 0.71 . . . . 0.0 111.622 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.58 168.19 23.35 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.438 2.759 . . . . 0.0 112.605 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.9 m -104.44 -32.68 8.9 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.386 1.074 . . . . 0.0 112.711 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.7 10.93 5.74 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.568 1.556 . . . . 0.0 115.404 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 N--CA 1.485 1.295 0 C-N-CA 126.181 1.792 . . . . 0.0 110.929 179.263 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -129.51 -53.79 1.17 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.273 1.429 . . . . 0.0 113.061 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.27 142.16 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.928 1.691 . . . . 0.0 110.512 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.4 m -77.96 137.47 38.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.669 0.787 . . . . 0.0 111.167 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.66 128.79 37.38 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.797 0.839 . . . . 0.0 111.997 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -67.04 152.29 96.2 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.678 0.791 . . . . 0.0 112.811 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.09 172.06 16.3 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.989 3.126 . . . . 0.0 112.289 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -124.9 49.43 1.86 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.798 1.639 . . . . 0.0 112.147 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.2 tt -132.69 151.17 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.024 1.73 . . . . 0.0 111.096 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.12 -172.0 2.58 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.793 1.637 . . . . 0.0 111.133 172.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 58.01 69.73 1.45 Allowed Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 126.829 2.051 . . . . 0.0 112.374 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -64.73 175.14 3.84 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.161 3.241 . . . . 0.0 113.559 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.9 m -134.48 169.99 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.9 2.08 . . . . 0.0 111.849 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -113.64 118.64 34.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.378 1.471 . . . . 0.0 110.215 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.7 168.05 43.97 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 122.689 1.161 . . . . 0.0 112.278 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -75.22 -9.77 58.85 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.852 1.661 . . . . 0.0 111.844 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.06 -15.38 59.61 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.779 1.632 . . . . 0.0 112.113 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.48 34.2 14.63 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.432 1.491 . . . . 0.0 113.909 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -132.25 155.81 47.62 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.85 2.46 . . . . 0.0 110.038 -174.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -93.49 140.46 29.56 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.884 1.274 . . . . 0.0 112.705 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.01 138.06 41.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.74 1.616 . . . . 0.0 111.083 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.96 65.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.23 1.012 . . . . 0.0 113.638 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -174.49 4.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.597 1.159 . . . . 0.0 112.57 167.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -24.33 67.16 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.61 -2.58 4.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.174 1.79 . . . . 0.0 115.396 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -46.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.908 1.683 . . . . 0.0 113.501 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.83 53.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.895 0.855 . . . . 0.0 110.983 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.37 -22.74 57.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.989 1.315 . . . . 0.0 113.259 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -10.84 59.15 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.596 1.559 . . . . 0.0 113.197 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -108.9 -9.08 15.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.238 1.815 . . . . 0.0 112.688 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.9 57.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.736 1.636 . . . . 0.0 115.349 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.64 161.44 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.504 1.522 . . . . 0.0 109.347 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -122.1 144.67 48.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.841 1.256 . . . . 0.0 109.768 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.561 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -63.73 135.87 27.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.27 -1.519 . . . . 0.0 110.848 175.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.47 -60.43 1.88 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.917 1.287 . . . . 0.0 109.285 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 p -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.357 1.463 . . . . 0.0 111.76 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -74.66 168.28 20.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.119 1.367 . . . . 0.0 112.681 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.0 159.22 12.07 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.106 1.812 . . . . 0.0 113.307 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 132.43 51.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.166 0.986 . . . . 0.0 110.758 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.26 142.16 46.95 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.738 -0.601 . . . . 0.0 111.683 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.16 160.66 44.92 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.17 2.58 . . . . 0.0 112.614 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.5 m -82.55 -60.56 2.15 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.231 1.012 . . . . 0.0 111.671 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.72 8.99 0.05 OUTLIER Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.759 1.171 . . . . 0.0 115.864 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.785 2.034 . . . . 0.0 111.943 -179.062 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.229 0.062 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -126.23 83.75 2.2 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.41 1.884 . . . . 0.0 110.64 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.12 147.53 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.422 1.489 . . . . 0.0 111.311 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.4 p -68.6 118.45 11.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.966 1.307 . . . . 0.0 112.401 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.96 169.93 16.46 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.239 1.016 . . . . 0.0 112.467 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.6 p -125.95 152.86 73.48 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.713 1.605 . . . . 0.0 111.364 168.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.65 179.25 6.69 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.649 2.899 . . . . 0.0 112.372 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -111.39 -2.88 15.45 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.581 1.553 . . . . 0.0 114.311 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -68.78 134.64 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.846 1.658 . . . . 0.0 110.792 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.58 47.91 0.63 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.45 1.9 . . . . 0.0 112.594 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -130.12 68.78 81.44 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 125.582 1.553 . . . . 0.0 111.677 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.17 170.46 11.85 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.525 2.817 . . . . 0.0 113.758 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 34' ' ' ILE . 26.9 m -136.93 171.04 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.562 2.345 . . . . 0.0 111.421 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 t -115.06 118.3 33.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.44 1.496 . . . . 0.0 110.321 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.97 167.18 48.97 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 122.464 1.035 . . . . 0.0 112.514 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -76.99 -12.15 59.9 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.584 1.554 . . . . 0.0 111.135 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.18 -14.59 59.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.589 1.555 . . . . 0.0 112.342 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.67 25.46 20.5 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.237 1.399 . . . . 0.0 115.145 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -121.93 152.07 40.05 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.385 2.274 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.4 m -80.66 143.95 32.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.25 1.42 . . . . 0.0 112.061 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -134.2 141.1 46.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.136 1.774 . . . . 0.0 110.59 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -24.67 64.77 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -159.76 -179.27 7.7 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.918 1.687 . . . . 0.0 110.809 166.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.7 p -63.33 -24.22 67.76 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 170.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.74 -14.59 53.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.55 1.54 . . . . 0.0 115.103 -170.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.07 -42.61 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.052 1.741 . . . . 0.0 113.339 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.99 39.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.985 0.898 . . . . 0.0 110.516 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -78.92 -29.03 43.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.427 1.491 . . . . 0.0 113.242 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.94 -27.23 64.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.435 1.094 . . . . 0.0 112.767 170.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.2 -24.25 23.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.839 1.255 . . . . 0.0 112.086 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.73 3.39 30.38 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.306 1.908 . . . . 0.0 114.996 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.53 158.69 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.31 1.844 . . . . 0.0 109.252 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 p -115.75 145.09 43.1 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.334 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -63.54 137.97 23.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 120.99 -1.069 . . . . 0.0 110.911 174.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -118.17 -57.82 2.05 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.028 1.331 . . . . 0.0 109.73 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -131.94 136.81 47.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -70.34 162.18 29.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.118 1.367 . . . . 0.0 112.223 172.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.97 162.66 19.62 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.647 2.07 . . . . 0.0 113.391 -171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.7 t -61.14 131.3 50.07 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.682 -0.893 . . . . 0.0 110.638 172.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.05 140.43 73.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.331 0.652 . . . . 0.0 111.295 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.88 165.98 30.48 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.936 2.424 . . . . 0.0 112.467 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.9 p -72.76 -11.46 60.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.488 1.515 . . . . 0.0 113.842 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.76 -8.83 4.9 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 126.528 2.013 . . . . 0.0 114.224 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.113 1.765 . . . . 0.0 113.097 173.799 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -73.31 -60.96 2.0 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.222 1.009 . . . . 0.0 111.791 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.35 158.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.146 0.978 . . . . 0.0 111.921 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.0 t -102.12 -31.03 10.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.873 1.269 . . . . 0.0 113.657 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.9 -44.5 0.15 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.092 1.357 . . . . 0.0 113.207 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.2 t 42.96 66.74 4.15 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.88 2.072 . . . . 0.0 113.831 -174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 160.25 50.45 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.385 2.723 . . . . 0.0 113.053 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -80.21 67.14 5.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.058 1.743 . . . . 0.0 111.396 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.6 tp -136.55 140.14 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.295 1.438 . . . . 0.0 111.608 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 tp -92.0 -163.94 1.11 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.71 1.604 . . . . 0.0 111.379 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt 52.09 71.56 1.45 Allowed Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.501 1.92 . . . . 0.0 112.64 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.28 169.23 11.21 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.148 2.565 . . . . 0.0 113.307 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.675 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.1 m -136.67 172.6 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.306 2.243 . . . . 0.0 111.328 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 t -113.94 118.21 33.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.435 1.494 . . . . 0.0 110.999 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.53 169.09 45.03 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 122.426 1.015 . . . . 0.0 112.417 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.2 t -75.93 -13.64 60.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.359 1.464 . . . . 0.0 111.266 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -8.39 59.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.866 1.267 . . . . 0.0 112.475 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.05 26.3 29.21 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.008 1.29 . . . . 0.0 114.984 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -123.1 152.77 40.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.288 2.235 . . . . 0.0 110.397 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -78.25 139.84 38.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.598 1.559 . . . . 0.0 112.261 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -133.95 141.42 47.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.356 1.862 . . . . 0.0 110.512 171.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.28 67.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 0.0 113.282 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.39 172.41 17.33 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.505 1.122 . . . . 0.0 112.959 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -62.83 -26.89 68.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.376 1.471 . . . . 0.0 113.18 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.09 -22.66 63.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.49 1.516 . . . . 0.0 114.896 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pt -105.44 -43.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.8 -34.97 42.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.14 0.972 . . . . 0.0 111.258 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.74 -29.84 56.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.596 1.158 . . . . 0.0 113.751 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -75.57 -10.74 59.7 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.662 1.185 . . . . 0.0 113.118 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -103.6 -0.88 29.07 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.083 1.753 . . . . 0.0 112.36 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.94 80.45 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.842 1.687 . . . . 0.0 115.264 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 t -78.62 161.16 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.525 1.53 . . . . 0.0 109.207 171.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.5 p -119.96 151.65 38.63 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.313 1.045 . . . . 0.0 109.976 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.35 138.37 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 175.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -123.75 -61.27 1.39 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.391 1.476 . . . . 0.0 110.073 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.4 m -131.68 156.91 45.04 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.918 1.287 . . . . 0.0 111.981 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.08 169.2 15.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.807 2.043 . . . . 0.0 112.934 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.82 165.08 5.8 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.686 2.089 . . . . 0.0 114.189 -175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.3 t -62.81 127.83 33.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.357 -1.084 . . . . 0.0 110.45 170.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.23 136.78 60.81 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.229 1.011 . . . . 0.0 111.813 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.33 161.26 46.25 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.772 2.315 . . . . 0.0 112.14 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.7 p -83.5 -0.07 48.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.29 1.436 . . . . 0.0 114.068 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.03 -11.71 0.23 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.214 1.387 . . . . 0.0 115.603 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.39 1.876 . . . . 0.0 111.281 174.558 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -114.91 -38.86 3.81 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.412 1.485 . . . . 0.0 113.567 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.68 125.31 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.082 1.353 . . . . 0.0 110.172 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.8 -71.93 0.69 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.081 0.953 . . . . 0.0 111.247 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.6 171.37 18.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.368 1.867 . . . . 0.0 111.944 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 p -152.76 72.87 7.29 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.367 1.467 . . . . 0.0 111.952 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.0 164.6 34.07 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.72 2.947 . . . . 0.0 112.722 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -128.75 -1.87 5.37 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -170.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.6 tt -61.8 150.71 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.898 1.279 . . . . 0.0 112.268 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.11 -175.93 1.29 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.242 1.417 . . . . 0.0 112.281 169.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt 57.86 71.48 1.05 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.911 2.084 . . . . 0.0 112.607 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.01 175.54 3.06 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.497 2.798 . . . . 0.0 113.255 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.626 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.6 m -131.87 171.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 127.375 2.27 . . . . 0.0 111.971 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.0 119.51 38.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.191 1.396 . . . . 0.0 111.446 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.78 169.54 41.73 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 122.587 1.104 . . . . 0.0 112.443 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -78.58 -10.43 59.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.532 1.533 . . . . 0.0 111.249 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.41 -12.92 60.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.01 1.324 . . . . 0.0 112.247 168.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.75 30.45 23.78 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.368 1.461 . . . . 0.0 114.222 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -129.86 158.82 38.41 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.31 2.244 . . . . 0.0 110.782 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -87.93 139.39 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.684 1.594 . . . . 0.0 113.213 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -138.67 144.8 39.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.048 2.139 . . . . 0.0 109.931 174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.94 72.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.194 -0.941 . . . . 0.0 112.745 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -153.97 176.14 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.094 1.758 . . . . 0.0 111.836 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -68.86 -21.22 64.28 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.147 1.379 . . . . 0.0 114.384 170.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.09 -4.3 28.14 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.142 1.377 . . . . 0.0 114.57 -173.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.74 -42.19 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.178 1.791 . . . . 0.0 114.087 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.61 -35.06 40.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.229 0.922 . . . . 0.0 111.391 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -79.51 -18.71 51.33 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.304 1.442 . . . . 0.0 113.869 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 t -73.82 -10.93 60.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.151 1.38 . . . . 0.0 113.004 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -120.1 3.95 10.9 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.706 2.002 . . . . 0.0 112.572 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.11 1.43 84.47 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.978 1.752 . . . . 0.0 115.617 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.69 157.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.255 1.422 . . . . 0.0 109.097 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 p -115.19 154.57 28.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.351 1.06 . . . . 0.0 109.87 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.1 138.52 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 120.934 -1.104 . . . . 0.0 110.605 173.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -123.56 -61.84 1.36 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.603 1.561 . . . . 0.0 109.993 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -133.13 170.31 15.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.976 1.311 . . . . 0.0 112.599 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -98.36 168.23 10.34 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.202 2.601 . . . . 0.0 112.638 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.65 164.53 6.55 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.321 1.915 . . . . 0.0 113.764 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -61.19 129.07 39.5 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.583 -0.951 . . . . 0.0 110.443 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.65 136.37 55.53 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 123.678 0.791 . . . . 0.0 111.716 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.56 157.8 57.79 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.922 2.415 . . . . 0.0 112.566 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.5 p -90.4 -11.21 41.15 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.141 1.377 . . . . 0.0 114.088 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.09 30.17 0.75 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.475 1.512 . . . . 0.0 114.909 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.504 1.921 . . . . 0.0 113.653 177.539 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -62.51 116.61 5.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.82 1.248 . . . . 0.0 112.08 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.02 121.14 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.645 1.578 . . . . 0.0 111.249 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 90.1 m -100.15 -5.89 27.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.51 131.6 51.26 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.503 1.047 . . . . 0.0 111.295 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.0 p -66.37 152.87 93.86 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.86 171.13 18.5 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.384 2.723 . . . . 0.0 112.532 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -92.99 -0.88 57.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.189 1.795 . . . . 0.0 115.259 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.3 tt -66.26 157.64 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.749 1.619 . . . . 0.0 112.973 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.0 tp -100.27 41.59 1.16 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.466 1.907 . . . . 0.0 111.947 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -125.9 70.51 66.95 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 125.825 1.65 . . . . 0.0 112.255 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.35 170.01 14.31 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.26 2.64 . . . . 0.0 113.531 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -137.8 170.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 128.06 2.544 . . . . 0.0 111.311 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -113.77 117.76 32.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.425 1.49 . . . . 0.0 110.352 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 167.88 48.59 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.544 1.08 . . . . 0.0 112.404 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 t -78.61 -7.57 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 111.301 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.82 -13.08 59.67 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.245 1.418 . . . . 0.0 112.247 170.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.0 31.58 14.5 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.026 1.298 . . . . 0.0 114.295 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -127.54 152.37 47.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.464 2.306 . . . . 0.0 110.327 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.7 m -85.2 140.63 30.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.513 1.525 . . . . 0.0 111.964 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.91 139.65 46.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.097 1.759 . . . . 0.0 110.626 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.25 -24.38 64.84 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -159.09 179.36 9.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.902 1.681 . . . . 0.0 110.734 163.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.1 p -62.75 -22.23 66.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.24 -26.99 68.12 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 -45.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.153 1.381 . . . . 0.0 113.475 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.49 -39.31 33.39 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.1 0.953 . . . . 0.0 110.899 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -78.71 -28.69 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.513 1.525 . . . . 0.0 113.714 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.85 -19.49 58.85 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.941 0.896 . . . . 0.0 112.854 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -89.08 -22.64 22.81 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.046 1.338 . . . . 0.0 112.079 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.59 2.66 37.54 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.655 2.074 . . . . 0.0 115.349 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.08 159.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.163 1.785 . . . . 0.0 109.257 168.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.5 p -117.72 145.54 44.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.427 173.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.456 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -62.83 136.79 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.073 -1.017 . . . . 0.0 110.929 174.348 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -117.06 -56.94 2.21 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.912 1.285 . . . . 0.0 109.896 -175.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -134.11 141.84 47.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.75 1.62 . . . . 0.0 112.267 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.19 162.65 29.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.292 1.437 . . . . 0.0 112.329 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.69 162.79 22.64 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.77 2.129 . . . . 0.0 113.46 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -62.18 131.16 48.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.673 -0.898 . . . . 0.0 110.927 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.71 139.36 62.57 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.13 159.67 51.48 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.972 2.448 . . . . 0.0 112.629 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 m -81.03 -13.38 58.87 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.644 1.177 . . . . 0.0 112.572 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.64 22.62 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.358 1.456 . . . . 0.0 114.692 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.1 tt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 126.232 1.813 . . . . 0.0 113.591 176.589 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.73 -75.63 0.52 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.755 -1.215 . . . . 0.0 110.331 175.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.1 158.98 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.04 1.336 . . . . 0.0 111.05 169.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.8 m -113.24 147.74 36.91 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.134 1.374 . . . . 0.0 111.114 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.88 158.57 30.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.224 0.61 . . . . 0.0 112.248 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 p -106.12 155.06 39.14 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.018 1.327 . . . . 0.0 112.175 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.1 174.45 12.76 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.254 2.636 . . . . 0.0 111.589 170.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -103.85 -4.66 23.24 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.051 1.341 . . . . 0.0 113.741 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.8 mm -69.0 147.44 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.602 1.961 . . . . 0.0 110.808 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.68 -161.59 0.3 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.017 1.727 . . . . 0.0 112.175 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.22 72.9 0.91 Allowed Pre-proline 0 N--CA 1.481 1.111 0 C-N-CA 127.144 2.178 . . . . 0.0 112.951 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.36 173.92 5.78 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.163 3.242 . . . . 0.0 114.28 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' A' ' 34' ' ' ILE . 28.7 m -136.23 171.27 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.514 2.326 . . . . 0.0 111.985 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 t -117.84 120.1 36.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.572 1.549 . . . . 0.0 110.598 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.88 48.67 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 122.774 1.208 . . . . 0.0 112.705 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -75.41 -11.14 59.98 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.719 2.008 . . . . 0.0 111.922 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.99 -13.77 59.6 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.523 1.529 . . . . 0.0 112.185 171.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.83 25.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.391 1.472 . . . . 0.0 114.533 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -121.59 149.58 42.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.22 2.208 . . . . 0.0 110.853 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -81.96 139.88 34.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.118 1.767 . . . . 0.0 112.05 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -133.2 141.27 48.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.247 1.819 . . . . 0.0 110.818 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.76 67.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.2 176.39 11.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.737 1.215 . . . . 0.0 112.317 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -64.0 -26.39 68.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.921 0.888 . . . . 0.0 113.306 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -60.39 -20.62 60.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.06 1.344 . . . . 0.0 114.552 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.8 -51.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 111.617 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.65 64.38 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.088 1.355 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.75 1.62 . . . . 0.0 113.075 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -84.56 -7.37 59.28 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.955 1.702 . . . . 0.0 113.316 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -113.31 1.71 15.26 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.315 1.846 . . . . 0.0 112.602 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 15.71 55.01 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.083 1.325 . . . . 0.0 115.373 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.76 159.26 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.311 1.844 . . . . 0.0 109.639 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.1 p -116.35 146.52 42.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.999 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -64.3 133.53 29.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 O-C-N 120.359 -1.463 . . . . 0.0 110.946 173.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -113.71 -58.68 2.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.775 1.23 . . . . 0.0 109.969 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -130.58 138.41 50.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.614 1.566 . . . . 0.0 111.946 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.48 164.44 26.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.689 1.596 . . . . 0.0 112.568 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 165.02 11.24 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.993 1.759 . . . . 0.0 113.397 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.43 133.5 55.11 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.376 -1.073 . . . . 0.0 111.024 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.76 143.69 75.36 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.069 0.547 . . . . 0.0 111.489 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.44 160.01 45.38 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.207 2.605 . . . . 0.0 112.757 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.7 p -84.29 -15.28 47.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.203 1.401 . . . . 0.0 114.269 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.52 1.04 0.32 Allowed Glycine 0 CA--C 1.539 1.572 0 N-CA-C 116.363 1.305 . . . . 0.0 116.363 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 C--O 1.255 1.353 0 C-N-CA 126.294 1.838 . . . . 0.0 112.027 178.292 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.7 tptm . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -142.18 -55.74 0.45 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.304 1.842 . . . . 0.0 112.163 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.55 102.42 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.754 1.222 . . . . 0.0 109.929 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.513 ' H ' HG22 ' A' ' 26' ' ' ILE . 14.4 m -118.01 124.99 49.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.215 1.806 . . . . 0.0 111.182 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.8 26.48 1.91 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.683 1.993 . . . . 0.0 116.295 171.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.6 p -63.58 151.8 87.34 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -166.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.09 177.85 8.37 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.814 3.01 . . . . 0.0 112.389 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -106.25 -2.12 22.75 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.084 1.754 . . . . 0.0 113.877 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mm -81.38 130.33 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.418 1.887 . . . . 0.0 111.691 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.05 51.13 1.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.18 1.792 . . . . 0.0 112.829 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -130.23 76.12 78.28 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.101 1.76 . . . . 0.0 110.766 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.61 169.18 14.86 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.116 2.544 . . . . 0.0 113.433 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.5 m -140.0 172.75 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 127.822 2.449 . . . . 0.0 111.287 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 t -114.56 115.55 27.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.285 1.434 . . . . 0.0 111.293 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.41 169.46 36.78 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 122.492 1.051 . . . . 0.0 112.228 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -79.57 -6.49 57.14 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.961 1.304 . . . . 0.0 111.2 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.88 -13.46 59.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.975 1.31 . . . . 0.0 112.149 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.82 31.19 24.44 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.326 1.441 . . . . 0.0 114.009 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -130.9 157.85 41.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.206 2.203 . . . . 0.0 110.749 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.7 m -89.1 138.02 31.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.365 1.466 . . . . 0.0 112.8 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.59 143.14 43.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.582 1.953 . . . . 0.0 110.368 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.97 -27.17 66.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 173.05 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 167.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -56.44 -32.86 65.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.914 1.686 . . . . 0.0 112.897 171.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -57.73 -27.97 63.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.412 1.085 . . . . 0.0 113.709 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 4' ' ' CYS . 17.6 pt -104.93 -36.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.51 -30.59 31.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.477 1.035 . . . . 0.0 111.212 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -77.18 -28.61 54.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.672 1.589 . . . . 0.0 113.366 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.1 -10.14 59.47 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.147 0.979 . . . . 0.0 112.993 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -106.24 -0.8 24.19 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.987 1.715 . . . . 0.0 112.147 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.93 89.32 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.702 1.62 . . . . 0.0 115.331 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -81.09 163.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.418 1.487 . . . . 0.0 108.668 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -125.91 157.84 36.67 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.918 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.673 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.07 138.65 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 124.305 1.042 . . . . 0.0 111.398 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -124.35 -59.36 1.48 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.517 1.527 . . . . 0.0 110.307 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -134.59 167.87 20.01 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 112.293 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -100.87 167.52 10.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.223 2.209 . . . . 0.0 112.734 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 163.77 5.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.783 2.135 . . . . 0.0 112.97 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -62.07 126.09 26.12 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.254 -1.145 . . . . 0.0 110.98 169.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.67 146.54 76.81 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.786 1.234 . . . . 0.0 111.789 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.67 159.87 47.7 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.903 2.402 . . . . 0.0 112.005 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 50.9 m -80.77 -16.42 53.87 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.061 0.944 . . . . 0.0 112.422 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.69 4.57 7.35 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.034 1.778 . . . . 0.0 114.968 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.1 mt . . . . . 0 C--O 1.253 1.251 0 C-N-CA 127.166 2.186 . . . . 0.0 110.29 -177.911 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.767 0.317 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -140.4 160.69 39.43 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.285 2.234 . . . . 0.0 110.743 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.17 157.88 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.791 1.636 . . . . 0.0 111.016 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 p -66.38 117.06 8.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.607 1.163 . . . . 0.0 111.82 170.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.48 154.96 41.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.687 0.795 . . . . 0.0 112.269 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -68.62 154.56 94.41 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.64 0.776 . . . . 0.0 111.976 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.02 176.61 9.69 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.075 3.184 . . . . 0.0 113.019 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.5 5.18 6.87 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.857 1.663 . . . . 0.0 114.428 -174.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.4 mm -104.19 142.57 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.362 1.465 . . . . 0.0 111.173 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.71 22.26 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.366 1.866 . . . . 0.0 114.993 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.9 mmpt? -113.92 80.15 5.13 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 126.458 1.903 . . . . 0.0 111.448 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.67 165.71 24.59 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.635 2.224 . . . . 0.0 112.901 172.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.674 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.5 m -139.96 172.14 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.555 2.342 . . . . 0.0 111.089 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.3 t -114.28 116.86 29.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.082 1.353 . . . . 0.0 111.013 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.13 169.54 46.05 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 122.639 1.133 . . . . 0.0 112.666 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -74.85 -12.26 60.34 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 111.998 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.03 -8.58 59.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.28 1.432 . . . . 0.0 112.268 172.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.26 30.51 22.2 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.841 1.21 . . . . 0.0 114.591 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -126.29 152.87 45.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.578 2.351 . . . . 0.0 109.963 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.2 m -81.67 140.09 34.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.115 1.366 . . . . 0.0 111.882 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -132.08 138.92 48.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.927 1.691 . . . . 0.0 109.842 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -23.22 63.29 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.49 178.82 8.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.881 1.273 . . . . 0.0 112.264 166.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 p -72.09 -7.56 49.65 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.4 t -75.94 -17.88 59.57 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -48.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.906 1.282 . . . . 0.0 113.409 -174.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.34 -40.07 16.38 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.566 1.146 . . . . 0.0 111.645 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -71.8 -36.43 70.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.601 -1.182 . . . . 0.0 113.854 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.11 -22.87 63.94 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.381 1.472 . . . . 0.0 112.512 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -88.23 -28.62 21.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.565 1.146 . . . . 0.0 111.844 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.59 1.24 13.64 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.335 1.921 . . . . 0.0 115.17 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.6 t -72.93 159.78 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.47 1.908 . . . . 0.0 109.457 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -113.5 154.81 26.45 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.726 0.81 . . . . 0.0 110.449 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.36 135.82 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 120.53 -1.356 . . . . 0.0 110.651 174.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -121.44 -58.98 1.74 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.314 1.446 . . . . 0.0 110.309 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -131.09 159.25 38.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.458 1.103 . . . . 0.0 112.319 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.26 166.17 13.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.456 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 164.49 7.7 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.711 2.101 . . . . 0.0 113.679 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 t -62.26 128.07 34.32 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.493 -1.004 . . . . 0.0 110.677 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.73 141.78 69.12 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.084 0.953 . . . . 0.0 111.611 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.65 164.39 35.74 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.951 2.434 . . . . 0.0 112.206 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 p -84.28 -27.6 27.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.358 1.063 . . . . 0.0 113.123 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.87 27.04 0.02 OUTLIER Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.844 1.211 . . . . 0.0 115.172 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.5 tt . . . . . 0 C--O 1.255 1.372 0 C-N-CA 125.561 1.545 . . . . 0.0 113.76 -179.735 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.6 mptt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -138.99 111.85 7.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.379 1.872 . . . . 0.0 110.871 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.42 161.19 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.614 1.966 . . . . 0.0 109.98 174.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.0 p -66.51 154.55 40.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.68 12.07 3.17 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.672 1.589 . . . . 0.0 113.591 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.2 m 43.11 65.54 5.34 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 127.03 2.132 . . . . 0.0 113.965 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.1 158.26 55.52 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.888 3.059 . . . . 0.0 113.21 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 5.73 48.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.355 1.862 . . . . 0.0 115.07 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.4 tt -53.77 140.42 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 126.694 1.998 . . . . 0.0 113.028 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.93 -178.75 6.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.385 1.474 . . . . 0.0 111.914 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 mttm 50.79 69.47 2.58 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 126.617 1.967 . . . . 0.0 112.598 -171.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.13 169.19 11.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.477 2.785 . . . . 0.0 113.246 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.763 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.6 m -132.76 171.33 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 127.24 2.216 . . . . 0.0 111.417 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -119.83 107.07 12.72 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.392 1.877 . . . . 0.0 109.625 -172.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.41 167.93 51.47 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 122.559 1.088 . . . . 0.0 112.297 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -76.42 -12.29 60.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.852 1.261 . . . . 0.0 111.323 -172.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -81.15 -14.32 57.76 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.039 1.336 . . . . 0.0 112.635 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.81 15.24 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.587 1.089 . . . . 0.0 114.67 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -121.46 154.13 36.99 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.723 2.009 . . . . 0.0 110.439 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -79.9 140.86 36.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.315 1.446 . . . . 0.0 111.475 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -134.33 139.72 45.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.403 1.481 . . . . 0.0 109.86 171.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.79 69.75 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.465 -0.772 . . . . 0.0 112.643 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -154.08 169.79 22.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.923 1.289 . . . . 0.0 111.523 171.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.4 m -56.37 -23.76 39.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.626 1.57 . . . . 0.0 113.605 170.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.1 m -62.72 -13.78 36.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.49 -51.13 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.456 1.503 . . . . 0.0 111.203 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.25 -42.29 60.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.523 1.129 . . . . 0.0 111.463 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -70.38 -21.48 62.86 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -11.09 59.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.943 1.697 . . . . 0.0 113.424 171.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -112.24 3.44 17.15 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.755 2.022 . . . . 0.0 111.953 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.15 5.11 89.13 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.582 1.563 . . . . 0.0 114.784 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -85.54 161.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.481 1.913 . . . . 0.0 109.491 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.7 p -122.28 155.27 36.27 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.467 1.107 . . . . 0.0 110.278 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -66.38 139.39 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.261 -0.899 . . . . 0.0 110.626 174.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -125.78 -57.44 1.44 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.178 1.391 . . . . 0.0 109.973 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 154.73 43.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.285 1.434 . . . . 0.0 112.981 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -76.23 162.72 27.71 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.841 2.057 . . . . 0.0 111.775 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.08 170.87 8.73 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.347 1.927 . . . . 0.0 113.859 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -58.63 133.39 55.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.711 -0.876 . . . . 0.0 111.187 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.49 143.84 79.91 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.827 1.651 . . . . 0.0 111.077 -173.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.86 -178.9 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.225 2.617 . . . . 0.0 112.369 175.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.9 m 69.33 31.44 3.88 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.41 1.484 . . . . 0.0 111.486 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.63 -14.68 0.04 OUTLIER Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.939 1.257 . . . . 0.0 115.507 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.252 1.197 0 CA-C-N 118.678 1.239 . . . . 0.0 112.755 173.53 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -144.1 148.43 35.11 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.588 1.555 . . . . 0.0 111.569 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.6 151.35 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.444 1.898 . . . . 0.0 110.507 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.1 m -89.63 138.67 31.27 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.739 0.816 . . . . 0.0 111.648 173.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.97 144.63 26.43 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 111.438 170.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.3 p -75.92 154.26 84.92 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.619 0.767 . . . . 0.0 112.468 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.25 164.13 34.89 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.951 2.434 . . . . 0.0 111.705 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -81.52 -17.23 49.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 tt -54.8 141.94 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.806 1.642 . . . . 0.0 112.807 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.08 -167.44 1.3 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.226 1.41 . . . . 0.0 112.179 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.8 tttm 54.75 71.21 1.37 Allowed Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 126.821 2.049 . . . . 0.0 112.556 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.5 178.59 2.05 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.169 3.246 . . . . 0.0 113.67 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.632 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.5 m -134.86 172.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.481 1.913 . . . . 0.0 112.217 -176.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.6 t -114.06 119.93 38.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 111.579 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.09 169.48 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 122.505 1.058 . . . . 0.0 112.3 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.2 p -74.79 -10.65 59.71 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.431 1.492 . . . . 0.0 112.183 -175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -80.85 -13.36 59.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 0.0 112.189 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.12 25.96 27.5 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.146 1.355 . . . . 0.0 114.593 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -121.26 154.15 36.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.572 2.349 . . . . 0.0 110.043 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -80.57 140.29 35.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 112.261 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -134.69 140.62 46.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.327 1.851 . . . . 0.0 110.406 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.69 70.47 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.668 0.787 . . . . 0.0 112.942 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -155.68 173.87 16.1 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 111.338 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.2 p -62.77 -19.76 64.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -66.82 -14.05 62.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 pt -112.07 -40.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.54 -34.23 49.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.507 1.049 . . . . 0.0 111.57 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -82.09 -13.88 56.62 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.5 t -74.47 -18.82 60.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.515 1.126 . . . . 0.0 113.159 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -122.63 1.23 9.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.072 1.349 . . . . 0.0 114.103 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.66 -0.38 34.36 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.054 1.311 . . . . 0.0 116.345 163.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.33 158.16 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.814 1.246 . . . . 0.0 108.823 167.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.7 p -118.36 161.9 19.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.064 -1.023 . . . . 0.0 110.839 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.7 137.08 23.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 120.764 -1.21 . . . . 0.0 110.713 175.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -122.11 -60.4 1.58 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.622 1.569 . . . . 0.0 110.033 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -134.45 166.46 22.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 112.282 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.88 170.24 9.7 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.13 2.172 . . . . 0.0 112.843 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.39 163.84 5.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.343 1.925 . . . . 0.0 113.648 -172.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -60.29 127.83 33.72 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.426 -1.043 . . . . 0.0 110.403 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.2 135.92 69.4 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.113 0.965 . . . . 0.0 111.478 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.52 159.21 53.6 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.845 2.363 . . . . 0.0 112.561 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -80.19 -7.85 59.16 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.59 2.2 29.1 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 126.138 1.828 . . . . 0.0 114.723 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.65 1.98 . . . . 0.0 113.457 177.08 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.426 0.155 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -109.4 171.89 7.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.862 2.065 . . . . 0.0 111.038 175.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.1 t 49.48 62.82 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 127.002 2.121 . . . . 0.0 111.888 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.6 m -66.73 141.97 57.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.841 0.856 . . . . 0.0 110.836 171.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.07 132.87 49.53 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.1 0.56 . . . . 0.0 110.977 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.4 p -58.65 151.11 53.92 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.814 0.846 . . . . 0.0 113.099 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.62 176.29 9.54 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.115 3.21 . . . . 0.0 112.919 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -112.23 25.68 11.31 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.698 1.999 . . . . 0.0 112.686 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.92 147.01 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.841 1.656 . . . . 0.0 109.562 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 mp -75.12 -161.9 0.16 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.963 1.705 . . . . 0.0 111.452 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt 57.48 66.79 2.74 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 126.816 2.047 . . . . 0.0 112.927 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.97 173.3 5.01 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.477 3.452 . . . . 0.0 114.362 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.7 m -135.96 169.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.21 2.204 . . . . 0.0 112.047 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.3 t -114.09 117.96 32.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.514 1.526 . . . . 0.0 110.454 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.36 169.46 49.58 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 122.707 1.171 . . . . 0.0 112.73 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 t -77.83 -8.39 57.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.147 1.379 . . . . 0.0 111.507 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 -8.29 58.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.877 1.271 . . . . 0.0 112.664 170.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.17 23.75 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.652 1.12 . . . . 0.0 115.14 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -122.88 154.17 38.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.592 2.357 . . . . 0.0 109.967 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -87.04 141.16 28.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.007 1.323 . . . . 0.0 111.638 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -133.44 138.0 46.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.968 1.707 . . . . 0.0 110.657 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.96 67.53 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -158.67 -178.43 7.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.941 1.296 . . . . 0.0 110.559 161.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 p -55.73 -23.49 29.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.477 1.511 . . . . 0.0 114.594 170.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 t -60.93 -16.77 46.07 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.618 1.567 . . . . 0.0 114.527 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.07 -49.39 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.417 1.487 . . . . 0.0 111.591 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.8 58.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.878 1.271 . . . . 0.0 111.101 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -68.95 -23.04 64.09 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.6 t -83.21 -3.59 57.55 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.576 1.55 . . . . 0.0 113.475 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -118.75 7.98 11.74 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.2 1.8 . . . . 0.0 112.327 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.42 7.08 87.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.328 1.442 . . . . 0.0 114.773 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -87.64 162.14 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.228 1.811 . . . . 0.0 109.601 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -125.24 150.72 46.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.341 1.057 . . . . 0.0 109.776 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.487 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -62.4 138.7 22.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.144 -0.973 . . . . 0.0 111.001 174.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.87 -57.98 1.99 Allowed 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 124.987 1.315 . . . . 0.0 109.649 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 p -133.33 135.02 44.53 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.264 1.425 . . . . 0.0 112.333 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -69.67 160.67 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.882 1.673 . . . . 0.0 111.939 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.96 161.04 22.62 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.372 1.939 . . . . 0.0 113.397 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 t -59.78 132.81 55.1 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.681 -0.893 . . . . 0.0 110.723 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.32 143.11 63.99 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.13 0.572 . . . . 0.0 111.075 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.34 169.76 18.88 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.936 2.424 . . . . 0.0 111.949 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.8 p -69.49 -14.23 62.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.358 1.463 . . . . 0.0 113.782 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.74 -13.16 3.41 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 127.099 2.285 . . . . 0.0 113.817 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tp . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.946 1.698 . . . . 0.0 113.145 174.182 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -125.75 73.14 1.32 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.866 1.666 . . . . 0.0 110.966 -173.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.2 t -129.59 104.01 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.69 1.596 . . . . 0.0 110.077 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 t -75.65 -173.21 2.11 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.701 1.201 . . . . 0.0 112.776 176.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.09 -27.23 52.82 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.49 1.516 . . . . 0.0 114.895 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.5 t 37.8 63.63 3.44 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 127.907 2.483 . . . . 0.0 114.801 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.65 166.84 28.76 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.954 3.103 . . . . 0.0 113.19 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -121.46 1.76 10.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.134 1.774 . . . . 0.0 113.729 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.1 mt -58.52 131.85 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.611 1.564 . . . . 0.0 109.645 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.23 -177.84 0.31 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.464 1.906 . . . . 0.0 114.545 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 tptm 61.08 67.77 1.37 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 127.091 2.156 . . . . 0.0 111.951 -174.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -65.52 169.62 12.4 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.798 2.999 . . . . 0.0 113.853 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.631 ' HB ' HD11 ' A' ' 34' ' ' ILE . 32.2 m -135.93 174.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.006 1.722 . . . . 0.0 112.44 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 t -119.2 122.48 42.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.13 169.28 51.35 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 122.506 1.059 . . . . 0.0 112.556 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -77.9 -10.72 59.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.315 1.446 . . . . 0.0 111.502 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.949 1.3 . . . . 0.0 112.391 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.51 26.26 23.49 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.089 1.328 . . . . 0.0 114.958 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -121.8 151.75 40.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.234 2.213 . . . . 0.0 110.27 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.8 m -79.66 139.86 37.26 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.627 1.571 . . . . 0.0 111.712 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.57 141.62 48.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.931 1.692 . . . . 0.0 109.974 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.58 76.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.128 -0.357 . . . . 0.0 111.771 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -151.36 167.04 29.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.6 1.16 . . . . 0.0 111.784 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -64.73 -14.4 58.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.029 1.731 . . . . 0.0 114.514 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -67.59 -22.21 65.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.05 1.34 . . . . 0.0 113.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.6 mt -92.76 -54.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.553 1.141 . . . . 0.0 111.345 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.39 61.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.475 1.11 . . . . 0.0 111.301 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -68.49 -24.22 64.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.194 0.997 . . . . 0.0 113.616 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -8.58 58.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.801 1.641 . . . . 0.0 113.704 173.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -111.55 4.0 18.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.869 2.067 . . . . 0.0 112.129 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.34 2.57 90.55 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.668 1.604 . . . . 0.0 115.024 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 t -78.89 164.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.292 1.837 . . . . 0.0 109.223 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 p -124.94 158.27 33.99 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.175 0.99 . . . . 0.0 110.159 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.631 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.6 138.57 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.232 -0.918 . . . . 0.0 110.642 175.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -122.24 -60.36 1.57 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.761 1.624 . . . . 0.0 109.855 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -131.02 152.79 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.605 1.162 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.23 165.4 23.27 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.846 2.058 . . . . 0.0 111.076 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.43 158.77 7.32 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.518 2.009 . . . . 0.0 113.705 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.0 t -60.85 130.17 45.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.513 -0.992 . . . . 0.0 110.57 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.65 143.33 75.14 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.594 0.757 . . . . 0.0 111.445 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.54 157.94 48.25 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.999 2.466 . . . . 0.0 112.738 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.8 m -79.76 -25.48 41.0 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.451 1.1 . . . . 0.0 112.495 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.8 0.86 0.55 Allowed Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.281 1.419 . . . . 0.0 115.845 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 mm . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.358 1.863 . . . . 0.0 111.805 179.206 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -73.15 -15.63 61.46 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 119.762 -1.836 . . . . 0.0 115.924 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.98 129.81 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.333 1.853 . . . . 0.0 110.182 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.4 m -68.03 135.94 53.05 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.246 0.546 . . . . 0.0 111.992 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.2 145.47 30.97 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.518 1.127 . . . . 0.0 111.568 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.31 152.21 85.39 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.498 1.119 . . . . 0.0 113.616 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.56 178.73 5.88 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.097 3.198 . . . . 0.0 112.452 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 9.7 mmpt? -94.62 -7.22 41.54 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.461 1.504 . . . . 0.0 114.573 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.2 tt -65.88 155.98 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.599 1.16 . . . . 0.0 111.928 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.16 70.35 0.74 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.629 1.572 . . . . 0.0 109.77 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -151.91 67.3 7.08 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 125.642 1.577 . . . . 0.0 111.492 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.73 165.04 24.5 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.697 2.264 . . . . 0.0 112.944 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' A' ' 34' ' ' ILE . 31.6 m -141.95 172.29 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 127.352 2.261 . . . . 0.0 111.552 -175.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.4 t -112.71 116.75 30.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.465 1.506 . . . . 0.0 111.445 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.46 49.5 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.593 1.107 . . . . 0.0 112.268 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 t -78.77 -6.94 57.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.006 1.322 . . . . 0.0 111.474 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -84.62 -13.12 52.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 112.549 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.93 16.5 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.696 1.141 . . . . 0.0 115.012 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -124.28 153.73 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.366 2.266 . . . . 0.0 109.861 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.3 m -80.71 140.84 35.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.409 1.484 . . . . 0.0 111.995 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -132.88 142.98 49.21 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.049 1.74 . . . . 0.0 109.911 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.08 -22.79 67.08 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -155.85 165.27 36.99 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.679 1.592 . . . . 0.0 111.65 165.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -49.93 -32.36 14.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.19 2.196 . . . . 0.0 113.539 167.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -58.58 -33.16 69.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.016 0.927 . . . . 0.0 112.986 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 mm -85.51 -43.46 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 0.0 111.703 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.89 -42.96 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.573 0.749 . . . . 0.0 110.384 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -67.26 -34.58 77.73 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.452 1.101 . . . . 0.0 113.595 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.6 t -66.33 -15.77 63.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.574 1.149 . . . . 0.0 113.942 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -103.34 2.17 33.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 112.092 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.23 89.05 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.941 1.734 . . . . 0.0 115.068 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.33 158.46 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.449 1.9 . . . . 0.0 109.325 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -115.27 155.23 27.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.148 0.979 . . . . 0.0 109.886 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.666 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.72 139.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.058 -1.026 . . . . 0.0 110.709 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -124.68 -59.54 1.44 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.617 1.567 . . . . 0.0 110.175 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -132.68 166.37 22.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.62 1.168 . . . . 0.0 112.928 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 162.98 13.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.989 2.516 . . . . 0.0 112.771 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.6 165.6 3.75 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.024 2.25 . . . . 0.0 113.27 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -59.76 124.52 20.41 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.849 1.26 . . . . 0.0 111.465 170.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.74 140.44 58.91 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.374 1.47 . . . . 0.0 111.617 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.81 -176.89 1.65 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.744 2.963 . . . . 0.0 113.367 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.0 m 67.65 49.81 0.94 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.982 1.713 . . . . 0.0 110.296 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.95 -0.39 0.2 Allowed Glycine 0 CA--C 1.538 1.512 0 N-CA-C 117.121 1.608 . . . . 0.0 117.121 172.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.255 1.391 0 CA-C-N 119.299 1.549 . . . . 0.0 110.595 175.069 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.333 0.111 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -22.51 66.07 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.09 117.36 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.96 1.704 . . . . 0.0 109.995 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m -71.82 140.89 49.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.812 0.845 . . . . 0.0 111.237 171.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.8 120.12 13.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.671 0.789 . . . . 0.0 110.978 170.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.5 m -57.3 145.63 66.18 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.31 1.044 . . . . 0.0 112.777 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.87 165.35 32.84 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.609 2.873 . . . . 0.0 112.344 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -92.05 -8.48 45.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.119 1.368 . . . . 0.0 114.508 -174.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 tt -67.41 156.13 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.638 1.575 . . . . 0.0 112.839 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.7 mt -88.44 -160.86 0.68 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.303 1.841 . . . . 0.0 111.356 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 55.29 70.41 1.6 Allowed Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 126.969 2.108 . . . . 0.0 112.555 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.63 169.31 11.59 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.382 2.721 . . . . 0.0 113.667 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.699 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.3 m -136.08 172.0 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.671 2.389 . . . . 0.0 111.086 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.49 107.32 13.17 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.362 1.865 . . . . 0.0 109.583 -171.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.58 167.53 52.12 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.48 1.044 . . . . 0.0 112.238 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.3 p -76.33 -8.53 57.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.896 1.279 . . . . 0.0 112.112 -173.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.5 -14.14 49.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.357 1.463 . . . . 0.0 112.579 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.83 9.82 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.29 0.948 . . . . 0.0 113.879 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.01 153.67 46.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.203 2.201 . . . . 0.0 110.287 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.1 m -84.07 139.52 32.43 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.312 1.445 . . . . 0.0 111.799 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -135.62 137.08 41.56 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.311 1.444 . . . . 0.0 110.312 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.91 -23.29 67.29 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.16 -0.962 . . . . 0.0 113.04 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.62 172.64 17.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.985 0.914 . . . . 0.0 113.336 166.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t -58.08 -26.51 62.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.946 1.298 . . . . 0.0 113.47 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.97 -30.46 59.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.294 1.438 . . . . 0.0 113.501 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.36 -52.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.213 1.405 . . . . 0.0 111.599 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.36 64.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.965 1.306 . . . . 0.0 111.474 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -64.15 -29.13 70.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.794 1.237 . . . . 0.0 113.338 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.55 -7.76 59.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.065 1.346 . . . . 0.0 113.752 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -108.12 4.42 24.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.225 1.81 . . . . 0.0 112.036 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.24 6.61 87.77 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.453 1.502 . . . . 0.0 114.598 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.6 t -89.24 164.22 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.757 2.023 . . . . 0.0 109.246 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -123.73 161.25 25.54 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.93 1.292 . . . . 0.0 110.205 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.699 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -72.11 136.03 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 120.787 -1.195 . . . . 0.0 110.324 174.483 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -119.28 -61.38 1.64 Allowed 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.505 1.522 . . . . 0.0 109.688 -177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 t -133.76 171.55 13.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.7 1.2 . . . . 0.0 112.833 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.77 168.93 11.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.434 2.694 . . . . 0.0 112.688 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.39 174.28 5.75 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.398 1.951 . . . . 0.0 113.808 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 t -59.42 127.55 32.65 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.575 -0.956 . . . . 0.0 110.863 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.43 135.78 84.04 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.64 1.576 . . . . 0.0 111.051 -173.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.61 155.5 63.01 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.85 2.366 . . . . 0.0 113.14 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.6 m -89.63 40.31 0.99 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.633 1.573 . . . . 0.0 111.697 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.07 -0.57 25.51 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.726 1.632 . . . . 0.0 115.632 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.888 2.075 . . . . 0.0 110.835 177.672 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -135.44 150.23 49.8 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.075 1.75 . . . . 0.0 110.67 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.07 -23.09 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 m -98.27 -53.69 3.28 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.077 1.351 . . . . 0.0 111.893 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.99 29.68 3.6 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.685 1.994 . . . . 0.0 114.904 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.7 m 49.57 83.54 0.22 Allowed Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 127.681 2.392 . . . . 0.0 113.508 -172.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.61 174.46 12.19 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.264 3.309 . . . . 0.0 112.724 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -133.69 75.61 1.61 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.028 1.731 . . . . 0.0 110.871 -171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.34 138.37 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.975 2.11 . . . . 0.0 108.311 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.35 178.4 4.57 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.428 1.491 . . . . 0.0 112.576 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt 57.81 68.91 1.71 Allowed Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 126.766 2.026 . . . . 0.0 112.055 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -66.15 172.33 8.88 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 124.051 3.167 . . . . 0.0 113.462 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.6 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.2 m -138.01 173.25 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.881 1.672 . . . . 0.0 112.631 -174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.22 119.05 34.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.525 1.53 . . . . 0.0 111.663 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.94 169.05 43.26 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 122.609 1.116 . . . . 0.0 112.786 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -78.71 -9.06 59.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.372 1.469 . . . . 0.0 112.303 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.48 -13.15 59.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.153 1.381 . . . . 0.0 112.143 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.57 34.56 15.96 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.875 1.226 . . . . 0.0 113.828 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -124.94 159.51 31.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.388 2.275 . . . . 0.0 110.255 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -100.21 136.77 39.59 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.453 1.501 . . . . 0.0 112.155 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -138.8 150.25 45.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.525 1.53 . . . . 0.0 111.569 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.17 -23.46 67.32 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -157.97 170.05 23.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.774 2.03 . . . . 0.0 110.655 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -59.6 -29.44 67.98 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.249 1.42 . . . . 0.0 113.428 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 t -54.81 -51.11 66.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.817 1.647 . . . . 0.0 112.563 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.627 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.5 mp -61.07 -48.18 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.247 1.419 . . . . 0.0 111.07 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.82 70.59 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.594 0.711 . . . . 0.0 110.087 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -71.75 -24.65 61.81 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -18.02 64.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.27 1.428 . . . . 0.0 113.942 168.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -113.26 -1.83 14.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.019 1.727 . . . . 0.0 112.621 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.73 2.11 82.08 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.785 1.66 . . . . 0.0 115.184 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -72.41 161.16 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.344 1.458 . . . . 0.0 108.672 165.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.0 p -120.78 167.27 12.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.645 1.178 . . . . 0.0 110.485 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.6 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -77.9 140.85 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 120.714 -1.241 . . . . 0.0 110.891 174.161 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.82 -61.06 1.4 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.053 1.741 . . . . 0.0 109.811 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -134.77 164.93 26.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 112.459 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -95.94 168.63 10.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.315 2.246 . . . . 0.0 112.121 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.65 160.16 7.38 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.331 1.919 . . . . 0.0 112.842 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 p -64.68 122.69 17.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.293 -1.122 . . . . 0.0 110.806 169.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 149.67 90.06 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.651 1.18 . . . . 0.0 111.947 -176.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.57 159.53 42.64 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.038 2.492 . . . . 0.0 112.945 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.0 p -101.93 -13.04 17.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.851 1.66 . . . . 0.0 113.707 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.13 -19.31 3.89 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.357 1.932 . . . . 0.0 114.66 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.253 1.273 0 C-N-CA 125.87 1.668 . . . . 0.0 110.538 172.368 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 110.758 -0.089 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.75 70.63 1.44 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.869 1.668 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.69 128.98 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.718 1.207 . . . . 0.0 112.286 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.2 m -97.21 14.39 26.09 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.416 1.886 . . . . 0.0 114.06 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.92 24.76 7.89 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.222 1.809 . . . . 0.0 113.947 -170.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.0 p -60.85 153.36 64.86 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.083 1.753 . . . . 0.0 115.341 -170.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.57 175.99 10.66 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.899 3.066 . . . . 0.0 112.773 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -122.72 8.72 9.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.487 1.915 . . . . 0.0 113.309 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.5 mt -66.18 137.35 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.462 2.305 . . . . 0.0 111.101 -174.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 tp -77.72 37.12 0.22 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.913 1.685 . . . . 0.0 113.722 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -130.81 70.95 82.59 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 125.695 1.598 . . . . 0.0 111.606 173.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.79 164.82 22.92 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.547 2.164 . . . . 0.0 112.816 172.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.2 m -140.24 172.82 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 128.161 2.584 . . . . 0.0 110.866 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.33 116.4 28.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.002 1.321 . . . . 0.0 111.292 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.65 168.26 43.44 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.481 1.045 . . . . 0.0 112.42 172.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.6 t -78.55 -11.07 59.94 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.006 1.322 . . . . 0.0 111.376 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.03 -12.82 60.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.93 1.292 . . . . 0.0 112.331 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.85 28.79 17.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.08 1.324 . . . . 0.0 114.72 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -125.82 154.29 42.84 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.286 2.234 . . . . 0.0 110.377 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -83.91 140.74 31.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.785 1.634 . . . . 0.0 112.373 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.88 141.97 42.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.303 1.841 . . . . 0.0 110.21 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.94 -19.76 65.36 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -154.68 169.61 23.49 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.303 1.441 . . . . 0.0 111.861 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.5 p -56.15 -29.55 60.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.726 1.611 . . . . 0.0 113.816 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -61.5 -33.97 74.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.784 0.802 . . . . 0.0 112.571 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mt -78.13 -44.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.329 1.451 . . . . 0.0 111.106 -175.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.44 -43.5 68.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.791 0.837 . . . . 0.0 110.149 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.76 -42.61 97.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.392 1.077 . . . . 0.0 112.884 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.8 t -58.69 -20.26 46.97 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.705 1.202 . . . . 0.0 113.862 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -106.14 3.55 28.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.027 1.731 . . . . 0.0 112.272 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 3.91 89.02 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.755 1.645 . . . . 0.0 115.351 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.44 160.73 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.375 1.87 . . . . 0.0 109.076 170.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.5 p -118.76 153.47 34.37 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.17 0.988 . . . . 0.0 109.815 172.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -67.19 139.86 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.17 -0.956 . . . . 0.0 110.761 175.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.73 -60.13 1.62 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.651 1.58 . . . . 0.0 109.939 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -134.09 158.3 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.436 1.095 . . . . 0.0 112.41 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.94 166.12 20.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 112.945 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.27 163.56 4.5 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.471 1.986 . . . . 0.0 114.16 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.9 t -61.04 127.75 33.07 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.448 -1.03 . . . . 0.0 110.789 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 146.42 78.54 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.13 0.972 . . . . 0.0 111.512 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.57 -177.2 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.452 2.768 . . . . 0.0 112.69 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.3 m 70.46 42.79 0.85 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.626 1.571 . . . . 0.0 110.803 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.13 21.3 0.1 OUTLIER Glycine 0 CA--C 1.537 1.427 0 N-CA-C 116.109 1.203 . . . . 0.0 116.109 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.782 1.633 . . . . 0.0 111.84 178.391 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -68.71 -22.98 64.32 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.55 160.32 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.761 2.024 . . . . 0.0 110.177 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.7 p -64.91 169.76 4.92 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.963 0.905 . . . . 0.0 113.196 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.84 162.93 30.67 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.203 1.401 . . . . 0.0 111.443 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.8 m -121.68 70.32 26.3 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.46 1.904 . . . . 0.0 111.36 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.55 162.3 40.23 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.56 2.84 . . . . 0.0 112.716 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -91.76 7.85 39.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.188 1.795 . . . . 0.0 113.79 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.6 tp -49.72 131.06 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 127.481 2.312 . . . . 0.0 112.953 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.17 176.21 4.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.205 1.402 . . . . 0.0 112.955 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? 51.59 65.43 6.48 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 126.566 1.946 . . . . 0.0 112.532 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.84 175.39 3.05 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.753 2.968 . . . . 0.0 113.558 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.67 ' HB ' HD11 ' A' ' 34' ' ' ILE . 30.7 m -132.52 172.38 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.596 1.958 . . . . 0.0 111.646 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -122.69 106.83 11.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.308 1.843 . . . . 0.0 109.69 -169.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.53 167.89 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 122.592 1.107 . . . . 0.0 112.411 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.3 t -77.28 -11.94 59.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.574 1.15 . . . . 0.0 111.226 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.12 -11.84 59.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.058 1.343 . . . . 0.0 112.508 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 38.05 11.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.719 1.152 . . . . 0.0 113.792 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 -130.28 154.24 47.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.99 2.116 . . . . 0.0 110.639 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.0 m -83.09 139.66 33.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.434 1.494 . . . . 0.0 111.999 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -135.22 140.52 45.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.942 171.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.9 70.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.49 -0.756 . . . . 0.0 112.623 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.47 174.21 14.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.048 1.339 . . . . 0.0 111.271 170.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -61.32 -24.64 66.58 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.876 1.27 . . . . 0.0 113.873 170.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.88 -32.33 65.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.013 1.325 . . . . 0.0 113.618 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.818 1.247 . . . . 0.0 112.114 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.04 -40.81 64.21 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.427 1.091 . . . . 0.0 111.418 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -66.81 -30.28 70.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.026 1.331 . . . . 0.0 112.97 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.56 -11.58 60.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.724 1.61 . . . . 0.0 113.789 174.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.94 3.63 18.95 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.539 1.935 . . . . 0.0 111.962 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.32 90.02 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.77 1.652 . . . . 0.0 115.093 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.43 156.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.827 1.651 . . . . 0.0 109.248 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.5 p -115.3 156.17 25.93 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.228 1.011 . . . . 0.0 110.064 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.67 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.15 137.34 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.181 -0.949 . . . . 0.0 110.246 174.147 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -121.29 -60.85 1.59 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 125.576 1.55 . . . . 0.0 109.664 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -133.03 171.84 13.44 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.812 1.245 . . . . 0.0 112.687 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.45 168.95 9.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.864 2.466 . . . . 0.0 111.971 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.11 168.49 10.79 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.983 1.754 . . . . 0.0 112.953 -170.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.3 t -58.64 128.98 39.92 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.578 -0.954 . . . . 0.0 110.416 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.88 139.8 91.04 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.001 1.72 . . . . 0.0 110.725 -174.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.81 179.29 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.248 2.632 . . . . 0.0 112.498 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.4 m 65.78 30.32 10.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.146 1.379 . . . . 0.0 111.467 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.08 -8.04 0.04 OUTLIER Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.341 1.448 . . . . 0.0 115.785 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 tt . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.818 1.647 . . . . 0.0 113.339 173.04 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.4 tttt . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 120.888 0.375 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -98.45 -21.56 16.49 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.4 138.63 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.761 2.024 . . . . 0.0 109.695 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 94.2 m -76.79 157.38 31.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.14 0.576 . . . . 0.0 111.885 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.33 168.78 15.22 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.417 0.687 . . . . 0.0 112.275 170.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.67 154.25 80.54 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.207 1.403 . . . . 0.0 111.826 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.46 169.44 22.4 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.275 2.65 . . . . 0.0 112.595 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -102.87 56.02 0.76 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.623 1.569 . . . . 0.0 111.925 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 tt -129.4 143.65 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.854 1.662 . . . . 0.0 111.584 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 tp -93.11 42.65 1.1 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.469 1.508 . . . . 0.0 111.91 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -123.65 66.58 37.09 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 126.483 1.913 . . . . 0.0 111.536 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.95 167.54 19.49 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.537 2.158 . . . . 0.0 112.941 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.684 ' HB ' HD11 ' A' ' 34' ' ' ILE . 26.5 m -136.55 170.02 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.919 2.487 . . . . 0.0 111.252 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -110.41 115.61 29.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.818 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.5 42.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 122.488 1.049 . . . . 0.0 112.546 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -77.49 -13.73 59.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.839 1.256 . . . . 0.0 111.104 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.36 -13.52 59.81 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.978 1.311 . . . . 0.0 112.471 171.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.07 60.97 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.953 1.739 . . . . 0.0 115.547 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.55 166.75 11.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.169 1.388 . . . . 0.0 111.427 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -92.48 139.24 30.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.88 1.672 . . . . 0.0 111.813 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -135.76 138.49 42.71 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.672 1.589 . . . . 0.0 110.454 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.66 -26.34 67.0 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -158.5 174.44 15.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.394 1.478 . . . . 0.0 111.98 167.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.0 t -67.62 -14.43 62.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.281 1.432 . . . . 0.0 114.683 171.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 t -69.39 -23.91 63.79 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.589 -1.319 . . . . 0.0 113.939 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.02 -47.55 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.996 1.318 . . . . 0.0 113.881 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.16 37.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.836 0.826 . . . . 0.0 111.557 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -79.2 -22.88 44.29 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.939 1.296 . . . . 0.0 113.887 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.38 -21.4 59.68 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.388 1.475 . . . . 0.0 112.719 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.27 -27.08 16.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.089 1.356 . . . . 0.0 112.119 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.26 0.23 16.5 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.25 1.881 . . . . 0.0 115.312 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.26 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.032 1.733 . . . . 0.0 109.255 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.3 p -119.5 154.59 33.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.111 0.965 . . . . 0.0 110.183 171.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.91 140.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.256 -0.902 . . . . 0.0 110.794 176.633 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.9 -62.22 1.13 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.579 1.552 . . . . 0.0 109.919 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -128.37 164.33 22.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.384 1.474 . . . . 0.0 111.995 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 167.4 11.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.629 2.372 . . . . 0.0 112.697 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.28 166.66 7.4 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.431 1.967 . . . . 0.0 113.95 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -63.68 128.03 33.99 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.616 -0.932 . . . . 0.0 110.547 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.19 142.57 44.16 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.649 1.18 . . . . 0.0 112.036 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.81 167.12 27.46 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.278 2.652 . . . . 0.0 112.695 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.3 p -75.82 -9.12 58.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.088 1.355 . . . . 0.0 114.176 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.51 10.9 30.24 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.458 1.504 . . . . 0.0 114.959 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.7 tt . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.929 1.692 . . . . 0.0 113.668 176.244 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 CA--C 1.537 0.66 0 CA-C-O 121.993 0.747 . . . . 0.0 113.26 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.3 m -134.42 172.5 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.324 2.25 . . . . 0.0 111.709 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.8 t -111.5 118.92 37.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.821 1.248 . . . . 0.0 111.364 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.57 169.69 49.67 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 122.581 1.1 . . . . 0.0 112.479 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 t -79.16 -6.75 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.875 1.27 . . . . 0.0 111.5 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.24 -12.29 58.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.879 1.271 . . . . 0.0 112.412 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.44 30.97 17.57 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.178 1.37 . . . . 0.0 114.543 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -127.22 155.67 43.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.424 2.29 . . . . 0.0 110.067 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.9 m -82.52 140.49 33.29 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.538 1.535 . . . . 0.0 112.261 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -137.24 142.38 42.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.115 1.766 . . . . 0.0 110.706 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.09 -26.54 68.34 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.56 173.24 17.17 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.655 1.582 . . . . 0.0 111.784 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -59.08 -32.86 70.18 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.422 1.089 . . . . 0.0 113.241 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.4 m -54.76 -33.73 61.67 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.484 1.514 . . . . 0.0 113.506 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 mm -81.21 -48.23 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.196 1.398 . . . . 0.0 110.649 -173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.48 -44.71 65.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.471 1.108 . . . . 0.0 110.29 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -59.78 -44.74 93.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.834 1.253 . . . . 0.0 112.396 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.43 -10.29 49.89 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.85 2.11 29.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.014 1.726 . . . . 0.0 112.133 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 6.13 88.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.838 1.685 . . . . 0.0 115.041 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.45 162.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.395 2.278 . . . . 0.0 109.223 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.9 p -119.0 155.86 30.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.96 171.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -68.08 140.13 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.114 -0.991 . . . . 0.0 110.519 174.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -125.42 -61.54 1.26 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.618 1.567 . . . . 0.0 109.897 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -134.62 173.51 11.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.819 1.248 . . . . 0.0 112.312 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -104.91 165.88 10.77 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.166 2.586 . . . . 0.0 112.951 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.22 166.61 6.0 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.146 1.831 . . . . 0.0 113.823 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.8 t -60.96 127.09 29.89 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.466 -1.02 . . . . 0.0 110.232 168.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.833 0 C-N-CA 124.003 0.921 . . . . 0.0 111.306 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo . . . . . 0 CA--C 1.538 0.699 0 CA-C-O 122.056 0.774 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.761 ' HB ' HD11 ' A' ' 34' ' ' ILE . 28.0 m -140.4 176.2 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.747 2.419 . . . . 0.0 111.538 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -119.65 119.75 34.63 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.694 1.597 . . . . 0.0 111.226 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.79 168.17 47.13 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.511 1.062 . . . . 0.0 112.268 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -74.42 -11.23 60.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.784 1.634 . . . . 0.0 112.036 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -78.76 -12.53 60.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.46 1.504 . . . . 0.0 112.157 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.68 30.82 17.26 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.287 1.423 . . . . 0.0 114.437 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -129.27 151.96 49.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.568 2.347 . . . . 0.0 110.344 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -80.37 140.42 36.07 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.624 1.57 . . . . 0.0 112.44 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -134.77 146.74 49.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.552 1.941 . . . . 0.0 110.985 172.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -22.74 67.05 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -158.62 171.05 20.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.255 1.422 . . . . 0.0 111.307 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -56.47 -35.64 68.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.823 1.249 . . . . 0.0 113.109 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.8 m -61.2 -27.65 68.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.828 1.251 . . . . 0.0 113.188 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 mm -84.56 -47.7 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.95 1.7 . . . . 0.0 110.261 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.24 -42.96 61.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.64 1.176 . . . . 0.0 111.031 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.05 -41.43 99.47 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.421 1.088 . . . . 0.0 112.637 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -67.65 -18.27 64.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -101.55 -1.83 32.0 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.818 1.647 . . . . 0.0 112.425 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.48 11.42 59.52 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.58 1.562 . . . . 0.0 115.639 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -101.63 169.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.594 2.358 . . . . 0.0 108.942 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.4 p -126.2 156.19 40.6 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.306 -1.496 . . . . 0.0 110.471 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.761 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.39 136.74 25.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 O-C-N 120.651 -1.281 . . . . 0.0 111.322 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -116.5 -58.58 2.07 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.358 1.463 . . . . 0.0 109.832 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -135.46 143.2 45.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.206 1.402 . . . . 0.0 112.282 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.56 166.14 24.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.726 1.61 . . . . 0.0 112.711 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 159.52 6.41 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.319 1.914 . . . . 0.0 113.641 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -60.4 131.35 50.49 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.063 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.55 0.95 0 C-N-CA 123.476 0.71 . . . . 0.0 111.622 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 CA-C-O 121.811 0.671 . . . . 0.0 113.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.9 m -134.48 169.99 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.9 2.08 . . . . 0.0 111.849 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -113.64 118.64 34.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.378 1.471 . . . . 0.0 110.215 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.7 168.05 43.97 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 122.689 1.161 . . . . 0.0 112.278 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -75.22 -9.77 58.85 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.852 1.661 . . . . 0.0 111.844 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.06 -15.38 59.61 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.779 1.632 . . . . 0.0 112.113 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.48 34.2 14.63 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.432 1.491 . . . . 0.0 113.909 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -132.25 155.81 47.62 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.85 2.46 . . . . 0.0 110.038 -174.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -93.49 140.46 29.56 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.884 1.274 . . . . 0.0 112.705 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.01 138.06 41.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.74 1.616 . . . . 0.0 111.083 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.96 65.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.23 1.012 . . . . 0.0 113.638 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -174.49 4.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.597 1.159 . . . . 0.0 112.57 167.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -24.33 67.16 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.61 -2.58 4.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.174 1.79 . . . . 0.0 115.396 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -46.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.908 1.683 . . . . 0.0 113.501 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.83 53.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.895 0.855 . . . . 0.0 110.983 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.37 -22.74 57.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.989 1.315 . . . . 0.0 113.259 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -10.84 59.15 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.596 1.559 . . . . 0.0 113.197 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -108.9 -9.08 15.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.238 1.815 . . . . 0.0 112.688 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.9 57.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.736 1.636 . . . . 0.0 115.349 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.64 161.44 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.504 1.522 . . . . 0.0 109.347 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -122.1 144.67 48.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.841 1.256 . . . . 0.0 109.768 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.561 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -63.73 135.87 27.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.27 -1.519 . . . . 0.0 110.848 175.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.47 -60.43 1.88 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.917 1.287 . . . . 0.0 109.285 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 p -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.357 1.463 . . . . 0.0 111.76 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -74.66 168.28 20.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.119 1.367 . . . . 0.0 112.681 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.0 159.22 12.07 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.106 1.812 . . . . 0.0 113.307 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 132.43 51.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.166 0.986 . . . . 0.0 110.758 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.891 0 O-C-N 121.738 -0.601 . . . . 0.0 111.683 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 CA-C-O 122.241 0.85 . . . . 0.0 113.758 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 34' ' ' ILE . 26.9 m -136.93 171.04 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.562 2.345 . . . . 0.0 111.421 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 t -115.06 118.3 33.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.44 1.496 . . . . 0.0 110.321 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.97 167.18 48.97 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 122.464 1.035 . . . . 0.0 112.514 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -76.99 -12.15 59.9 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.584 1.554 . . . . 0.0 111.135 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.18 -14.59 59.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.589 1.555 . . . . 0.0 112.342 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.67 25.46 20.5 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.237 1.399 . . . . 0.0 115.145 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -121.93 152.07 40.05 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.385 2.274 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.4 m -80.66 143.95 32.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.25 1.42 . . . . 0.0 112.061 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -134.2 141.1 46.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.136 1.774 . . . . 0.0 110.59 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -24.67 64.77 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -159.76 -179.27 7.7 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.918 1.687 . . . . 0.0 110.809 166.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.7 p -63.33 -24.22 67.76 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 170.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.74 -14.59 53.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.55 1.54 . . . . 0.0 115.103 -170.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.07 -42.61 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.052 1.741 . . . . 0.0 113.339 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.99 39.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.985 0.898 . . . . 0.0 110.516 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -78.92 -29.03 43.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.427 1.491 . . . . 0.0 113.242 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.94 -27.23 64.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.435 1.094 . . . . 0.0 112.767 170.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.2 -24.25 23.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.839 1.255 . . . . 0.0 112.086 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.73 3.39 30.38 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.306 1.908 . . . . 0.0 114.996 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.53 158.69 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.31 1.844 . . . . 0.0 109.252 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 p -115.75 145.09 43.1 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.334 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -63.54 137.97 23.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 120.99 -1.069 . . . . 0.0 110.911 174.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -118.17 -57.82 2.05 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.028 1.331 . . . . 0.0 109.73 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -131.94 136.81 47.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -70.34 162.18 29.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.118 1.367 . . . . 0.0 112.223 172.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.97 162.66 19.62 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.647 2.07 . . . . 0.0 113.391 -171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.7 t -61.14 131.3 50.07 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.682 -0.893 . . . . 0.0 110.638 172.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 123.331 0.652 . . . . 0.0 111.295 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 CA--C 1.537 0.664 0 CA-C-O 122.153 0.814 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.675 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.1 m -136.67 172.6 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.306 2.243 . . . . 0.0 111.328 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 t -113.94 118.21 33.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.435 1.494 . . . . 0.0 110.999 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.53 169.09 45.03 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 122.426 1.015 . . . . 0.0 112.417 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.2 t -75.93 -13.64 60.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.359 1.464 . . . . 0.0 111.266 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -8.39 59.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.866 1.267 . . . . 0.0 112.475 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.05 26.3 29.21 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.008 1.29 . . . . 0.0 114.984 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -123.1 152.77 40.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.288 2.235 . . . . 0.0 110.397 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -78.25 139.84 38.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.598 1.559 . . . . 0.0 112.261 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -133.95 141.42 47.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.356 1.862 . . . . 0.0 110.512 171.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.28 67.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 0.0 113.282 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.39 172.41 17.33 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.505 1.122 . . . . 0.0 112.959 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -62.83 -26.89 68.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.376 1.471 . . . . 0.0 113.18 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.09 -22.66 63.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.49 1.516 . . . . 0.0 114.896 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pt -105.44 -43.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.8 -34.97 42.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.14 0.972 . . . . 0.0 111.258 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.74 -29.84 56.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.596 1.158 . . . . 0.0 113.751 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -75.57 -10.74 59.7 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.662 1.185 . . . . 0.0 113.118 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -103.6 -0.88 29.07 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.083 1.753 . . . . 0.0 112.36 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.94 80.45 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.842 1.687 . . . . 0.0 115.264 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 t -78.62 161.16 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.525 1.53 . . . . 0.0 109.207 171.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.5 p -119.96 151.65 38.63 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.313 1.045 . . . . 0.0 109.976 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.35 138.37 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 175.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -123.75 -61.27 1.39 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.391 1.476 . . . . 0.0 110.073 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.4 m -131.68 156.91 45.04 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.918 1.287 . . . . 0.0 111.981 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.08 169.2 15.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.807 2.043 . . . . 0.0 112.934 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.82 165.08 5.8 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.686 2.089 . . . . 0.0 114.189 -175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.3 t -62.81 127.83 33.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.357 -1.084 . . . . 0.0 110.45 170.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 124.229 1.011 . . . . 0.0 111.813 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 CA--C 1.536 0.613 0 CA-C-O 121.858 0.691 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.626 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.6 m -131.87 171.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 127.375 2.27 . . . . 0.0 111.971 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.0 119.51 38.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.191 1.396 . . . . 0.0 111.446 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.78 169.54 41.73 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 122.587 1.104 . . . . 0.0 112.443 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -78.58 -10.43 59.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.532 1.533 . . . . 0.0 111.249 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.41 -12.92 60.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.01 1.324 . . . . 0.0 112.247 168.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.75 30.45 23.78 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.368 1.461 . . . . 0.0 114.222 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -129.86 158.82 38.41 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.31 2.244 . . . . 0.0 110.782 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -87.93 139.39 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.684 1.594 . . . . 0.0 113.213 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -138.67 144.8 39.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.048 2.139 . . . . 0.0 109.931 174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.94 72.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.194 -0.941 . . . . 0.0 112.745 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -153.97 176.14 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.094 1.758 . . . . 0.0 111.836 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -68.86 -21.22 64.28 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.147 1.379 . . . . 0.0 114.384 170.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.09 -4.3 28.14 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.142 1.377 . . . . 0.0 114.57 -173.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.74 -42.19 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.178 1.791 . . . . 0.0 114.087 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.61 -35.06 40.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.229 0.922 . . . . 0.0 111.391 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -79.51 -18.71 51.33 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.304 1.442 . . . . 0.0 113.869 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 t -73.82 -10.93 60.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.151 1.38 . . . . 0.0 113.004 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -120.1 3.95 10.9 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.706 2.002 . . . . 0.0 112.572 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.11 1.43 84.47 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.978 1.752 . . . . 0.0 115.617 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.69 157.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.255 1.422 . . . . 0.0 109.097 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 p -115.19 154.57 28.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.351 1.06 . . . . 0.0 109.87 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.1 138.52 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 120.934 -1.104 . . . . 0.0 110.605 173.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -123.56 -61.84 1.36 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.603 1.561 . . . . 0.0 109.993 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -133.13 170.31 15.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.976 1.311 . . . . 0.0 112.599 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -98.36 168.23 10.34 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.202 2.601 . . . . 0.0 112.638 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.65 164.53 6.55 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.321 1.915 . . . . 0.0 113.764 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -61.19 129.07 39.5 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.583 -0.951 . . . . 0.0 110.443 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 123.678 0.791 . . . . 0.0 111.716 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo . . . . . 0 CA--C 1.537 0.669 0 CA-C-O 122.216 0.84 . . . . 0.0 113.531 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -137.8 170.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 128.06 2.544 . . . . 0.0 111.311 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -113.77 117.76 32.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.425 1.49 . . . . 0.0 110.352 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 167.88 48.59 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.544 1.08 . . . . 0.0 112.404 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 t -78.61 -7.57 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 111.301 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.82 -13.08 59.67 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.245 1.418 . . . . 0.0 112.247 170.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.0 31.58 14.5 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.026 1.298 . . . . 0.0 114.295 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -127.54 152.37 47.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.464 2.306 . . . . 0.0 110.327 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.7 m -85.2 140.63 30.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.513 1.525 . . . . 0.0 111.964 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.91 139.65 46.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.097 1.759 . . . . 0.0 110.626 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.25 -24.38 64.84 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -159.09 179.36 9.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.902 1.681 . . . . 0.0 110.734 163.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.1 p -62.75 -22.23 66.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.24 -26.99 68.12 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 -45.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.153 1.381 . . . . 0.0 113.475 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.49 -39.31 33.39 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.1 0.953 . . . . 0.0 110.899 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -78.71 -28.69 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.513 1.525 . . . . 0.0 113.714 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.85 -19.49 58.85 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.941 0.896 . . . . 0.0 112.854 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -89.08 -22.64 22.81 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.046 1.338 . . . . 0.0 112.079 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.59 2.66 37.54 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.655 2.074 . . . . 0.0 115.349 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.08 159.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.163 1.785 . . . . 0.0 109.257 168.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.5 p -117.72 145.54 44.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.427 173.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.456 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -62.83 136.79 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.073 -1.017 . . . . 0.0 110.929 174.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -117.06 -56.94 2.21 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.912 1.285 . . . . 0.0 109.896 -175.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -134.11 141.84 47.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.75 1.62 . . . . 0.0 112.267 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.19 162.65 29.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.292 1.437 . . . . 0.0 112.329 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.69 162.79 22.64 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.77 2.129 . . . . 0.0 113.46 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -62.18 131.16 48.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.673 -0.898 . . . . 0.0 110.927 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 CA--C 1.538 0.713 0 N-CA-C 114.28 0.838 . . . . 0.0 114.28 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' A' ' 34' ' ' ILE . 28.7 m -136.23 171.27 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.514 2.326 . . . . 0.0 111.985 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 t -117.84 120.1 36.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.572 1.549 . . . . 0.0 110.598 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.88 48.67 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 122.774 1.208 . . . . 0.0 112.705 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -75.41 -11.14 59.98 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.719 2.008 . . . . 0.0 111.922 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.99 -13.77 59.6 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.523 1.529 . . . . 0.0 112.185 171.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.83 25.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.391 1.472 . . . . 0.0 114.533 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -121.59 149.58 42.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.22 2.208 . . . . 0.0 110.853 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -81.96 139.88 34.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.118 1.767 . . . . 0.0 112.05 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -133.2 141.27 48.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.247 1.819 . . . . 0.0 110.818 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.76 67.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.2 176.39 11.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.737 1.215 . . . . 0.0 112.317 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -64.0 -26.39 68.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.921 0.888 . . . . 0.0 113.306 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -60.39 -20.62 60.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.06 1.344 . . . . 0.0 114.552 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.8 -51.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 111.617 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.65 64.38 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.088 1.355 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.75 1.62 . . . . 0.0 113.075 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -84.56 -7.37 59.28 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.955 1.702 . . . . 0.0 113.316 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -113.31 1.71 15.26 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.315 1.846 . . . . 0.0 112.602 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 15.71 55.01 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.083 1.325 . . . . 0.0 115.373 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.76 159.26 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.311 1.844 . . . . 0.0 109.639 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.1 p -116.35 146.52 42.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.999 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -64.3 133.53 29.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 O-C-N 120.359 -1.463 . . . . 0.0 110.946 173.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -113.71 -58.68 2.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.775 1.23 . . . . 0.0 109.969 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -130.58 138.41 50.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.614 1.566 . . . . 0.0 111.946 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.48 164.44 26.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.689 1.596 . . . . 0.0 112.568 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 165.02 11.24 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.993 1.759 . . . . 0.0 113.397 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.43 133.5 55.11 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.376 -1.073 . . . . 0.0 111.024 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.888 0 C-N-CA 123.069 0.547 . . . . 0.0 111.489 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 122.424 0.927 . . . . 0.0 113.433 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.5 m -140.0 172.75 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 127.822 2.449 . . . . 0.0 111.287 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 t -114.56 115.55 27.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.285 1.434 . . . . 0.0 111.293 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.41 169.46 36.78 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 122.492 1.051 . . . . 0.0 112.228 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -79.57 -6.49 57.14 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.961 1.304 . . . . 0.0 111.2 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.88 -13.46 59.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.975 1.31 . . . . 0.0 112.149 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.82 31.19 24.44 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.326 1.441 . . . . 0.0 114.009 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -130.9 157.85 41.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.206 2.203 . . . . 0.0 110.749 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.7 m -89.1 138.02 31.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.365 1.466 . . . . 0.0 112.8 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.59 143.14 43.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.582 1.953 . . . . 0.0 110.368 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.97 -27.17 66.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 173.05 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 167.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -56.44 -32.86 65.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.914 1.686 . . . . 0.0 112.897 171.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -57.73 -27.97 63.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.412 1.085 . . . . 0.0 113.709 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.6 pt -104.93 -36.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.51 -30.59 31.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.477 1.035 . . . . 0.0 111.212 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -77.18 -28.61 54.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.672 1.589 . . . . 0.0 113.366 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.1 -10.14 59.47 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.147 0.979 . . . . 0.0 112.993 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -106.24 -0.8 24.19 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.987 1.715 . . . . 0.0 112.147 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.93 89.32 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.702 1.62 . . . . 0.0 115.331 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -81.09 163.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.418 1.487 . . . . 0.0 108.668 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -125.91 157.84 36.67 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.918 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.673 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.07 138.65 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 124.305 1.042 . . . . 0.0 111.398 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -124.35 -59.36 1.48 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.517 1.527 . . . . 0.0 110.307 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -134.59 167.87 20.01 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 112.293 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -100.87 167.52 10.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.223 2.209 . . . . 0.0 112.734 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 163.77 5.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.783 2.135 . . . . 0.0 112.97 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -62.07 126.09 26.12 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.254 -1.145 . . . . 0.0 110.98 169.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.831 0 C-N-CA 124.786 1.234 . . . . 0.0 111.789 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo . . . . . 0 CA--C 1.535 0.526 0 CA-C-O 122.05 0.771 . . . . 0.0 112.901 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.674 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.5 m -139.96 172.14 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.555 2.342 . . . . 0.0 111.089 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.3 t -114.28 116.86 29.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.082 1.353 . . . . 0.0 111.013 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.13 169.54 46.05 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 122.639 1.133 . . . . 0.0 112.666 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -74.85 -12.26 60.34 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 111.998 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.03 -8.58 59.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.28 1.432 . . . . 0.0 112.268 172.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.26 30.51 22.2 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.841 1.21 . . . . 0.0 114.591 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -126.29 152.87 45.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.578 2.351 . . . . 0.0 109.963 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.2 m -81.67 140.09 34.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.115 1.366 . . . . 0.0 111.882 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -132.08 138.92 48.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.927 1.691 . . . . 0.0 109.842 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -23.22 63.29 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.49 178.82 8.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.881 1.273 . . . . 0.0 112.264 166.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 p -72.09 -7.56 49.65 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.4 t -75.94 -17.88 59.57 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -48.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.906 1.282 . . . . 0.0 113.409 -174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.34 -40.07 16.38 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.566 1.146 . . . . 0.0 111.645 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -71.8 -36.43 70.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.601 -1.182 . . . . 0.0 113.854 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.11 -22.87 63.94 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.381 1.472 . . . . 0.0 112.512 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -88.23 -28.62 21.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.565 1.146 . . . . 0.0 111.844 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.59 1.24 13.64 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.335 1.921 . . . . 0.0 115.17 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.6 t -72.93 159.78 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.47 1.908 . . . . 0.0 109.457 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -113.5 154.81 26.45 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.726 0.81 . . . . 0.0 110.449 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.36 135.82 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 120.53 -1.356 . . . . 0.0 110.651 174.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -121.44 -58.98 1.74 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.314 1.446 . . . . 0.0 110.309 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -131.09 159.25 38.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.458 1.103 . . . . 0.0 112.319 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.26 166.17 13.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.456 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 164.49 7.7 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.711 2.101 . . . . 0.0 113.679 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 t -62.26 128.07 34.32 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.493 -1.004 . . . . 0.0 110.677 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.852 0 C-N-CA 124.084 0.953 . . . . 0.0 111.611 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 CA--C 1.536 0.59 0 CA-C-O 121.79 0.662 . . . . 0.0 113.246 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.763 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.6 m -132.76 171.33 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 127.24 2.216 . . . . 0.0 111.417 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -119.83 107.07 12.72 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.392 1.877 . . . . 0.0 109.625 -172.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.41 167.93 51.47 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 122.559 1.088 . . . . 0.0 112.297 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -76.42 -12.29 60.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.852 1.261 . . . . 0.0 111.323 -172.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -81.15 -14.32 57.76 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.039 1.336 . . . . 0.0 112.635 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.81 15.24 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.587 1.089 . . . . 0.0 114.67 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -121.46 154.13 36.99 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.723 2.009 . . . . 0.0 110.439 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -79.9 140.86 36.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.315 1.446 . . . . 0.0 111.475 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -134.33 139.72 45.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.403 1.481 . . . . 0.0 109.86 171.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.79 69.75 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.465 -0.772 . . . . 0.0 112.643 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -154.08 169.79 22.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.923 1.289 . . . . 0.0 111.523 171.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.4 m -56.37 -23.76 39.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.626 1.57 . . . . 0.0 113.605 170.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.1 m -62.72 -13.78 36.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.49 -51.13 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.456 1.503 . . . . 0.0 111.203 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.25 -42.29 60.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.523 1.129 . . . . 0.0 111.463 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -70.38 -21.48 62.86 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -11.09 59.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.943 1.697 . . . . 0.0 113.424 171.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -112.24 3.44 17.15 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.755 2.022 . . . . 0.0 111.953 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.15 5.11 89.13 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.582 1.563 . . . . 0.0 114.784 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -85.54 161.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.481 1.913 . . . . 0.0 109.491 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.7 p -122.28 155.27 36.27 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.467 1.107 . . . . 0.0 110.278 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -66.38 139.39 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.261 -0.899 . . . . 0.0 110.626 174.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -125.78 -57.44 1.44 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.178 1.391 . . . . 0.0 109.973 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 154.73 43.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.285 1.434 . . . . 0.0 112.981 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -76.23 162.72 27.71 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.841 2.057 . . . . 0.0 111.775 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.08 170.87 8.73 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.347 1.927 . . . . 0.0 113.859 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -58.63 133.39 55.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.711 -0.876 . . . . 0.0 111.187 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.548 0.897 0 C-N-CA 125.827 1.651 . . . . 0.0 111.077 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 CA-C-O 121.69 0.621 . . . . 0.0 113.67 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.632 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.5 m -134.86 172.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.481 1.913 . . . . 0.0 112.217 -176.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.6 t -114.06 119.93 38.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 111.579 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.09 169.48 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 122.505 1.058 . . . . 0.0 112.3 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.2 p -74.79 -10.65 59.71 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.431 1.492 . . . . 0.0 112.183 -175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -80.85 -13.36 59.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 0.0 112.189 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.12 25.96 27.5 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.146 1.355 . . . . 0.0 114.593 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -121.26 154.15 36.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.572 2.349 . . . . 0.0 110.043 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -80.57 140.29 35.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 112.261 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -134.69 140.62 46.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.327 1.851 . . . . 0.0 110.406 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.69 70.47 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.668 0.787 . . . . 0.0 112.942 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -155.68 173.87 16.1 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 111.338 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.2 p -62.77 -19.76 64.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -66.82 -14.05 62.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 pt -112.07 -40.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.54 -34.23 49.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.507 1.049 . . . . 0.0 111.57 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -82.09 -13.88 56.62 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.5 t -74.47 -18.82 60.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.515 1.126 . . . . 0.0 113.159 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -122.63 1.23 9.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.072 1.349 . . . . 0.0 114.103 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.66 -0.38 34.36 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.054 1.311 . . . . 0.0 116.345 163.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.33 158.16 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.814 1.246 . . . . 0.0 108.823 167.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.7 p -118.36 161.9 19.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.064 -1.023 . . . . 0.0 110.839 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.7 137.08 23.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 120.764 -1.21 . . . . 0.0 110.713 175.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -122.11 -60.4 1.58 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.622 1.569 . . . . 0.0 110.033 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -134.45 166.46 22.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 112.282 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.88 170.24 9.7 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.13 2.172 . . . . 0.0 112.843 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.39 163.84 5.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.343 1.925 . . . . 0.0 113.648 -172.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -60.29 127.83 33.72 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.426 -1.043 . . . . 0.0 110.403 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 124.113 0.965 . . . . 0.0 111.478 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 CA--C 1.536 0.625 0 N-CA-C 114.362 0.87 . . . . 0.0 114.362 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.7 m -135.96 169.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.21 2.204 . . . . 0.0 112.047 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.3 t -114.09 117.96 32.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.514 1.526 . . . . 0.0 110.454 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.36 169.46 49.58 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 122.707 1.171 . . . . 0.0 112.73 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 t -77.83 -8.39 57.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.147 1.379 . . . . 0.0 111.507 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 -8.29 58.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.877 1.271 . . . . 0.0 112.664 170.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.17 23.75 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.652 1.12 . . . . 0.0 115.14 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -122.88 154.17 38.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.592 2.357 . . . . 0.0 109.967 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -87.04 141.16 28.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.007 1.323 . . . . 0.0 111.638 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -133.44 138.0 46.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.968 1.707 . . . . 0.0 110.657 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.96 67.53 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -158.67 -178.43 7.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.941 1.296 . . . . 0.0 110.559 161.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 p -55.73 -23.49 29.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.477 1.511 . . . . 0.0 114.594 170.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 t -60.93 -16.77 46.07 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.618 1.567 . . . . 0.0 114.527 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.07 -49.39 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.417 1.487 . . . . 0.0 111.591 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.8 58.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.878 1.271 . . . . 0.0 111.101 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -68.95 -23.04 64.09 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.6 t -83.21 -3.59 57.55 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.576 1.55 . . . . 0.0 113.475 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -118.75 7.98 11.74 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.2 1.8 . . . . 0.0 112.327 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.42 7.08 87.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.328 1.442 . . . . 0.0 114.773 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -87.64 162.14 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.228 1.811 . . . . 0.0 109.601 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -125.24 150.72 46.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.341 1.057 . . . . 0.0 109.776 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.487 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -62.4 138.7 22.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.144 -0.973 . . . . 0.0 111.001 174.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.87 -57.98 1.99 Allowed 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 124.987 1.315 . . . . 0.0 109.649 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 p -133.33 135.02 44.53 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.264 1.425 . . . . 0.0 112.333 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -69.67 160.67 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.882 1.673 . . . . 0.0 111.939 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.96 161.04 22.62 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.372 1.939 . . . . 0.0 113.397 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 t -59.78 132.81 55.1 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.681 -0.893 . . . . 0.0 110.723 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.838 0 C-N-CA 123.13 0.572 . . . . 0.0 111.075 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 CA--C 1.532 0.408 0 N-CA-C 113.853 0.674 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.631 ' HB ' HD11 ' A' ' 34' ' ' ILE . 32.2 m -135.93 174.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.006 1.722 . . . . 0.0 112.44 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 t -119.2 122.48 42.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.13 169.28 51.35 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 122.506 1.059 . . . . 0.0 112.556 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -77.9 -10.72 59.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.315 1.446 . . . . 0.0 111.502 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.949 1.3 . . . . 0.0 112.391 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.51 26.26 23.49 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.089 1.328 . . . . 0.0 114.958 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -121.8 151.75 40.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.234 2.213 . . . . 0.0 110.27 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.8 m -79.66 139.86 37.26 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.627 1.571 . . . . 0.0 111.712 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.57 141.62 48.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.931 1.692 . . . . 0.0 109.974 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.58 76.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.128 -0.357 . . . . 0.0 111.771 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -151.36 167.04 29.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.6 1.16 . . . . 0.0 111.784 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -64.73 -14.4 58.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.029 1.731 . . . . 0.0 114.514 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -67.59 -22.21 65.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.05 1.34 . . . . 0.0 113.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.6 mt -92.76 -54.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.553 1.141 . . . . 0.0 111.345 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.39 61.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.475 1.11 . . . . 0.0 111.301 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -68.49 -24.22 64.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.194 0.997 . . . . 0.0 113.616 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -8.58 58.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.801 1.641 . . . . 0.0 113.704 173.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -111.55 4.0 18.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.869 2.067 . . . . 0.0 112.129 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.34 2.57 90.55 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.668 1.604 . . . . 0.0 115.024 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 t -78.89 164.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.292 1.837 . . . . 0.0 109.223 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 p -124.94 158.27 33.99 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.175 0.99 . . . . 0.0 110.159 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.631 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.6 138.57 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.232 -0.918 . . . . 0.0 110.642 175.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -122.24 -60.36 1.57 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.761 1.624 . . . . 0.0 109.855 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -131.02 152.79 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.605 1.162 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.23 165.4 23.27 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.846 2.058 . . . . 0.0 111.076 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.43 158.77 7.32 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.518 2.009 . . . . 0.0 113.705 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.0 t -60.85 130.17 45.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.513 -0.992 . . . . 0.0 110.57 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.878 0 C-N-CA 123.594 0.757 . . . . 0.0 111.445 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 CA--C 1.534 0.482 0 CA-C-O 121.87 0.696 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' A' ' 34' ' ' ILE . 31.6 m -141.95 172.29 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 127.352 2.261 . . . . 0.0 111.552 -175.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.4 t -112.71 116.75 30.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.465 1.506 . . . . 0.0 111.445 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.46 49.5 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.593 1.107 . . . . 0.0 112.268 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 t -78.77 -6.94 57.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.006 1.322 . . . . 0.0 111.474 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -84.62 -13.12 52.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 112.549 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.93 16.5 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.696 1.141 . . . . 0.0 115.012 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -124.28 153.73 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.366 2.266 . . . . 0.0 109.861 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.3 m -80.71 140.84 35.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.409 1.484 . . . . 0.0 111.995 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -132.88 142.98 49.21 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.049 1.74 . . . . 0.0 109.911 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.08 -22.79 67.08 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -155.85 165.27 36.99 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.679 1.592 . . . . 0.0 111.65 165.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -49.93 -32.36 14.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.19 2.196 . . . . 0.0 113.539 167.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -58.58 -33.16 69.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.016 0.927 . . . . 0.0 112.986 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 mm -85.51 -43.46 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 0.0 111.703 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.89 -42.96 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.573 0.749 . . . . 0.0 110.384 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -67.26 -34.58 77.73 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.452 1.101 . . . . 0.0 113.595 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.6 t -66.33 -15.77 63.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.574 1.149 . . . . 0.0 113.942 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -103.34 2.17 33.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 112.092 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.23 89.05 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.941 1.734 . . . . 0.0 115.068 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.33 158.46 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.449 1.9 . . . . 0.0 109.325 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -115.27 155.23 27.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.148 0.979 . . . . 0.0 109.886 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.666 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.72 139.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.058 -1.026 . . . . 0.0 110.709 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -124.68 -59.54 1.44 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.617 1.567 . . . . 0.0 110.175 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -132.68 166.37 22.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.62 1.168 . . . . 0.0 112.928 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 162.98 13.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.989 2.516 . . . . 0.0 112.771 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.6 165.6 3.75 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.024 2.25 . . . . 0.0 113.27 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -59.76 124.52 20.41 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.849 1.26 . . . . 0.0 111.465 170.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.374 1.47 . . . . 0.0 111.617 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 CA--C 1.536 0.599 0 CA-C-O 122.126 0.802 . . . . 0.0 113.667 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.699 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.3 m -136.08 172.0 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.671 2.389 . . . . 0.0 111.086 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.49 107.32 13.17 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.362 1.865 . . . . 0.0 109.583 -171.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.58 167.53 52.12 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.48 1.044 . . . . 0.0 112.238 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.3 p -76.33 -8.53 57.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.896 1.279 . . . . 0.0 112.112 -173.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.5 -14.14 49.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.357 1.463 . . . . 0.0 112.579 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.83 9.82 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.29 0.948 . . . . 0.0 113.879 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.01 153.67 46.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.203 2.201 . . . . 0.0 110.287 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.1 m -84.07 139.52 32.43 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.312 1.445 . . . . 0.0 111.799 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -135.62 137.08 41.56 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.311 1.444 . . . . 0.0 110.312 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.91 -23.29 67.29 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.16 -0.962 . . . . 0.0 113.04 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.62 172.64 17.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.985 0.914 . . . . 0.0 113.336 166.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t -58.08 -26.51 62.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.946 1.298 . . . . 0.0 113.47 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.97 -30.46 59.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.294 1.438 . . . . 0.0 113.501 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.36 -52.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.213 1.405 . . . . 0.0 111.599 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.36 64.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.965 1.306 . . . . 0.0 111.474 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -64.15 -29.13 70.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.794 1.237 . . . . 0.0 113.338 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.55 -7.76 59.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.065 1.346 . . . . 0.0 113.752 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -108.12 4.42 24.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.225 1.81 . . . . 0.0 112.036 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.24 6.61 87.77 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.453 1.502 . . . . 0.0 114.598 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.6 t -89.24 164.22 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.757 2.023 . . . . 0.0 109.246 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -123.73 161.25 25.54 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.93 1.292 . . . . 0.0 110.205 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.699 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -72.11 136.03 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 120.787 -1.195 . . . . 0.0 110.324 174.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -119.28 -61.38 1.64 Allowed 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.505 1.522 . . . . 0.0 109.688 -177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 t -133.76 171.55 13.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.7 1.2 . . . . 0.0 112.833 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.77 168.93 11.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.434 2.694 . . . . 0.0 112.688 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.39 174.28 5.75 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.398 1.951 . . . . 0.0 113.808 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 t -59.42 127.55 32.65 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.575 -0.956 . . . . 0.0 110.863 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.823 0 C-N-CA 125.64 1.576 . . . . 0.0 111.051 -173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo . . . . . 0 CA--C 1.537 0.629 0 CA-C-O 121.547 0.561 . . . . 0.0 113.462 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.6 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.2 m -138.01 173.25 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.881 1.672 . . . . 0.0 112.631 -174.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.22 119.05 34.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.525 1.53 . . . . 0.0 111.663 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.94 169.05 43.26 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 122.609 1.116 . . . . 0.0 112.786 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -78.71 -9.06 59.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.372 1.469 . . . . 0.0 112.303 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.48 -13.15 59.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.153 1.381 . . . . 0.0 112.143 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.57 34.56 15.96 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.875 1.226 . . . . 0.0 113.828 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -124.94 159.51 31.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.388 2.275 . . . . 0.0 110.255 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -100.21 136.77 39.59 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.453 1.501 . . . . 0.0 112.155 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -138.8 150.25 45.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.525 1.53 . . . . 0.0 111.569 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.17 -23.46 67.32 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -157.97 170.05 23.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.774 2.03 . . . . 0.0 110.655 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -59.6 -29.44 67.98 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.249 1.42 . . . . 0.0 113.428 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 t -54.81 -51.11 66.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.817 1.647 . . . . 0.0 112.563 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.627 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.5 mp -61.07 -48.18 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.247 1.419 . . . . 0.0 111.07 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.82 70.59 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.594 0.711 . . . . 0.0 110.087 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -71.75 -24.65 61.81 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -18.02 64.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.27 1.428 . . . . 0.0 113.942 168.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -113.26 -1.83 14.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.019 1.727 . . . . 0.0 112.621 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.73 2.11 82.08 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.785 1.66 . . . . 0.0 115.184 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -72.41 161.16 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.344 1.458 . . . . 0.0 108.672 165.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.0 p -120.78 167.27 12.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.645 1.178 . . . . 0.0 110.485 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.6 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -77.9 140.85 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 120.714 -1.241 . . . . 0.0 110.891 174.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.82 -61.06 1.4 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.053 1.741 . . . . 0.0 109.811 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -134.77 164.93 26.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 112.459 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -95.94 168.63 10.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.315 2.246 . . . . 0.0 112.121 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.65 160.16 7.38 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.331 1.919 . . . . 0.0 112.842 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 p -64.68 122.69 17.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.293 -1.122 . . . . 0.0 110.806 169.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 C-N-CA 124.651 1.18 . . . . 0.0 111.947 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 CA--C 1.536 0.59 0 CA-C-O 122.226 0.844 . . . . 0.0 112.816 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.2 m -140.24 172.82 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 128.161 2.584 . . . . 0.0 110.866 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.33 116.4 28.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.002 1.321 . . . . 0.0 111.292 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.65 168.26 43.44 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.481 1.045 . . . . 0.0 112.42 172.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.6 t -78.55 -11.07 59.94 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.006 1.322 . . . . 0.0 111.376 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.03 -12.82 60.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.93 1.292 . . . . 0.0 112.331 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.85 28.79 17.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.08 1.324 . . . . 0.0 114.72 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -125.82 154.29 42.84 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.286 2.234 . . . . 0.0 110.377 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -83.91 140.74 31.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.785 1.634 . . . . 0.0 112.373 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.88 141.97 42.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.303 1.841 . . . . 0.0 110.21 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.94 -19.76 65.36 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -154.68 169.61 23.49 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.303 1.441 . . . . 0.0 111.861 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.5 p -56.15 -29.55 60.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.726 1.611 . . . . 0.0 113.816 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -61.5 -33.97 74.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.784 0.802 . . . . 0.0 112.571 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mt -78.13 -44.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.329 1.451 . . . . 0.0 111.106 -175.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.44 -43.5 68.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.791 0.837 . . . . 0.0 110.149 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.76 -42.61 97.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.392 1.077 . . . . 0.0 112.884 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.8 t -58.69 -20.26 46.97 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.705 1.202 . . . . 0.0 113.862 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -106.14 3.55 28.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.027 1.731 . . . . 0.0 112.272 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 3.91 89.02 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.755 1.645 . . . . 0.0 115.351 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.44 160.73 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.375 1.87 . . . . 0.0 109.076 170.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.5 p -118.76 153.47 34.37 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.17 0.988 . . . . 0.0 109.815 172.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -67.19 139.86 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.17 -0.956 . . . . 0.0 110.761 175.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.73 -60.13 1.62 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.651 1.58 . . . . 0.0 109.939 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -134.09 158.3 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.436 1.095 . . . . 0.0 112.41 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.94 166.12 20.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 112.945 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.27 163.56 4.5 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.471 1.986 . . . . 0.0 114.16 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.9 t -61.04 127.75 33.07 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.448 -1.03 . . . . 0.0 110.789 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 124.13 0.972 . . . . 0.0 111.512 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 CA-C-O 121.629 0.595 . . . . 0.0 113.558 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.67 ' HB ' HD11 ' A' ' 34' ' ' ILE . 30.7 m -132.52 172.38 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.596 1.958 . . . . 0.0 111.646 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -122.69 106.83 11.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.308 1.843 . . . . 0.0 109.69 -169.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.53 167.89 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 122.592 1.107 . . . . 0.0 112.411 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.3 t -77.28 -11.94 59.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.574 1.15 . . . . 0.0 111.226 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.12 -11.84 59.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.058 1.343 . . . . 0.0 112.508 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 38.05 11.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.719 1.152 . . . . 0.0 113.792 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 -130.28 154.24 47.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.99 2.116 . . . . 0.0 110.639 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.0 m -83.09 139.66 33.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.434 1.494 . . . . 0.0 111.999 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -135.22 140.52 45.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.942 171.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.9 70.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.49 -0.756 . . . . 0.0 112.623 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.47 174.21 14.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.048 1.339 . . . . 0.0 111.271 170.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -61.32 -24.64 66.58 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.876 1.27 . . . . 0.0 113.873 170.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.88 -32.33 65.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.013 1.325 . . . . 0.0 113.618 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.818 1.247 . . . . 0.0 112.114 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.04 -40.81 64.21 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.427 1.091 . . . . 0.0 111.418 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -66.81 -30.28 70.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.026 1.331 . . . . 0.0 112.97 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.56 -11.58 60.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.724 1.61 . . . . 0.0 113.789 174.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.94 3.63 18.95 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.539 1.935 . . . . 0.0 111.962 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.32 90.02 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.77 1.652 . . . . 0.0 115.093 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.43 156.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.827 1.651 . . . . 0.0 109.248 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.5 p -115.3 156.17 25.93 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.228 1.011 . . . . 0.0 110.064 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.67 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.15 137.34 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.181 -0.949 . . . . 0.0 110.246 174.147 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -121.29 -60.85 1.59 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 125.576 1.55 . . . . 0.0 109.664 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -133.03 171.84 13.44 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.812 1.245 . . . . 0.0 112.687 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.45 168.95 9.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.864 2.466 . . . . 0.0 111.971 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.11 168.49 10.79 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.983 1.754 . . . . 0.0 112.953 -170.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.3 t -58.64 128.98 39.92 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.578 -0.954 . . . . 0.0 110.416 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 126.001 1.72 . . . . 0.0 110.725 -174.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 CA--C 1.535 0.528 0 CA-C-O 122.398 0.916 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.684 ' HB ' HD11 ' A' ' 34' ' ' ILE . 26.5 m -136.55 170.02 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.919 2.487 . . . . 0.0 111.252 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -110.41 115.61 29.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.818 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.5 42.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 122.488 1.049 . . . . 0.0 112.546 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -77.49 -13.73 59.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.839 1.256 . . . . 0.0 111.104 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.36 -13.52 59.81 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.978 1.311 . . . . 0.0 112.471 171.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.07 60.97 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.953 1.739 . . . . 0.0 115.547 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.55 166.75 11.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.169 1.388 . . . . 0.0 111.427 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -92.48 139.24 30.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.88 1.672 . . . . 0.0 111.813 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -135.76 138.49 42.71 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.672 1.589 . . . . 0.0 110.454 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.66 -26.34 67.0 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -158.5 174.44 15.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.394 1.478 . . . . 0.0 111.98 167.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.0 t -67.62 -14.43 62.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.281 1.432 . . . . 0.0 114.683 171.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 t -69.39 -23.91 63.79 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.589 -1.319 . . . . 0.0 113.939 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.02 -47.55 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.996 1.318 . . . . 0.0 113.881 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.16 37.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.836 0.826 . . . . 0.0 111.557 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -79.2 -22.88 44.29 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.939 1.296 . . . . 0.0 113.887 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.38 -21.4 59.68 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.388 1.475 . . . . 0.0 112.719 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.27 -27.08 16.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.089 1.356 . . . . 0.0 112.119 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.26 0.23 16.5 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.25 1.881 . . . . 0.0 115.312 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.26 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.032 1.733 . . . . 0.0 109.255 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.3 p -119.5 154.59 33.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.111 0.965 . . . . 0.0 110.183 171.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.91 140.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.256 -0.902 . . . . 0.0 110.794 176.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.9 -62.22 1.13 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.579 1.552 . . . . 0.0 109.919 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -128.37 164.33 22.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.384 1.474 . . . . 0.0 111.995 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 167.4 11.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.629 2.372 . . . . 0.0 112.697 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.28 166.66 7.4 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.431 1.967 . . . . 0.0 113.95 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -63.68 128.03 33.99 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.616 -0.932 . . . . 0.0 110.547 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.903 0 C-N-CA 124.649 1.18 . . . . 0.0 112.036 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -89.02 158.94 17.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.884 1.274 . . . . 0.0 111.016 171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.5 p -152.61 147.28 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.301 1.84 . . . . 0.0 110.27 173.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.3 m -72.92 140.55 47.54 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.595 -0.691 . . . . 0.0 112.396 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.13 100.86 13.18 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.41 1.484 . . . . 0.0 110.65 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 49.1 t -50.5 128.81 25.51 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.848 1.259 . . . . 0.0 113.273 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 26' ' ' ILE . 85.3 Cg_endo -73.29 169.05 23.2 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.76 2.973 . . . . 0.0 112.662 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -84.19 4.03 32.49 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.378 1.871 . . . . 0.0 114.73 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.9 tp -61.1 160.15 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.344 1.857 . . . . 0.0 113.068 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.3 pp -115.74 -172.83 2.23 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.087 2.155 . . . . 0.0 111.687 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt 52.1 71.12 1.57 Allowed Pre-proline 0 N--CA 1.483 1.176 0 C-N-CA 125.946 1.698 . . . . 0.0 112.333 -169.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.22 171.73 7.34 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.445 2.764 . . . . 0.0 113.26 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.3 m -134.42 172.5 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 127.324 2.25 . . . . 0.0 111.709 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.8 t -111.5 118.92 37.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.821 1.248 . . . . 0.0 111.364 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.57 169.69 49.67 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 122.581 1.1 . . . . 0.0 112.479 172.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 t -79.16 -6.75 57.27 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.875 1.27 . . . . 0.0 111.5 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -82.24 -12.29 58.16 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.879 1.271 . . . . 0.0 112.412 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.44 30.97 17.57 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.178 1.37 . . . . 0.0 114.543 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -127.22 155.67 43.07 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.424 2.29 . . . . 0.0 110.067 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.9 m -82.52 140.49 33.29 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.538 1.535 . . . . 0.0 112.261 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -137.24 142.38 42.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.115 1.766 . . . . 0.0 110.706 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.09 -26.54 68.34 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.56 173.24 17.17 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.655 1.582 . . . . 0.0 111.784 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.7 p -59.08 -32.86 70.18 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.422 1.089 . . . . 0.0 113.241 172.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.4 m -54.76 -33.73 61.67 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.484 1.514 . . . . 0.0 113.506 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 7' ' ' PRO . 4.5 mm -81.21 -48.23 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.196 1.398 . . . . 0.0 110.649 -173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.48 -44.71 65.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.471 1.108 . . . . 0.0 110.29 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -59.78 -44.74 93.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.834 1.253 . . . . 0.0 112.396 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.9 t -67.43 -10.29 49.89 Favored 'General case' 0 CA--C 1.551 1.006 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -104.85 2.11 29.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.014 1.726 . . . . 0.0 112.133 173.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.23 6.13 88.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.838 1.685 . . . . 0.0 115.041 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -87.45 162.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.395 2.278 . . . . 0.0 109.223 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.9 p -119.0 155.86 30.64 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.123 -0.985 . . . . 0.0 109.96 171.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -68.08 140.13 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.114 -0.991 . . . . 0.0 110.519 174.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -125.42 -61.54 1.26 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.618 1.567 . . . . 0.0 109.897 -175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 t -134.62 173.51 11.59 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.819 1.248 . . . . 0.0 112.312 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -104.91 165.88 10.77 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.166 2.586 . . . . 0.0 112.951 -173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.22 166.61 6.0 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.146 1.831 . . . . 0.0 113.823 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.8 t -60.96 127.09 29.89 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.466 -1.02 . . . . 0.0 110.232 168.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.92 142.79 65.34 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.003 0.921 . . . . 0.0 111.306 -178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -72.13 167.43 26.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.959 2.44 . . . . 0.0 111.983 175.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.1 m -71.54 -10.47 59.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.841 1.256 . . . . 0.0 112.844 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.52 -6.3 9.17 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.966 2.222 . . . . 0.0 114.2 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.2 mt . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.782 2.033 . . . . 0.0 110.772 177.035 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 119.374 -0.346 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.39 -21.2 18.51 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.37 153.89 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.385 1.474 . . . . 0.0 111.641 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 83.2 m -132.32 15.21 4.57 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.626 1.57 . . . . 0.0 114.647 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 57.51 92.2 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.11 2.964 . . . . 0.0 115.675 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.7 p -74.81 161.28 78.35 Favored Pre-proline 0 CA--C 1.553 1.08 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.0 -13.24 15.83 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.966 3.11 . . . . 0.0 114.613 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 tptp 46.39 54.27 8.73 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.966 2.506 . . . . 0.0 113.366 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.9 tt -91.05 12.11 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.46 1.904 . . . . 0.0 114.272 -170.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 63.54 17.53 10.43 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.818 2.047 . . . . 0.0 114.295 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -132.84 65.59 74.52 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.625 1.17 . . . . 0.0 113.162 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.01 170.16 12.17 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.724 2.949 . . . . 0.0 113.77 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.761 ' HB ' HD11 ' A' ' 34' ' ' ILE . 28.0 m -140.4 176.2 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.747 2.419 . . . . 0.0 111.538 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -119.65 119.75 34.63 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.694 1.597 . . . . 0.0 111.226 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.79 168.17 47.13 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 122.511 1.062 . . . . 0.0 112.268 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -74.42 -11.23 60.18 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.784 1.634 . . . . 0.0 112.036 -175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -78.76 -12.53 60.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.46 1.504 . . . . 0.0 112.157 171.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.68 30.82 17.26 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.287 1.423 . . . . 0.0 114.437 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -129.27 151.96 49.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.568 2.347 . . . . 0.0 110.344 -177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -80.37 140.42 36.07 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.624 1.57 . . . . 0.0 112.44 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -134.77 146.74 49.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.552 1.941 . . . . 0.0 110.985 172.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -22.74 67.05 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -158.62 171.05 20.83 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.255 1.422 . . . . 0.0 111.307 166.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.5 p -56.47 -35.64 68.17 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.823 1.249 . . . . 0.0 113.109 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.8 m -61.2 -27.65 68.58 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.828 1.251 . . . . 0.0 113.188 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 mm -84.56 -47.7 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.95 1.7 . . . . 0.0 110.261 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.24 -42.96 61.35 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.64 1.176 . . . . 0.0 111.031 171.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -63.05 -41.43 99.47 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.421 1.088 . . . . 0.0 112.637 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -67.65 -18.27 64.89 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -101.55 -1.83 32.0 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.818 1.647 . . . . 0.0 112.425 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.48 11.42 59.52 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.58 1.562 . . . . 0.0 115.639 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.6 t -101.63 169.2 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 127.594 2.358 . . . . 0.0 108.942 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.4 p -126.2 156.19 40.6 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.306 -1.496 . . . . 0.0 110.471 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.761 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.39 136.74 25.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 O-C-N 120.651 -1.281 . . . . 0.0 111.322 -179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -116.5 -58.58 2.07 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 125.358 1.463 . . . . 0.0 109.832 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -135.46 143.2 45.76 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.206 1.402 . . . . 0.0 112.282 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.56 166.14 24.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.726 1.61 . . . . 0.0 112.711 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 159.52 6.41 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.319 1.914 . . . . 0.0 113.641 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 t -60.4 131.35 50.49 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.063 173.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 133.04 78.72 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.476 0.71 . . . . 0.0 111.622 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.58 168.19 23.35 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.438 2.759 . . . . 0.0 112.605 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.9 m -104.44 -32.68 8.9 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.386 1.074 . . . . 0.0 112.711 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.7 10.93 5.74 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.568 1.556 . . . . 0.0 115.404 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 N--CA 1.485 1.295 0 C-N-CA 126.181 1.792 . . . . 0.0 110.929 179.263 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -129.51 -53.79 1.17 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.273 1.429 . . . . 0.0 113.061 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.27 142.16 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.928 1.691 . . . . 0.0 110.512 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.4 m -77.96 137.47 38.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.669 0.787 . . . . 0.0 111.167 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.66 128.79 37.38 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.797 0.839 . . . . 0.0 111.997 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.9 m -67.04 152.29 96.2 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.678 0.791 . . . . 0.0 112.811 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.09 172.06 16.3 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.989 3.126 . . . . 0.0 112.289 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -124.9 49.43 1.86 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.798 1.639 . . . . 0.0 112.147 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.2 tt -132.69 151.17 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.024 1.73 . . . . 0.0 111.096 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.12 -172.0 2.58 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.793 1.637 . . . . 0.0 111.133 172.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 58.01 69.73 1.45 Allowed Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 126.829 2.051 . . . . 0.0 112.374 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -64.73 175.14 3.84 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.161 3.241 . . . . 0.0 113.559 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.9 m -134.48 169.99 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.9 2.08 . . . . 0.0 111.849 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -113.64 118.64 34.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.378 1.471 . . . . 0.0 110.215 174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.7 168.05 43.97 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 122.689 1.161 . . . . 0.0 112.278 172.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.7 p -75.22 -9.77 58.85 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.852 1.661 . . . . 0.0 111.844 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.06 -15.38 59.61 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.779 1.632 . . . . 0.0 112.113 170.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.48 34.2 14.63 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.432 1.491 . . . . 0.0 113.909 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -132.25 155.81 47.62 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.85 2.46 . . . . 0.0 110.038 -174.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -93.49 140.46 29.56 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.884 1.274 . . . . 0.0 112.705 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.01 138.06 41.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.74 1.616 . . . . 0.0 111.083 176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.96 65.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.23 1.012 . . . . 0.0 113.638 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -174.49 4.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.597 1.159 . . . . 0.0 112.57 167.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.4 p -65.44 -24.33 67.16 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -66.61 -2.58 4.99 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.174 1.79 . . . . 0.0 115.396 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -46.75 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.908 1.683 . . . . 0.0 113.501 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.06 -38.83 53.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.895 0.855 . . . . 0.0 110.983 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.37 -22.74 57.29 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.989 1.315 . . . . 0.0 113.259 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.93 -10.84 59.15 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.596 1.559 . . . . 0.0 113.197 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -108.9 -9.08 15.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.238 1.815 . . . . 0.0 112.688 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.9 57.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.736 1.636 . . . . 0.0 115.349 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.64 161.44 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.504 1.522 . . . . 0.0 109.347 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.8 p -122.1 144.67 48.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.841 1.256 . . . . 0.0 109.768 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.561 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -63.73 135.87 27.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.27 -1.519 . . . . 0.0 110.848 175.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.47 -60.43 1.88 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.917 1.287 . . . . 0.0 109.285 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.3 p -134.29 141.45 46.95 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.357 1.463 . . . . 0.0 111.76 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -74.66 168.28 20.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.119 1.367 . . . . 0.0 112.681 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.0 159.22 12.07 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.106 1.812 . . . . 0.0 113.307 -170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 132.43 51.12 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.166 0.986 . . . . 0.0 110.758 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.26 142.16 46.95 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.738 -0.601 . . . . 0.0 111.683 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.16 160.66 44.92 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.17 2.58 . . . . 0.0 112.614 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 66.5 m -82.55 -60.56 2.15 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.231 1.012 . . . . 0.0 111.671 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.72 8.99 0.05 OUTLIER Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.759 1.171 . . . . 0.0 115.864 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.785 2.034 . . . . 0.0 111.943 -179.062 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 95.7 mttt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.229 0.062 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -126.23 83.75 2.2 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.41 1.884 . . . . 0.0 110.64 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.12 147.53 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.422 1.489 . . . . 0.0 111.311 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.4 p -68.6 118.45 11.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.966 1.307 . . . . 0.0 112.401 175.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.96 169.93 16.46 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.239 1.016 . . . . 0.0 112.467 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.6 p -125.95 152.86 73.48 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.713 1.605 . . . . 0.0 111.364 168.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -77.65 179.25 6.69 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.649 2.899 . . . . 0.0 112.372 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -111.39 -2.88 15.45 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.581 1.553 . . . . 0.0 114.311 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -68.78 134.64 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.846 1.658 . . . . 0.0 110.792 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.58 47.91 0.63 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.45 1.9 . . . . 0.0 112.594 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -130.12 68.78 81.44 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 125.582 1.553 . . . . 0.0 111.677 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.17 170.46 11.85 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.525 2.817 . . . . 0.0 113.758 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 34' ' ' ILE . 26.9 m -136.93 171.04 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.562 2.345 . . . . 0.0 111.421 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.3 t -115.06 118.3 33.01 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.44 1.496 . . . . 0.0 110.321 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.97 167.18 48.97 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 122.464 1.035 . . . . 0.0 112.514 173.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -76.99 -12.15 59.9 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.584 1.554 . . . . 0.0 111.135 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.18 -14.59 59.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.589 1.555 . . . . 0.0 112.342 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.67 25.46 20.5 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.237 1.399 . . . . 0.0 115.145 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -121.93 152.07 40.05 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.385 2.274 . . . . 0.0 110.345 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.4 m -80.66 143.95 32.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.25 1.42 . . . . 0.0 112.061 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -134.2 141.1 46.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.136 1.774 . . . . 0.0 110.59 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.07 -24.67 64.77 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -159.76 -179.27 7.7 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.918 1.687 . . . . 0.0 110.809 166.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.7 p -63.33 -24.22 67.76 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 170.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.74 -14.59 53.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.55 1.54 . . . . 0.0 115.103 -170.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.07 -42.61 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.052 1.741 . . . . 0.0 113.339 -173.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.99 39.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.985 0.898 . . . . 0.0 110.516 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -78.92 -29.03 43.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.427 1.491 . . . . 0.0 113.242 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.94 -27.23 64.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.435 1.094 . . . . 0.0 112.767 170.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -88.2 -24.25 23.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.839 1.255 . . . . 0.0 112.086 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.73 3.39 30.38 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 126.306 1.908 . . . . 0.0 114.996 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.53 158.69 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 126.31 1.844 . . . . 0.0 109.252 168.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.0 p -115.75 145.09 43.1 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.271 1.028 . . . . 0.0 109.334 173.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -63.54 137.97 23.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 120.99 -1.069 . . . . 0.0 110.911 174.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -118.17 -57.82 2.05 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 125.028 1.331 . . . . 0.0 109.73 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.6 p -131.94 136.81 47.63 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -70.34 162.18 29.04 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.118 1.367 . . . . 0.0 112.223 172.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.97 162.66 19.62 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.647 2.07 . . . . 0.0 113.391 -171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.7 t -61.14 131.3 50.07 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.682 -0.893 . . . . 0.0 110.638 172.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.05 140.43 73.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.331 0.652 . . . . 0.0 111.295 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.88 165.98 30.48 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.936 2.424 . . . . 0.0 112.467 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.9 p -72.76 -11.46 60.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.488 1.515 . . . . 0.0 113.842 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 133.76 -8.83 4.9 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 126.528 2.013 . . . . 0.0 114.224 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.113 1.765 . . . . 0.0 113.097 173.799 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -73.31 -60.96 2.0 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.222 1.009 . . . . 0.0 111.791 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.35 158.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.146 0.978 . . . . 0.0 111.921 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.0 t -102.12 -31.03 10.81 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.873 1.269 . . . . 0.0 113.657 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.9 -44.5 0.15 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.092 1.357 . . . . 0.0 113.207 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.2 t 42.96 66.74 4.15 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 126.88 2.072 . . . . 0.0 113.831 -174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 160.25 50.45 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.385 2.723 . . . . 0.0 113.053 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -80.21 67.14 5.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.058 1.743 . . . . 0.0 111.396 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.6 tp -136.55 140.14 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.295 1.438 . . . . 0.0 111.608 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 tp -92.0 -163.94 1.11 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.71 1.604 . . . . 0.0 111.379 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt 52.09 71.56 1.45 Allowed Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.501 1.92 . . . . 0.0 112.64 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.28 169.23 11.21 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.148 2.565 . . . . 0.0 113.307 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.675 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.1 m -136.67 172.6 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.306 2.243 . . . . 0.0 111.328 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 t -113.94 118.21 33.52 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.435 1.494 . . . . 0.0 110.999 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.53 169.09 45.03 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 122.426 1.015 . . . . 0.0 112.417 172.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.2 t -75.93 -13.64 60.25 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.359 1.464 . . . . 0.0 111.266 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.99 -8.39 59.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.866 1.267 . . . . 0.0 112.475 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.05 26.3 29.21 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.008 1.29 . . . . 0.0 114.984 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.8 tpt85 -123.1 152.77 40.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.288 2.235 . . . . 0.0 110.397 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -78.25 139.84 38.89 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.598 1.559 . . . . 0.0 112.261 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -133.95 141.42 47.29 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.356 1.862 . . . . 0.0 110.512 171.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -28.28 67.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 0.0 113.282 175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.39 172.41 17.33 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.505 1.122 . . . . 0.0 112.959 170.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -62.83 -26.89 68.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.376 1.471 . . . . 0.0 113.18 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.2 t -60.09 -22.66 63.02 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.49 1.516 . . . . 0.0 114.896 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 pt -105.44 -43.89 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.8 -34.97 42.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 122.14 0.972 . . . . 0.0 111.258 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -76.74 -29.84 56.35 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.596 1.158 . . . . 0.0 113.751 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -75.57 -10.74 59.7 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.662 1.185 . . . . 0.0 113.118 172.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -103.6 -0.88 29.07 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.083 1.753 . . . . 0.0 112.36 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 1.94 80.45 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.842 1.687 . . . . 0.0 115.264 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.5 t -78.62 161.16 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.525 1.53 . . . . 0.0 109.207 171.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.5 p -119.96 151.65 38.63 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.313 1.045 . . . . 0.0 109.976 170.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.35 138.37 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 175.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -123.75 -61.27 1.39 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.391 1.476 . . . . 0.0 110.073 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.4 m -131.68 156.91 45.04 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.918 1.287 . . . . 0.0 111.981 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.08 169.2 15.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.807 2.043 . . . . 0.0 112.934 176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.82 165.08 5.8 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 126.686 2.089 . . . . 0.0 114.189 -175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.3 t -62.81 127.83 33.1 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.357 -1.084 . . . . 0.0 110.45 170.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.23 136.78 60.81 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.229 1.011 . . . . 0.0 111.813 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.33 161.26 46.25 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.772 2.315 . . . . 0.0 112.14 175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.7 p -83.5 -0.07 48.61 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.29 1.436 . . . . 0.0 114.068 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 158.03 -11.71 0.23 Allowed Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.214 1.387 . . . . 0.0 115.603 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.253 1.249 0 C-N-CA 126.39 1.876 . . . . 0.0 111.281 174.558 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -114.91 -38.86 3.81 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.412 1.485 . . . . 0.0 113.567 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.0 t -75.68 125.31 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.082 1.353 . . . . 0.0 110.172 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.8 -71.93 0.69 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.081 0.953 . . . . 0.0 111.247 172.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.6 171.37 18.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.368 1.867 . . . . 0.0 111.944 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 p -152.76 72.87 7.29 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.367 1.467 . . . . 0.0 111.952 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.0 164.6 34.07 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.72 2.947 . . . . 0.0 112.722 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -128.75 -1.87 5.37 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -170.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.6 tt -61.8 150.71 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.898 1.279 . . . . 0.0 112.268 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -71.11 -175.93 1.29 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.242 1.417 . . . . 0.0 112.281 169.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt 57.86 71.48 1.05 Allowed Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 126.911 2.084 . . . . 0.0 112.607 -175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.01 175.54 3.06 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.497 2.798 . . . . 0.0 113.255 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.626 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.6 m -131.87 171.85 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 127.375 2.27 . . . . 0.0 111.971 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.7 t -113.0 119.51 38.14 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.191 1.396 . . . . 0.0 111.446 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.78 169.54 41.73 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 122.587 1.104 . . . . 0.0 112.443 171.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -78.58 -10.43 59.73 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.532 1.533 . . . . 0.0 111.249 -174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.41 -12.92 60.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.01 1.324 . . . . 0.0 112.247 168.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.75 30.45 23.78 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.368 1.461 . . . . 0.0 114.222 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.9 ttp180 -129.86 158.82 38.41 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 127.31 2.244 . . . . 0.0 110.782 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.4 m -87.93 139.39 30.56 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.684 1.594 . . . . 0.0 113.213 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -138.67 144.8 39.78 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 127.048 2.139 . . . . 0.0 109.931 174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.94 72.54 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.194 -0.941 . . . . 0.0 112.745 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -153.97 176.14 12.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.094 1.758 . . . . 0.0 111.836 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -68.86 -21.22 64.28 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.147 1.379 . . . . 0.0 114.384 170.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -72.09 -4.3 28.14 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.142 1.377 . . . . 0.0 114.57 -173.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.74 -42.19 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.178 1.791 . . . . 0.0 114.087 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.61 -35.06 40.08 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.229 0.922 . . . . 0.0 111.391 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -79.51 -18.71 51.33 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.304 1.442 . . . . 0.0 113.869 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.6 t -73.82 -10.93 60.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.151 1.38 . . . . 0.0 113.004 167.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -120.1 3.95 10.9 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.706 2.002 . . . . 0.0 112.572 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.11 1.43 84.47 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.978 1.752 . . . . 0.0 115.617 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.69 157.64 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.255 1.422 . . . . 0.0 109.097 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 p -115.19 154.57 28.76 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.351 1.06 . . . . 0.0 109.87 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.1 138.52 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 O-C-N 120.934 -1.104 . . . . 0.0 110.605 173.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -123.56 -61.84 1.36 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.603 1.561 . . . . 0.0 109.993 -175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -133.13 170.31 15.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.976 1.311 . . . . 0.0 112.599 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -98.36 168.23 10.34 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.202 2.601 . . . . 0.0 112.638 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.65 164.53 6.55 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 126.321 1.915 . . . . 0.0 113.764 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 t -61.19 129.07 39.5 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.583 -0.951 . . . . 0.0 110.443 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.65 136.37 55.53 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 123.678 0.791 . . . . 0.0 111.716 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.56 157.8 57.79 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.922 2.415 . . . . 0.0 112.566 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 36.5 p -90.4 -11.21 41.15 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.141 1.377 . . . . 0.0 114.088 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.09 30.17 0.75 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.475 1.512 . . . . 0.0 114.909 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.504 1.921 . . . . 0.0 113.653 177.539 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -62.51 116.61 5.27 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.82 1.248 . . . . 0.0 112.08 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.02 121.14 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.645 1.578 . . . . 0.0 111.249 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 90.1 m -100.15 -5.89 27.07 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.51 131.6 51.26 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.503 1.047 . . . . 0.0 111.295 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.0 p -66.37 152.87 93.86 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.86 171.13 18.5 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.384 2.723 . . . . 0.0 112.532 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -92.99 -0.88 57.11 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.189 1.795 . . . . 0.0 115.259 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.3 tt -66.26 157.64 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.749 1.619 . . . . 0.0 112.973 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.0 tp -100.27 41.59 1.16 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.466 1.907 . . . . 0.0 111.947 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -125.9 70.51 66.95 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 125.825 1.65 . . . . 0.0 112.255 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.35 170.01 14.31 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.26 2.64 . . . . 0.0 113.531 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.456 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -137.8 170.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 128.06 2.544 . . . . 0.0 111.311 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.9 t -113.77 117.76 32.38 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.425 1.49 . . . . 0.0 110.352 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.17 167.88 48.59 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.544 1.08 . . . . 0.0 112.404 173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 t -78.61 -7.57 57.74 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 111.301 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.82 -13.08 59.67 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.245 1.418 . . . . 0.0 112.247 170.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.0 31.58 14.5 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.026 1.298 . . . . 0.0 114.295 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.5 tpp85 -127.54 152.37 47.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.464 2.306 . . . . 0.0 110.327 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 92.7 m -85.2 140.63 30.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.513 1.525 . . . . 0.0 111.964 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.91 139.65 46.3 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.097 1.759 . . . . 0.0 110.626 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.25 -24.38 64.84 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -159.09 179.36 9.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.902 1.681 . . . . 0.0 110.734 163.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 61.1 p -62.75 -22.23 66.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 170.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 81.9 m -61.24 -26.99 68.12 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -173.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 -45.22 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.153 1.381 . . . . 0.0 113.475 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.49 -39.31 33.39 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 122.1 0.953 . . . . 0.0 110.899 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -78.71 -28.69 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.513 1.525 . . . . 0.0 113.714 -175.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.85 -19.49 58.85 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.941 0.896 . . . . 0.0 112.854 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -89.08 -22.64 22.81 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.046 1.338 . . . . 0.0 112.079 169.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.59 2.66 37.54 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.655 2.074 . . . . 0.0 115.349 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -73.08 159.42 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 126.163 1.785 . . . . 0.0 109.257 168.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.5 p -117.72 145.54 44.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.13 0.972 . . . . 0.0 109.427 173.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.456 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -62.83 136.79 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.073 -1.017 . . . . 0.0 110.929 174.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -117.06 -56.94 2.21 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.912 1.285 . . . . 0.0 109.896 -175.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -134.11 141.84 47.28 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.75 1.62 . . . . 0.0 112.267 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -72.19 162.65 29.17 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.292 1.437 . . . . 0.0 112.329 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.69 162.79 22.64 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 126.77 2.129 . . . . 0.0 113.46 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 42.0 t -62.18 131.16 48.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.673 -0.898 . . . . 0.0 110.927 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.71 139.36 62.57 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 123.445 0.698 . . . . 0.0 111.334 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.13 159.67 51.48 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.972 2.448 . . . . 0.0 112.629 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 m -81.03 -13.38 58.87 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.644 1.177 . . . . 0.0 112.572 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.15 16.64 22.62 Favored Glycine 0 CA--C 1.539 1.552 0 C-N-CA 125.358 1.456 . . . . 0.0 114.692 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.1 tt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 126.232 1.813 . . . . 0.0 113.591 176.589 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -95.73 -75.63 0.52 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.755 -1.215 . . . . 0.0 110.331 175.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.1 158.98 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.04 1.336 . . . . 0.0 111.05 169.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.8 m -113.24 147.74 36.91 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.134 1.374 . . . . 0.0 111.114 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.88 158.57 30.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.224 0.61 . . . . 0.0 112.248 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 29.4 p -106.12 155.06 39.14 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.018 1.327 . . . . 0.0 112.175 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -75.1 174.45 12.76 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.254 2.636 . . . . 0.0 111.589 170.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 tptt -103.85 -4.66 23.24 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.051 1.341 . . . . 0.0 113.741 -175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.8 mm -69.0 147.44 12.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.602 1.961 . . . . 0.0 110.808 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.68 -161.59 0.3 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.017 1.727 . . . . 0.0 112.175 175.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.22 72.9 0.91 Allowed Pre-proline 0 N--CA 1.481 1.111 0 C-N-CA 127.144 2.178 . . . . 0.0 112.951 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.36 173.92 5.78 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 124.163 3.242 . . . . 0.0 114.28 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' A' ' 34' ' ' ILE . 28.7 m -136.23 171.27 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.514 2.326 . . . . 0.0 111.985 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.2 t -117.84 120.1 36.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.572 1.549 . . . . 0.0 110.598 172.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.19 167.88 48.67 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 122.774 1.208 . . . . 0.0 112.705 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -75.41 -11.14 59.98 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.719 2.008 . . . . 0.0 111.922 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.99 -13.77 59.6 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.523 1.529 . . . . 0.0 112.185 171.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.83 25.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.391 1.472 . . . . 0.0 114.533 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -121.59 149.58 42.94 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 127.22 2.208 . . . . 0.0 110.853 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.2 m -81.96 139.88 34.33 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.118 1.767 . . . . 0.0 112.05 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -133.2 141.27 48.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.247 1.819 . . . . 0.0 110.818 173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.25 -22.76 67.07 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -161.2 176.39 11.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.737 1.215 . . . . 0.0 112.317 169.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -64.0 -26.39 68.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.921 0.888 . . . . 0.0 113.306 174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.5 m -60.39 -20.62 60.25 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.06 1.344 . . . . 0.0 114.552 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.8 -51.19 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 111.617 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.46 -42.65 64.38 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.088 1.355 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.75 1.62 . . . . 0.0 113.075 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -84.56 -7.37 59.28 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.955 1.702 . . . . 0.0 113.316 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -113.31 1.71 15.26 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.315 1.846 . . . . 0.0 112.602 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.27 15.71 55.01 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.083 1.325 . . . . 0.0 115.373 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.76 159.26 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 126.311 1.844 . . . . 0.0 109.639 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.1 p -116.35 146.52 42.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.933 0.893 . . . . 0.0 109.999 173.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -64.3 133.53 29.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 O-C-N 120.359 -1.463 . . . . 0.0 110.946 173.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -113.71 -58.68 2.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.775 1.23 . . . . 0.0 109.969 -177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.7 p -130.58 138.41 50.14 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.614 1.566 . . . . 0.0 111.946 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -73.48 164.44 26.66 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.689 1.596 . . . . 0.0 112.568 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.11 165.02 11.24 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.993 1.759 . . . . 0.0 113.397 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.43 133.5 55.11 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.376 -1.073 . . . . 0.0 111.024 172.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.76 143.69 75.36 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.069 0.547 . . . . 0.0 111.489 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.44 160.01 45.38 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.207 2.605 . . . . 0.0 112.757 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.7 p -84.29 -15.28 47.2 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.203 1.401 . . . . 0.0 114.269 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.52 1.04 0.32 Allowed Glycine 0 CA--C 1.539 1.572 0 N-CA-C 116.363 1.305 . . . . 0.0 116.363 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 C--O 1.255 1.353 0 C-N-CA 126.294 1.838 . . . . 0.0 112.027 178.292 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.7 tptm . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -142.18 -55.74 0.45 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.304 1.842 . . . . 0.0 112.163 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.55 102.42 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.754 1.222 . . . . 0.0 109.929 173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.513 ' H ' HG22 ' A' ' 26' ' ' ILE . 14.4 m -118.01 124.99 49.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.215 1.806 . . . . 0.0 111.182 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.8 26.48 1.91 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.683 1.993 . . . . 0.0 116.295 171.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 22.6 p -63.58 151.8 87.34 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -166.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -77.09 177.85 8.37 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.814 3.01 . . . . 0.0 112.389 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -106.25 -2.12 22.75 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.084 1.754 . . . . 0.0 113.877 -174.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mm -81.38 130.33 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.418 1.887 . . . . 0.0 111.691 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.05 51.13 1.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.18 1.792 . . . . 0.0 112.829 176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -130.23 76.12 78.28 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.101 1.76 . . . . 0.0 110.766 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.61 169.18 14.86 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.116 2.544 . . . . 0.0 113.433 177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.5 m -140.0 172.75 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 127.822 2.449 . . . . 0.0 111.287 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 t -114.56 115.55 27.37 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.285 1.434 . . . . 0.0 111.293 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.41 169.46 36.78 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 122.492 1.051 . . . . 0.0 112.228 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 t -79.57 -6.49 57.14 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.961 1.304 . . . . 0.0 111.2 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.88 -13.46 59.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.975 1.31 . . . . 0.0 112.149 167.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.82 31.19 24.44 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.326 1.441 . . . . 0.0 114.009 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -130.9 157.85 41.81 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.206 2.203 . . . . 0.0 110.749 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.7 m -89.1 138.02 31.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.365 1.466 . . . . 0.0 112.8 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.59 143.14 43.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.582 1.953 . . . . 0.0 110.368 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.97 -27.17 66.6 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 176.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -163.07 173.05 14.03 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 167.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 m -56.44 -32.86 65.32 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.914 1.686 . . . . 0.0 112.897 171.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -57.73 -27.97 63.46 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.412 1.085 . . . . 0.0 113.709 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 4' ' ' CYS . 17.6 pt -104.93 -36.66 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.51 -30.59 31.07 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.477 1.035 . . . . 0.0 111.212 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -77.18 -28.61 54.08 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.672 1.589 . . . . 0.0 113.366 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.1 -10.14 59.47 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.147 0.979 . . . . 0.0 112.993 171.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -106.24 -0.8 24.19 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.987 1.715 . . . . 0.0 112.147 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.43 4.93 89.32 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.702 1.62 . . . . 0.0 115.331 -177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -81.09 163.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.418 1.487 . . . . 0.0 108.668 169.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 t -125.91 157.84 36.67 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.918 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.673 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.07 138.65 20.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 124.305 1.042 . . . . 0.0 111.398 -179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -124.35 -59.36 1.48 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.517 1.527 . . . . 0.0 110.307 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -134.59 167.87 20.01 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 112.293 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -100.87 167.52 10.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.223 2.209 . . . . 0.0 112.734 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.91 163.77 5.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.783 2.135 . . . . 0.0 112.97 -169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.1 p -62.07 126.09 26.12 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.254 -1.145 . . . . 0.0 110.98 169.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.67 146.54 76.81 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.786 1.234 . . . . 0.0 111.789 -176.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.67 159.87 47.7 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.903 2.402 . . . . 0.0 112.005 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 50.9 m -80.77 -16.42 53.87 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.061 0.944 . . . . 0.0 112.422 176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.69 4.57 7.35 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 126.034 1.778 . . . . 0.0 114.968 -177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.1 mt . . . . . 0 C--O 1.253 1.251 0 C-N-CA 127.166 2.186 . . . . 0.0 110.29 -177.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.767 0.317 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -140.4 160.69 39.43 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 127.285 2.234 . . . . 0.0 110.743 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.17 157.88 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.791 1.636 . . . . 0.0 111.016 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 p -66.38 117.06 8.09 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.607 1.163 . . . . 0.0 111.82 170.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.48 154.96 41.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.687 0.795 . . . . 0.0 112.269 171.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.5 m -68.62 154.56 94.41 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.64 0.776 . . . . 0.0 111.976 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.02 176.61 9.69 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 124.075 3.184 . . . . 0.0 113.019 177.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.5 5.18 6.87 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.857 1.663 . . . . 0.0 114.428 -174.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.4 mm -104.19 142.57 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.362 1.465 . . . . 0.0 111.173 -172.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.71 22.26 0.75 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.366 1.866 . . . . 0.0 114.993 177.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 11' ' ' LYS . 9.9 mmpt? -113.92 80.15 5.13 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 126.458 1.903 . . . . 0.0 111.448 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -66.67 165.71 24.59 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.635 2.224 . . . . 0.0 112.901 172.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.674 ' HB ' HD11 ' A' ' 34' ' ' ILE . 34.5 m -139.96 172.14 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 127.555 2.342 . . . . 0.0 111.089 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.3 t -114.28 116.86 29.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.082 1.353 . . . . 0.0 111.013 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.13 169.54 46.05 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 122.639 1.133 . . . . 0.0 112.666 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -74.85 -12.26 60.34 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 111.998 -175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.03 -8.58 59.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.28 1.432 . . . . 0.0 112.268 172.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.26 30.51 22.2 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.841 1.21 . . . . 0.0 114.591 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -126.29 152.87 45.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.578 2.351 . . . . 0.0 109.963 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.2 m -81.67 140.09 34.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.115 1.366 . . . . 0.0 111.882 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -132.08 138.92 48.33 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.927 1.691 . . . . 0.0 109.842 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -23.22 63.29 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -162.49 178.82 8.27 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.881 1.273 . . . . 0.0 112.264 166.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.3 p -72.09 -7.56 49.65 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.4 t -75.94 -17.88 59.57 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.5 -48.18 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.906 1.282 . . . . 0.0 113.409 -174.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.34 -40.07 16.38 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.566 1.146 . . . . 0.0 111.645 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.0 ptt85 -71.8 -36.43 70.29 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.601 -1.182 . . . . 0.0 113.854 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.11 -22.87 63.94 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.381 1.472 . . . . 0.0 112.512 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -88.23 -28.62 21.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.565 1.146 . . . . 0.0 111.844 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.59 1.24 13.64 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.335 1.921 . . . . 0.0 115.17 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.6 t -72.93 159.78 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.47 1.908 . . . . 0.0 109.457 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 84.7 p -113.5 154.81 26.45 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.726 0.81 . . . . 0.0 110.449 171.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.674 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.36 135.82 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 120.53 -1.356 . . . . 0.0 110.651 174.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -121.44 -58.98 1.74 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 125.314 1.446 . . . . 0.0 110.309 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -131.09 159.25 38.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.458 1.103 . . . . 0.0 112.319 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -89.26 166.17 13.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.787 2.035 . . . . 0.0 112.456 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 164.49 7.7 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 126.711 2.101 . . . . 0.0 113.679 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 t -62.26 128.07 34.32 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.493 -1.004 . . . . 0.0 110.677 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.73 141.78 69.12 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 124.084 0.953 . . . . 0.0 111.611 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.65 164.39 35.74 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.951 2.434 . . . . 0.0 112.206 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 p -84.28 -27.6 27.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.358 1.063 . . . . 0.0 113.123 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 166.87 27.04 0.02 OUTLIER Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.844 1.211 . . . . 0.0 115.172 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.5 tt . . . . . 0 C--O 1.255 1.372 0 C-N-CA 125.561 1.545 . . . . 0.0 113.76 -179.735 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.6 mptt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -138.99 111.85 7.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.379 1.872 . . . . 0.0 110.871 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.5 p -148.42 161.19 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.614 1.966 . . . . 0.0 109.98 174.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.0 p -66.51 154.55 40.05 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.68 12.07 3.17 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.672 1.589 . . . . 0.0 113.591 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 84.2 m 43.11 65.54 5.34 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 127.03 2.132 . . . . 0.0 113.965 -173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.1 158.26 55.52 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.888 3.059 . . . . 0.0 113.21 -172.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 5.73 48.49 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 126.355 1.862 . . . . 0.0 115.07 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.4 tt -53.77 140.42 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 126.694 1.998 . . . . 0.0 113.028 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.93 -178.75 6.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.385 1.474 . . . . 0.0 111.914 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.8 mttm 50.79 69.47 2.58 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 126.617 1.967 . . . . 0.0 112.598 -171.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.13 169.19 11.04 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.477 2.785 . . . . 0.0 113.246 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.763 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.6 m -132.76 171.33 18.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 127.24 2.216 . . . . 0.0 111.417 -176.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -119.83 107.07 12.72 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.392 1.877 . . . . 0.0 109.625 -172.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.41 167.93 51.47 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 122.559 1.088 . . . . 0.0 112.297 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -76.42 -12.29 60.03 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.852 1.261 . . . . 0.0 111.323 -172.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -81.15 -14.32 57.76 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.039 1.336 . . . . 0.0 112.635 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.47 31.81 15.24 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.587 1.089 . . . . 0.0 114.67 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -121.46 154.13 36.99 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.723 2.009 . . . . 0.0 110.439 173.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -79.9 140.86 36.55 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.315 1.446 . . . . 0.0 111.475 174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -134.33 139.72 45.86 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.403 1.481 . . . . 0.0 109.86 171.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -29.79 69.75 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.465 -0.772 . . . . 0.0 112.643 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -154.08 169.79 22.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.923 1.289 . . . . 0.0 111.523 171.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.4 m -56.37 -23.76 39.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.626 1.57 . . . . 0.0 113.605 170.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.1 m -62.72 -13.78 36.55 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.8 mt -104.49 -51.13 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.456 1.503 . . . . 0.0 111.203 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.25 -42.29 60.93 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.523 1.129 . . . . 0.0 111.463 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -70.38 -21.48 62.86 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -11.09 59.81 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.943 1.697 . . . . 0.0 113.424 171.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -112.24 3.44 17.15 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.755 2.022 . . . . 0.0 111.953 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.15 5.11 89.13 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.582 1.563 . . . . 0.0 114.784 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -85.54 161.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.481 1.913 . . . . 0.0 109.491 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.7 p -122.28 155.27 36.27 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.467 1.107 . . . . 0.0 110.278 171.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER -66.38 139.39 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.261 -0.899 . . . . 0.0 110.626 174.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -125.78 -57.44 1.44 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.178 1.391 . . . . 0.0 109.973 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.37 154.73 43.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.285 1.434 . . . . 0.0 112.981 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -76.23 162.72 27.71 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 126.841 2.057 . . . . 0.0 111.775 167.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.08 170.87 8.73 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.347 1.927 . . . . 0.0 113.859 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -58.63 133.39 55.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.711 -0.876 . . . . 0.0 111.187 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.49 143.84 79.91 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 125.827 1.651 . . . . 0.0 111.077 -173.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.86 -178.9 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.225 2.617 . . . . 0.0 112.369 175.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.9 m 69.33 31.44 3.88 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.41 1.484 . . . . 0.0 111.486 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.63 -14.68 0.04 OUTLIER Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.939 1.257 . . . . 0.0 115.507 175.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.252 1.197 0 CA-C-N 118.678 1.239 . . . . 0.0 112.755 173.53 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -144.1 148.43 35.11 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.588 1.555 . . . . 0.0 111.569 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.6 151.35 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.444 1.898 . . . . 0.0 110.507 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 65.1 m -89.63 138.67 31.27 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.739 0.816 . . . . 0.0 111.648 173.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.97 144.63 26.43 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.123 0.969 . . . . 0.0 111.438 170.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.3 p -75.92 154.26 84.92 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.619 0.767 . . . . 0.0 112.468 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.25 164.13 34.89 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.951 2.434 . . . . 0.0 111.705 168.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -81.52 -17.23 49.27 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 tt -54.8 141.94 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.806 1.642 . . . . 0.0 112.807 -177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.08 -167.44 1.3 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.226 1.41 . . . . 0.0 112.179 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.8 tttm 54.75 71.21 1.37 Allowed Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 126.821 2.049 . . . . 0.0 112.556 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.5 178.59 2.05 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.169 3.246 . . . . 0.0 113.67 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.632 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.5 m -134.86 172.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.481 1.913 . . . . 0.0 112.217 -176.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.6 t -114.06 119.93 38.84 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.365 1.466 . . . . 0.0 111.579 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.09 169.48 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 122.505 1.058 . . . . 0.0 112.3 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.2 p -74.79 -10.65 59.71 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.431 1.492 . . . . 0.0 112.183 -175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -80.85 -13.36 59.01 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.238 1.415 . . . . 0.0 112.189 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.12 25.96 27.5 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 125.146 1.355 . . . . 0.0 114.593 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -121.26 154.15 36.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 127.572 2.349 . . . . 0.0 110.043 -178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.9 m -80.57 140.29 35.87 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.467 1.507 . . . . 0.0 112.261 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -134.69 140.62 46.13 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.327 1.851 . . . . 0.0 110.406 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.69 70.47 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.668 0.787 . . . . 0.0 112.942 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -155.68 173.87 16.1 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 111.338 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.2 p -62.77 -19.76 64.31 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 170.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -66.82 -14.05 62.24 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.7 pt -112.07 -40.98 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.54 -34.23 49.15 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.507 1.049 . . . . 0.0 111.57 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -82.09 -13.88 56.62 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.5 t -74.47 -18.82 60.57 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.515 1.126 . . . . 0.0 113.159 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -122.63 1.23 9.45 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.072 1.349 . . . . 0.0 114.103 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.66 -0.38 34.36 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.054 1.311 . . . . 0.0 116.345 163.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.33 158.16 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.814 1.246 . . . . 0.0 108.823 167.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 90.7 p -118.36 161.9 19.19 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.064 -1.023 . . . . 0.0 110.839 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -73.7 137.08 23.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 120.764 -1.21 . . . . 0.0 110.713 175.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -122.11 -60.4 1.58 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.622 1.569 . . . . 0.0 110.033 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -134.45 166.46 22.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.882 1.273 . . . . 0.0 112.282 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -93.88 170.24 9.7 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.13 2.172 . . . . 0.0 112.843 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.39 163.84 5.85 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.343 1.925 . . . . 0.0 113.648 -172.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.1 t -60.29 127.83 33.72 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.426 -1.043 . . . . 0.0 110.403 167.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.2 135.92 69.4 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.113 0.965 . . . . 0.0 111.478 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.52 159.21 53.6 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.845 2.363 . . . . 0.0 112.561 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -80.19 -7.85 59.16 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.59 2.2 29.1 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 126.138 1.828 . . . . 0.0 114.723 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.65 1.98 . . . . 0.0 113.457 177.08 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.426 0.155 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -109.4 171.89 7.18 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.862 2.065 . . . . 0.0 111.038 175.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.1 t 49.48 62.82 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 127.002 2.121 . . . . 0.0 111.888 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 84.6 m -66.73 141.97 57.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.841 0.856 . . . . 0.0 110.836 171.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.07 132.87 49.53 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.1 0.56 . . . . 0.0 110.977 171.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.4 p -58.65 151.11 53.92 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.814 0.846 . . . . 0.0 113.099 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.62 176.29 9.54 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.115 3.21 . . . . 0.0 112.919 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 ttmm -112.23 25.68 11.31 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.698 1.999 . . . . 0.0 112.686 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.92 147.01 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.841 1.656 . . . . 0.0 109.562 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.7 mp -75.12 -161.9 0.16 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.963 1.705 . . . . 0.0 111.452 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt 57.48 66.79 2.74 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 126.816 2.047 . . . . 0.0 112.927 177.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.97 173.3 5.01 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.477 3.452 . . . . 0.0 114.362 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 34' ' ' ILE . 27.7 m -135.96 169.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.21 2.204 . . . . 0.0 112.047 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.3 t -114.09 117.96 32.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.514 1.526 . . . . 0.0 110.454 173.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.36 169.46 49.58 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 122.707 1.171 . . . . 0.0 112.73 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 t -77.83 -8.39 57.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.147 1.379 . . . . 0.0 111.507 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.53 -8.29 58.41 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.877 1.271 . . . . 0.0 112.664 170.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.28 27.17 23.75 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.652 1.12 . . . . 0.0 115.14 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -122.88 154.17 38.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.592 2.357 . . . . 0.0 109.967 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -87.04 141.16 28.87 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.007 1.323 . . . . 0.0 111.638 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -133.44 138.0 46.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.968 1.707 . . . . 0.0 110.657 175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.4 -25.96 67.53 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -158.67 -178.43 7.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.941 1.296 . . . . 0.0 110.559 161.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.2 p -55.73 -23.49 29.52 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.477 1.511 . . . . 0.0 114.594 170.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.7 t -60.93 -16.77 46.07 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.618 1.567 . . . . 0.0 114.527 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 mt -105.07 -49.39 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.417 1.487 . . . . 0.0 111.591 -174.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.81 -42.8 58.54 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.878 1.271 . . . . 0.0 111.101 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -68.95 -23.04 64.09 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.6 t -83.21 -3.59 57.55 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.576 1.55 . . . . 0.0 113.475 174.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -118.75 7.98 11.74 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.2 1.8 . . . . 0.0 112.327 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.42 7.08 87.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.328 1.442 . . . . 0.0 114.773 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.7 t -87.64 162.14 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.228 1.811 . . . . 0.0 109.601 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -125.24 150.72 46.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.341 1.057 . . . . 0.0 109.776 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.487 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -62.4 138.7 22.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 O-C-N 121.144 -0.973 . . . . 0.0 111.001 174.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.87 -57.98 1.99 Allowed 'General case' 0 CA--C 1.522 -0.098 0 C-N-CA 124.987 1.315 . . . . 0.0 109.649 -177.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 p -133.33 135.02 44.53 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.264 1.425 . . . . 0.0 112.333 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -69.67 160.67 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.882 1.673 . . . . 0.0 111.939 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.96 161.04 22.62 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.372 1.939 . . . . 0.0 113.397 -171.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 t -59.78 132.81 55.1 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.681 -0.893 . . . . 0.0 110.723 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.32 143.11 63.99 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.13 0.572 . . . . 0.0 111.075 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.34 169.76 18.88 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.936 2.424 . . . . 0.0 111.949 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.8 p -69.49 -14.23 62.76 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.358 1.463 . . . . 0.0 113.782 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.74 -13.16 3.41 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 127.099 2.285 . . . . 0.0 113.817 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.2 tp . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.946 1.698 . . . . 0.0 113.145 174.182 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -125.75 73.14 1.32 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.866 1.666 . . . . 0.0 110.966 -173.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.2 t -129.59 104.01 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.69 1.596 . . . . 0.0 110.077 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.7 t -75.65 -173.21 2.11 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.701 1.201 . . . . 0.0 112.776 176.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.09 -27.23 52.82 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.49 1.516 . . . . 0.0 114.895 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.5 t 37.8 63.63 3.44 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 127.907 2.483 . . . . 0.0 114.801 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.65 166.84 28.76 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.954 3.103 . . . . 0.0 113.19 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -121.46 1.76 10.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.134 1.774 . . . . 0.0 113.729 -175.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.1 mt -58.52 131.85 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.611 1.564 . . . . 0.0 109.645 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.23 -177.84 0.31 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.464 1.906 . . . . 0.0 114.545 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 tptm 61.08 67.77 1.37 Allowed Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 127.091 2.156 . . . . 0.0 111.951 -174.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -65.52 169.62 12.4 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.798 2.999 . . . . 0.0 113.853 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.631 ' HB ' HD11 ' A' ' 34' ' ' ILE . 32.2 m -135.93 174.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.006 1.722 . . . . 0.0 112.44 -176.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 t -119.2 122.48 42.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.527 1.531 . . . . 0.0 111.65 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.13 169.28 51.35 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 122.506 1.059 . . . . 0.0 112.556 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 t -77.9 -10.72 59.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.315 1.446 . . . . 0.0 111.502 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -79.06 -12.73 60.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.949 1.3 . . . . 0.0 112.391 170.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.51 26.26 23.49 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.089 1.328 . . . . 0.0 114.958 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -121.8 151.75 40.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.234 2.213 . . . . 0.0 110.27 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.8 m -79.66 139.86 37.26 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.627 1.571 . . . . 0.0 111.712 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.57 141.62 48.78 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.931 1.692 . . . . 0.0 109.974 170.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.71 -37.58 76.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.128 -0.357 . . . . 0.0 111.771 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -151.36 167.04 29.16 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.6 1.16 . . . . 0.0 111.784 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -64.73 -14.4 58.52 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.029 1.731 . . . . 0.0 114.514 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -67.59 -22.21 65.38 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.05 1.34 . . . . 0.0 113.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.6 mt -92.76 -54.2 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.553 1.141 . . . . 0.0 111.345 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.99 -45.39 61.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.475 1.11 . . . . 0.0 111.301 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -68.49 -24.22 64.66 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.194 0.997 . . . . 0.0 113.616 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -78.67 -8.58 58.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.801 1.641 . . . . 0.0 113.704 173.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -111.55 4.0 18.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.869 2.067 . . . . 0.0 112.129 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.34 2.57 90.55 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.668 1.604 . . . . 0.0 115.024 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 t -78.89 164.88 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.292 1.837 . . . . 0.0 109.223 171.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 p -124.94 158.27 33.99 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.175 0.99 . . . . 0.0 110.159 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.631 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.6 138.57 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.232 -0.918 . . . . 0.0 110.642 175.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -122.24 -60.36 1.57 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.761 1.624 . . . . 0.0 109.855 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.3 t -131.02 152.79 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.605 1.162 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -79.23 165.4 23.27 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.846 2.058 . . . . 0.0 111.076 170.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.43 158.77 7.32 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 126.518 2.009 . . . . 0.0 113.705 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.0 t -60.85 130.17 45.12 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.513 -0.992 . . . . 0.0 110.57 171.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.65 143.33 75.14 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.594 0.757 . . . . 0.0 111.445 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.54 157.94 48.25 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.999 2.466 . . . . 0.0 112.738 177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.8 m -79.76 -25.48 41.0 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.451 1.1 . . . . 0.0 112.495 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.8 0.86 0.55 Allowed Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.281 1.419 . . . . 0.0 115.845 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 mm . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.358 1.863 . . . . 0.0 111.805 179.206 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 113.329 0.862 . . . . 0.0 113.329 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -73.15 -15.63 61.46 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 119.762 -1.836 . . . . 0.0 115.924 -175.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.98 129.81 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 126.333 1.853 . . . . 0.0 110.182 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 97.4 m -68.03 135.94 53.05 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.246 0.546 . . . . 0.0 111.992 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.2 145.47 30.97 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.518 1.127 . . . . 0.0 111.568 172.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 96.1 m -63.31 152.21 85.39 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.498 1.119 . . . . 0.0 113.616 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.56 178.73 5.88 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 124.097 3.198 . . . . 0.0 112.452 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 9.7 mmpt? -94.62 -7.22 41.54 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.461 1.504 . . . . 0.0 114.573 -178.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.2 tt -65.88 155.98 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.599 1.16 . . . . 0.0 111.928 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.16 70.35 0.74 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.629 1.572 . . . . 0.0 109.77 176.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -151.91 67.3 7.08 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 125.642 1.577 . . . . 0.0 111.492 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.73 165.04 24.5 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.697 2.264 . . . . 0.0 112.944 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.666 ' HB ' HD11 ' A' ' 34' ' ' ILE . 31.6 m -141.95 172.29 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 127.352 2.261 . . . . 0.0 111.552 -175.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.4 t -112.71 116.75 30.61 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.465 1.506 . . . . 0.0 111.445 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.74 168.46 49.5 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 122.593 1.107 . . . . 0.0 112.268 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 t -78.77 -6.94 57.22 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.006 1.322 . . . . 0.0 111.474 -174.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -84.62 -13.12 52.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 112.549 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.93 16.5 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.696 1.141 . . . . 0.0 115.012 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -124.28 153.73 41.29 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 127.366 2.266 . . . . 0.0 109.861 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.3 m -80.71 140.84 35.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.409 1.484 . . . . 0.0 111.995 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -132.88 142.98 49.21 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.049 1.74 . . . . 0.0 109.911 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.08 -22.79 67.08 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -155.85 165.27 36.99 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.679 1.592 . . . . 0.0 111.65 165.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -49.93 -32.36 14.61 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.19 2.196 . . . . 0.0 113.539 167.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -58.58 -33.16 69.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.016 0.927 . . . . 0.0 112.986 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 mm -85.51 -43.46 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.113 1.365 . . . . 0.0 111.703 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.89 -42.96 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.573 0.749 . . . . 0.0 110.384 173.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt85 -67.26 -34.58 77.73 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.452 1.101 . . . . 0.0 113.595 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.6 t -66.33 -15.77 63.52 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.574 1.149 . . . . 0.0 113.942 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -103.34 2.17 33.69 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.729 1.612 . . . . 0.0 112.092 175.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.07 5.23 89.05 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.941 1.734 . . . . 0.0 115.068 -177.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.33 158.46 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 126.449 1.9 . . . . 0.0 109.325 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.5 p -115.27 155.23 27.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.148 0.979 . . . . 0.0 109.886 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.666 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.72 139.34 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.058 -1.026 . . . . 0.0 110.709 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -124.68 -59.54 1.44 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.617 1.567 . . . . 0.0 110.175 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -132.68 166.37 22.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.62 1.168 . . . . 0.0 112.928 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.11 162.98 13.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.989 2.516 . . . . 0.0 112.771 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.6 165.6 3.75 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 127.024 2.25 . . . . 0.0 113.27 -172.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 p -59.76 124.52 20.41 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.849 1.26 . . . . 0.0 111.465 170.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.74 140.44 58.91 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.374 1.47 . . . . 0.0 111.617 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -69.81 -176.89 1.65 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.744 2.963 . . . . 0.0 113.367 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.0 m 67.65 49.81 0.94 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.982 1.713 . . . . 0.0 110.296 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.95 -0.39 0.2 Allowed Glycine 0 CA--C 1.538 1.512 0 N-CA-C 117.121 1.608 . . . . 0.0 117.121 172.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--O 1.255 1.391 0 CA-C-N 119.299 1.549 . . . . 0.0 110.595 175.069 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.333 0.111 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -22.51 66.07 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.09 117.36 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.96 1.704 . . . . 0.0 109.995 175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 73.3 m -71.82 140.89 49.6 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.812 0.845 . . . . 0.0 111.237 171.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.8 120.12 13.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.671 0.789 . . . . 0.0 110.978 170.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.5 m -57.3 145.63 66.18 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.31 1.044 . . . . 0.0 112.777 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.87 165.35 32.84 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.609 2.873 . . . . 0.0 112.344 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -92.05 -8.48 45.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.119 1.368 . . . . 0.0 114.508 -174.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.7 tt -67.41 156.13 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.638 1.575 . . . . 0.0 112.839 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.7 mt -88.44 -160.86 0.68 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.303 1.841 . . . . 0.0 111.356 172.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 55.29 70.41 1.6 Allowed Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 126.969 2.108 . . . . 0.0 112.555 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.63 169.31 11.59 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.382 2.721 . . . . 0.0 113.667 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.699 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.3 m -136.08 172.0 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.671 2.389 . . . . 0.0 111.086 -176.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -119.49 107.32 13.17 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.362 1.865 . . . . 0.0 109.583 -171.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.58 167.53 52.12 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 122.48 1.044 . . . . 0.0 112.238 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.3 p -76.33 -8.53 57.3 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.896 1.279 . . . . 0.0 112.112 -173.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -84.5 -14.14 49.91 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.357 1.463 . . . . 0.0 112.579 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.83 9.82 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.29 0.948 . . . . 0.0 113.879 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -128.01 153.67 46.49 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.203 2.201 . . . . 0.0 110.287 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.1 m -84.07 139.52 32.43 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.312 1.445 . . . . 0.0 111.799 178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -135.62 137.08 41.56 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.311 1.444 . . . . 0.0 110.312 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.91 -23.29 67.29 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.16 -0.962 . . . . 0.0 113.04 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.62 172.64 17.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.985 0.914 . . . . 0.0 113.336 166.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.5 t -58.08 -26.51 62.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.946 1.298 . . . . 0.0 113.47 175.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.9 t -54.97 -30.46 59.2 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.294 1.438 . . . . 0.0 113.501 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 mt -86.36 -52.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 125.213 1.405 . . . . 0.0 111.599 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.36 64.36 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.965 1.306 . . . . 0.0 111.474 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -64.15 -29.13 70.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.794 1.237 . . . . 0.0 113.338 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.55 -7.76 59.34 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.065 1.346 . . . . 0.0 113.752 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -108.12 4.42 24.9 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.225 1.81 . . . . 0.0 112.036 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.24 6.61 87.77 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.453 1.502 . . . . 0.0 114.598 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.6 t -89.24 164.22 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.757 2.023 . . . . 0.0 109.246 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -123.73 161.25 25.54 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.93 1.292 . . . . 0.0 110.205 172.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.699 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -72.11 136.03 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 120.787 -1.195 . . . . 0.0 110.324 174.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -119.28 -61.38 1.64 Allowed 'General case' 0 C--O 1.231 0.095 0 C-N-CA 125.505 1.522 . . . . 0.0 109.688 -177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.4 t -133.76 171.55 13.99 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.7 1.2 . . . . 0.0 112.833 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -90.77 168.93 11.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 128.434 2.694 . . . . 0.0 112.688 178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.39 174.28 5.75 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.398 1.951 . . . . 0.0 113.808 -176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.4 t -59.42 127.55 32.65 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.575 -0.956 . . . . 0.0 110.863 171.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.43 135.78 84.04 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.64 1.576 . . . . 0.0 111.051 -173.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.61 155.5 63.01 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.85 2.366 . . . . 0.0 113.14 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.6 m -89.63 40.31 0.99 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.633 1.573 . . . . 0.0 111.697 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.07 -0.57 25.51 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.726 1.632 . . . . 0.0 115.632 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.888 2.075 . . . . 0.0 110.835 177.672 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -135.44 150.23 49.8 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.075 1.75 . . . . 0.0 110.67 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.9 m -73.07 -23.09 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 m -98.27 -53.69 3.28 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.077 1.351 . . . . 0.0 111.893 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 49.99 29.68 3.6 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.685 1.994 . . . . 0.0 114.904 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.7 m 49.57 83.54 0.22 Allowed Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 127.681 2.392 . . . . 0.0 113.508 -172.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.61 174.46 12.19 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.264 3.309 . . . . 0.0 112.724 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -133.69 75.61 1.61 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.028 1.731 . . . . 0.0 110.871 -171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.34 138.37 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.975 2.11 . . . . 0.0 108.311 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -73.35 178.4 4.57 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.428 1.491 . . . . 0.0 112.576 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt 57.81 68.91 1.71 Allowed Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 126.766 2.026 . . . . 0.0 112.055 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -66.15 172.33 8.88 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 124.051 3.167 . . . . 0.0 113.462 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.6 ' HB ' HD11 ' A' ' 34' ' ' ILE . 33.2 m -138.01 173.25 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.881 1.672 . . . . 0.0 112.631 -174.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 t -116.22 119.05 34.51 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.525 1.53 . . . . 0.0 111.663 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.94 169.05 43.26 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 122.609 1.116 . . . . 0.0 112.786 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.4 p -78.71 -9.06 59.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.372 1.469 . . . . 0.0 112.303 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -79.48 -13.15 59.76 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.153 1.381 . . . . 0.0 112.143 169.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.57 34.56 15.96 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.875 1.226 . . . . 0.0 113.828 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -124.94 159.51 31.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.388 2.275 . . . . 0.0 110.255 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -100.21 136.77 39.59 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.453 1.501 . . . . 0.0 112.155 -174.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -138.8 150.25 45.87 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.525 1.53 . . . . 0.0 111.569 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.17 -23.46 67.32 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -157.97 170.05 23.2 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.774 2.03 . . . . 0.0 110.655 176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -59.6 -29.44 67.98 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.249 1.42 . . . . 0.0 113.428 172.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.5 t -54.81 -51.11 66.82 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.817 1.647 . . . . 0.0 112.563 -176.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.627 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.5 mp -61.07 -48.18 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.247 1.419 . . . . 0.0 111.07 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.62 -46.82 70.59 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.594 0.711 . . . . 0.0 110.087 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -71.75 -24.65 61.81 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -18.02 64.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.27 1.428 . . . . 0.0 113.942 168.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -113.26 -1.83 14.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.019 1.727 . . . . 0.0 112.621 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.73 2.11 82.08 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.785 1.66 . . . . 0.0 115.184 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 t -72.41 161.16 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.344 1.458 . . . . 0.0 108.672 165.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.0 p -120.78 167.27 12.67 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.645 1.178 . . . . 0.0 110.485 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.6 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -77.9 140.85 16.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 120.714 -1.241 . . . . 0.0 110.891 174.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.82 -61.06 1.4 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 126.053 1.741 . . . . 0.0 109.811 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -134.77 164.93 26.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.843 1.257 . . . . 0.0 112.459 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -95.94 168.63 10.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.315 2.246 . . . . 0.0 112.121 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.65 160.16 7.38 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.331 1.919 . . . . 0.0 112.842 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 p -64.68 122.69 17.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.293 -1.122 . . . . 0.0 110.806 169.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.94 149.67 90.06 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.651 1.18 . . . . 0.0 111.947 -176.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.57 159.53 42.64 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.038 2.492 . . . . 0.0 112.945 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 40.0 p -101.93 -13.04 17.77 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.851 1.66 . . . . 0.0 113.707 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.13 -19.31 3.89 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.357 1.932 . . . . 0.0 114.66 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.253 1.273 0 C-N-CA 125.87 1.668 . . . . 0.0 110.538 172.368 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 110.758 -0.089 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.75 70.63 1.44 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.869 1.668 . . . . 0.0 110.823 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.69 128.98 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.718 1.207 . . . . 0.0 112.286 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 15.2 m -97.21 14.39 26.09 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.416 1.886 . . . . 0.0 114.06 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.92 24.76 7.89 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.222 1.809 . . . . 0.0 113.947 -170.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.0 p -60.85 153.36 64.86 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.083 1.753 . . . . 0.0 115.341 -170.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.57 175.99 10.66 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.899 3.066 . . . . 0.0 112.773 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -122.72 8.72 9.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 126.487 1.915 . . . . 0.0 113.309 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.5 mt -66.18 137.35 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.462 2.305 . . . . 0.0 111.101 -174.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 tp -77.72 37.12 0.22 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.913 1.685 . . . . 0.0 113.722 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -130.81 70.95 82.59 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 125.695 1.598 . . . . 0.0 111.606 173.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.79 164.82 22.92 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.547 2.164 . . . . 0.0 112.816 172.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.729 ' HB ' HD11 ' A' ' 34' ' ' ILE . 35.2 m -140.24 172.82 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 128.161 2.584 . . . . 0.0 110.866 -177.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 t -114.33 116.4 28.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.002 1.321 . . . . 0.0 111.292 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.65 168.26 43.44 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 122.481 1.045 . . . . 0.0 112.42 172.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.6 t -78.55 -11.07 59.94 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.006 1.322 . . . . 0.0 111.376 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -78.03 -12.82 60.02 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.93 1.292 . . . . 0.0 112.331 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.85 28.79 17.44 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.08 1.324 . . . . 0.0 114.72 177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -125.82 154.29 42.84 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.286 2.234 . . . . 0.0 110.377 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.0 m -83.91 140.74 31.76 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.785 1.634 . . . . 0.0 112.373 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -136.88 141.97 42.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.303 1.841 . . . . 0.0 110.21 173.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.94 -19.76 65.36 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -154.68 169.61 23.49 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.303 1.441 . . . . 0.0 111.861 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.5 p -56.15 -29.55 60.92 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.726 1.611 . . . . 0.0 113.816 169.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.8 t -61.5 -33.97 74.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.784 0.802 . . . . 0.0 112.571 -176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 mt -78.13 -44.56 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.329 1.451 . . . . 0.0 111.106 -175.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.44 -43.5 68.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.791 0.837 . . . . 0.0 110.149 172.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.76 -42.61 97.79 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.392 1.077 . . . . 0.0 112.884 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.8 t -58.69 -20.26 46.97 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.705 1.202 . . . . 0.0 113.862 172.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -106.14 3.55 28.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.027 1.731 . . . . 0.0 112.272 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 3.91 89.02 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 125.755 1.645 . . . . 0.0 115.351 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.44 160.73 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.375 1.87 . . . . 0.0 109.076 170.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.5 p -118.76 153.47 34.37 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.17 0.988 . . . . 0.0 109.815 172.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.729 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -67.19 139.86 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 O-C-N 121.17 -0.956 . . . . 0.0 110.761 175.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.73 -60.13 1.62 Allowed 'General case' 0 C--O 1.232 0.143 0 C-N-CA 125.651 1.58 . . . . 0.0 109.939 -177.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -134.09 158.3 43.96 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.436 1.095 . . . . 0.0 112.41 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.94 166.12 20.15 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.443 2.297 . . . . 0.0 112.945 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.27 163.56 4.5 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.471 1.986 . . . . 0.0 114.16 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.9 t -61.04 127.75 33.07 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.448 -1.03 . . . . 0.0 110.789 171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 146.42 78.54 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 124.13 0.972 . . . . 0.0 111.512 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.57 -177.2 2.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.452 2.768 . . . . 0.0 112.69 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.3 m 70.46 42.79 0.85 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.626 1.571 . . . . 0.0 110.803 175.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.13 21.3 0.1 OUTLIER Glycine 0 CA--C 1.537 1.427 0 N-CA-C 116.109 1.203 . . . . 0.0 116.109 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 C--O 1.254 1.301 0 C-N-CA 125.782 1.633 . . . . 0.0 111.84 178.391 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -68.71 -22.98 64.32 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.55 160.32 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.761 2.024 . . . . 0.0 110.177 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 28.7 p -64.91 169.76 4.92 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.963 0.905 . . . . 0.0 113.196 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.84 162.93 30.67 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.203 1.401 . . . . 0.0 111.443 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 77.8 m -121.68 70.32 26.3 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.46 1.904 . . . . 0.0 111.36 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.55 162.3 40.23 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.56 2.84 . . . . 0.0 112.716 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -91.76 7.85 39.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 126.188 1.795 . . . . 0.0 113.79 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 9.6 tp -49.72 131.06 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 127.481 2.312 . . . . 0.0 112.953 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.2 mt -70.17 176.21 4.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.205 1.402 . . . . 0.0 112.955 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? 51.59 65.43 6.48 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 126.566 1.946 . . . . 0.0 112.532 -170.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.84 175.39 3.05 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.753 2.968 . . . . 0.0 113.558 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.67 ' HB ' HD11 ' A' ' 34' ' ' ILE . 30.7 m -132.52 172.38 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 126.596 1.958 . . . . 0.0 111.646 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.2 t -122.69 106.83 11.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 126.308 1.843 . . . . 0.0 109.69 -169.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.53 167.89 49.59 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 122.592 1.107 . . . . 0.0 112.411 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.3 t -77.28 -11.94 59.89 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.574 1.15 . . . . 0.0 111.226 -173.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.12 -11.84 59.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.058 1.343 . . . . 0.0 112.508 172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.55 38.05 11.26 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.719 1.152 . . . . 0.0 113.792 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 tpp85 -130.28 154.24 47.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.99 2.116 . . . . 0.0 110.639 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 93.0 m -83.09 139.66 33.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.434 1.494 . . . . 0.0 111.999 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -135.22 140.52 45.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.814 1.646 . . . . 0.0 109.942 171.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.9 70.52 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.49 -0.756 . . . . 0.0 112.623 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -152.47 174.21 14.17 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.048 1.339 . . . . 0.0 111.271 170.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.8 p -61.32 -24.64 66.58 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.876 1.27 . . . . 0.0 113.873 170.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -56.88 -32.33 65.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.013 1.325 . . . . 0.0 113.618 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.35 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.818 1.247 . . . . 0.0 112.114 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.04 -40.81 64.21 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.427 1.091 . . . . 0.0 111.418 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -66.81 -30.28 70.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.026 1.331 . . . . 0.0 112.97 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.56 -11.58 60.48 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.724 1.61 . . . . 0.0 113.789 174.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -110.94 3.63 18.95 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.539 1.935 . . . . 0.0 111.962 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.32 90.02 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.77 1.652 . . . . 0.0 115.093 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 t -83.43 156.76 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.827 1.651 . . . . 0.0 109.248 173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.5 p -115.3 156.17 25.93 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.228 1.011 . . . . 0.0 110.064 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.67 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -70.15 137.34 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 121.181 -0.949 . . . . 0.0 110.246 174.147 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -121.29 -60.85 1.59 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 125.576 1.55 . . . . 0.0 109.664 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -133.03 171.84 13.44 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.812 1.245 . . . . 0.0 112.687 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -100.45 168.95 9.42 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.864 2.466 . . . . 0.0 111.971 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.11 168.49 10.79 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.983 1.754 . . . . 0.0 112.953 -170.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.3 t -58.64 128.98 39.92 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.578 -0.954 . . . . 0.0 110.416 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.88 139.8 91.04 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.001 1.72 . . . . 0.0 110.725 -174.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.81 179.29 4.38 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.248 2.632 . . . . 0.0 112.498 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.4 m 65.78 30.32 10.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.146 1.379 . . . . 0.0 111.467 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.08 -8.04 0.04 OUTLIER Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.341 1.448 . . . . 0.0 115.785 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.9 tt . . . . . 0 C--O 1.255 1.35 0 C-N-CA 125.818 1.647 . . . . 0.0 113.339 173.04 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.4 tttt . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 120.888 0.375 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -98.45 -21.56 16.49 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.4 138.63 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.761 2.024 . . . . 0.0 109.695 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 94.2 m -76.79 157.38 31.64 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.14 0.576 . . . . 0.0 111.885 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.33 168.78 15.22 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.417 0.687 . . . . 0.0 112.275 170.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.67 154.25 80.54 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.207 1.403 . . . . 0.0 111.826 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.46 169.44 22.4 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.275 2.65 . . . . 0.0 112.595 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -102.87 56.02 0.76 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.623 1.569 . . . . 0.0 111.925 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.8 tt -129.4 143.65 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.854 1.662 . . . . 0.0 111.584 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 tp -93.11 42.65 1.1 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.469 1.508 . . . . 0.0 111.91 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -123.65 66.58 37.09 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 126.483 1.913 . . . . 0.0 111.536 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.95 167.54 19.49 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.537 2.158 . . . . 0.0 112.941 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.684 ' HB ' HD11 ' A' ' 34' ' ' ILE . 26.5 m -136.55 170.02 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 127.919 2.487 . . . . 0.0 111.252 -177.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.5 t -110.41 115.61 29.97 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.389 1.476 . . . . 0.0 110.818 176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.43 170.5 42.15 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 122.488 1.049 . . . . 0.0 112.546 173.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 t -77.49 -13.73 59.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.839 1.256 . . . . 0.0 111.104 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.36 -13.52 59.81 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.978 1.311 . . . . 0.0 112.471 171.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.07 60.97 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.953 1.739 . . . . 0.0 115.547 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.55 166.75 11.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.169 1.388 . . . . 0.0 111.427 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.6 m -92.48 139.24 30.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.88 1.672 . . . . 0.0 111.813 174.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -135.76 138.49 42.71 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.672 1.589 . . . . 0.0 110.454 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.66 -26.34 67.0 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -158.5 174.44 15.09 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.394 1.478 . . . . 0.0 111.98 167.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.0 t -67.62 -14.43 62.94 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.281 1.432 . . . . 0.0 114.683 171.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 t -69.39 -23.91 63.79 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 120.589 -1.319 . . . . 0.0 113.939 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.02 -47.55 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.996 1.318 . . . . 0.0 113.881 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.16 37.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.836 0.826 . . . . 0.0 111.557 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -79.2 -22.88 44.29 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.939 1.296 . . . . 0.0 113.887 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.38 -21.4 59.68 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.388 1.475 . . . . 0.0 112.719 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -94.27 -27.08 16.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.089 1.356 . . . . 0.0 112.119 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.26 0.23 16.5 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.25 1.881 . . . . 0.0 115.312 173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.26 161.29 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 126.032 1.733 . . . . 0.0 109.255 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.3 p -119.5 154.59 33.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.111 0.965 . . . . 0.0 110.183 171.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.684 HD11 ' HB ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -69.91 140.71 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.256 -0.902 . . . . 0.0 110.794 176.633 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.9 -62.22 1.13 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.579 1.552 . . . . 0.0 109.919 -176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.5 m -128.37 164.33 22.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.384 1.474 . . . . 0.0 111.995 -177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 167.4 11.1 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.629 2.372 . . . . 0.0 112.697 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.28 166.66 7.4 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.431 1.967 . . . . 0.0 113.95 -171.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -63.68 128.03 33.99 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.616 -0.932 . . . . 0.0 110.547 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.19 142.57 44.16 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.649 1.18 . . . . 0.0 112.036 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -71.81 167.12 27.46 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.278 2.652 . . . . 0.0 112.695 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.3 p -75.82 -9.12 58.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.088 1.355 . . . . 0.0 114.176 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.51 10.9 30.24 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.458 1.504 . . . . 0.0 114.959 -177.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.7 tt . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.929 1.692 . . . . 0.0 113.668 176.244 . . . . . . . . 0 0 . 1 stop_ save_